Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40058,0.195230217190284,0.0049326537074386,0.185562215923705,0.204898218456864,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCG,Pro-glucagon,39477,0.451281090495294,0.0113175337775318,0.429098724291331,0.473463456699256,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,39882,0.255408772405667,0.00464736822925177,0.246299930676333,0.264517614135,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFGE8,Lactadherin,39858,0.220382544981685,0.00385162205948264,0.212833365745099,0.227931724218271,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,-0.102486652018108,0.00259665095977114,-0.10757608789926,-0.0973972161369568,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,-0.113425694283395,0.00295261448174978,-0.119212818667625,-0.107638569899166,1.4058974546208e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37437,0.289815069608254,0.0076015599677267,0.27491601207151,0.304714127144999,3.04109186217639e-302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37437,0.140861371857363,0.00371669839524636,0.13357664300268,0.148146100712045,7.23628102708782e-299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,0.0981273804556871,0.00270001789954465,0.0928353453725796,0.103419415538795,6.96655600663451e-278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS8,Prostasin,39805,0.130968945527959,0.00373004169590398,0.123658063803988,0.138279827251931,3.22144681250778e-260
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40030,0.214821851105364,0.00617347273312314,0.202721844548443,0.226921857662286,6.57459036133998e-256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,39585,0.197834630155709,0.00599549919921475,0.186083451725248,0.20958580858617,6.1757750533748e-231
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,39868,-0.14509911756829,0.00441882801679586,-0.153760020481209,-0.13643821465537,6.46732631260401e-229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,39839,0.0885924379761836,0.00270043697071382,0.0832995815135846,0.0938852944387827,1.67086559537796e-228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KITLG,Kit ligand,39868,-0.112830565360082,0.00346675282500887,-0.1196254008971,-0.106035729823065,4.73383349815895e-225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.20100949397818,0.00622465155426714,0.188809176931816,0.213209811024543,1.16984031257522e-221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN1,CCN family member 1,39758,0.230201487398951,0.00714457979315047,0.216198111004376,0.244204863793525,1.06971234291446e-220
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,39854,0.238244681058051,0.00744601451270584,0.223650492613147,0.252838869502954,8.47323853842692e-218
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,39976,-0.105976779841609,0.00336466782821615,-0.112571528784913,-0.0993820308983052,2.31124231549012e-211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,39868,0.178835919678469,0.00586779986681082,0.16733503193952,0.190336807417418,2.29813526221522e-198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,0.134046449176426,0.00443908210622262,0.125345848248229,0.142747050104622,6.83943310811445e-195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,0.144492929148383,0.00478910351956336,0.135106286250038,0.153879572046727,2.02905902237592e-194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYY,Peptide YY,37021,0.258381371843265,0.00866519680681225,0.241397586101913,0.275365157584617,4.08398594313373e-189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.147762452068836,0.00503067800891321,0.137902323171366,0.157622580966306,9.84915852181104e-185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37445,-0.0714614602990477,0.00243938365996343,-0.076242652272576,-0.0666802683255194,5.54302380199303e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40052,0.115464949561131,0.003994360910749,0.107636002176063,0.123293896946199,3.36511715048899e-179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.086286771763266,0.00298469904644276,0.0804367616322382,0.0921367818942938,3.78611740225798e-179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,39868,0.167053206934926,0.00581207823784819,0.155661533588744,0.178444880281109,3.45336953513445e-177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FURIN,Furin,39913,0.0913366320355524,0.00318899339059654,0.0850862049899832,0.0975870590811216,5.33554601759609e-176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40009,0.156991897420788,0.00554553228924522,0.146122654133868,0.167861140707709,4.08565741932353e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.165999001709002,0.00589672690059419,0.154441416983837,0.177556586434166,3.99444450811762e-170
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37039,0.209369750146376,0.00754235421725468,0.194586735880557,0.224152764412195,7.104477653439e-165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.103009806259432,0.00374464192384546,0.095670308088695,0.110349304430169,9.62115710977986e-163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.0847556084437017,0.00308690441739515,0.0787052757856072,0.0908059411017962,2.98771003387691e-162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40009,0.354465194291232,0.0130922835831271,0.328804318468303,0.380126070114161,6.48262284288532e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.117778232668704,0.00439158348582696,0.109170729036483,0.126385736300925,5.52540454703448e-155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSD,Cathepsin D,38721,0.0991273417946593,0.00369829508991295,0.0918786834184299,0.106376000170889,1.35561571724423e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,39931,0.103823943364509,0.00388805750223459,0.0962033506601293,0.111444536068889,9.56440485094716e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,39788,0.224763095360763,0.00842066398749413,0.208258593945274,0.241267596776251,1.37096795153451e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,-0.0764256894116913,0.00288027268435037,-0.082071023873018,-0.0707803549503645,7.41600819269557e-152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.107020393502225,0.00403783304673269,0.0991062407306292,0.114934546273821,1.47585355933661e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,37453,-0.166077033899373,0.00625393873021054,-0.178334753810586,-0.15381931398816,1.57040691134924e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGF,Placenta growth factor,40058,0.0640251704880959,0.00243412037233885,0.0592542945583117,0.06879604641788,2.3720177288887e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,39788,0.139212413002475,0.00529257973728368,0.128838956717399,0.149585869287551,2.66343922536628e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0863350924302,0.00329236889139193,0.0798820494030719,0.0927881354573282,1.9200831660718e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0747737765248557,0.00284969357623676,-0.0803591759342798,-0.0691883771154317,5.48249812166496e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MVK,Mevalonate kinase,39587,0.195274939848604,0.00748771453910046,0.180599019351967,0.209950860345241,8.1151474508627e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,0.122610788561942,0.00470898260735587,0.113381182651525,0.13184039447236,2.30759785454241e-146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.207250178897685,0.00797914101145794,0.191611062515228,0.222889295280143,1.13064936916477e-145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40058,0.0833479900651784,0.00321660133977131,0.0770434514392266,0.0896525286911302,4.36349969515853e-145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,39919,0.14325713044905,0.00555838200228702,0.132362701724567,0.154151559173533,1.4482858415869e-143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS4,Galectin-4,39862,0.128165955136423,0.00499182205187915,0.11838198391474,0.137949926358106,1.67397739459802e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,39839,0.117310092007747,0.00458984520869933,0.108313995398696,0.126306188616797,2.98798410836768e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,0.072961049475185,0.00285822929562934,0.0673589200557514,0.0785631788946185,6.47895789735647e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.130542959303664,0.00511645532518804,0.120514706866296,0.140571211741033,9.1925853692866e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0816497656471621,0.00321066233700014,0.0753568674666418,0.0879426638276823,6.38601896342348e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40052,0.124666512105585,0.00493938078890009,0.114985325759341,0.134347698451829,6.78633398662309e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37437,0.219903485727724,0.00873011684955322,0.2027924567026,0.237014514752848,7.15910629850293e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,0.0761069503765377,0.00303144000579507,0.0701653279651794,0.082048572787896,7.28831862940447e-136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.34241877998976,0.0137211735628778,0.31552527980652,0.369312280173001,7.71678293900432e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9,Complement component C9,37445,-0.12577407449206,0.005038300262213,-0.135649143005998,-0.115899005978123,1.59835085364107e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40011,0.278018929592101,0.0113064006859009,0.255858384247736,0.300179474936467,4.1649576005768e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.196954760762497,0.00800660394639538,0.181261817027563,0.212647704497432,9.53503874903896e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,0.129645235647614,0.00528744727248074,0.119281838993552,0.140008632301677,6.21430191890122e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40030,0.076707216422396,0.00314419781874892,0.0705445886976481,0.0828698441471439,3.98580427122835e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,39841,0.196206246886764,0.00805549072702255,0.180417485061799,0.211995008711728,1.07719493685284e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOM,Apolipoprotein M,39908,-0.0615819763313522,0.00252972035736384,-0.0665402282317853,-0.0566237244309191,1.44562568640987e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F7,Coagulation factor VII,39899,0.0686704267649953,0.00284149015344518,0.0631011060642427,0.0742397474657478,9.04161225401669e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0955160537337392,0.00397091376620147,0.0877330627519843,0.103299044715494,1.39416558109365e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,0.185327699553022,0.00771768504156816,0.170201036871548,0.200454362234495,3.3534581845952e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,39840,-0.102748305552081,0.0042918331182188,-0.11116029846379,-0.0943363126403725,1.79064500575683e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,39749,0.0815495136286729,0.00340658344325066,0.0748726100799015,0.0882264171774442,1.91245508142852e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0843146423141533,0.00354112518103597,0.0773740369593228,0.0912552476689838,9.68551788010017e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,39858,0.0532213728274308,0.00225286112718009,0.0488057650181578,0.0576369806367038,2.59244115940892e-121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.171391562585836,0.00728985681270904,0.157103443232926,0.185679681938746,7.84441390831172e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0808116741926167,0.00344871773201676,0.0740521874378638,0.0875711609473696,1.92484188145036e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0501186672059399,0.00214179753094205,0.0459207440452935,0.0543165903665863,4.17427426759614e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,0.0580880564858348,0.00248875798658791,0.0532100908321225,0.0629660221395471,1.61073766335075e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.121412421408194,0.00520107292220024,0.111218318480682,0.131606524335707,1.63789772792532e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.199019148825998,0.00864119530681375,0.182082406024643,0.215955891627353,1.82396327511433e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,0.164673936664566,0.00715396006737348,0.150652174932514,0.178695698396618,2.45732035412657e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBP,Protein AMBP,40003,0.0422286633435209,0.0018368111146318,0.0386285135588426,0.0458288131281992,4.09640900824336e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0846832201710586,0.00367687737869865,0.0774765405088093,0.0918898998333079,4.1085584324625e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0657599086307487,0.00286129874571103,0.0601517630891551,0.0713680541723423,5.14038428703109e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40052,0.0946536092015608,0.00412094457056895,0.0865765578432457,0.102730660559876,6.50309161008519e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,39979,0.129235332626451,0.00563157512488282,0.118197445381681,0.140273219871222,1.0475712593034e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0675013229421661,0.00295523219021367,0.0617090678493473,0.0732935780349849,1.13882337596644e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,0.0788880696332322,0.00345774888870187,0.0721108818113766,0.0856652574550879,2.19214298742591e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40058,0.0698025190632072,0.00309671805338335,0.0637329516785758,0.0758720864478385,8.31677248209263e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.127073299728539,0.00564029320600432,0.11601832504477,0.138128274412307,1.22678991143722e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F9,Coagulation factor IX,39908,0.0389168584356078,0.00173186480365408,0.0355224034204458,0.0423113134507698,3.95884691538701e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH2,Cadherin-2,39868,0.0749157435821514,0.00333722652063403,0.0683747796017087,0.0814567075625941,6.53951988451333e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,39984,0.103216206693403,0.0046819534719402,0.0940395778884003,0.112392835498406,3.87762873217722e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MME,Neprilysin,39788,0.164743878806347,0.00748698721528283,0.150069383864393,0.179418373748301,9.8537983783624e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC13,Mucin-13,39489,0.105851078522839,0.00481412536523815,0.0964153928069718,0.115286764238705,1.4982811524877e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.102778333886101,0.00467457481386162,0.0936161672509318,0.111940500521269,2.89965725813634e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST3,Cystatin-C,39897,0.0555277724910265,0.00253059708953566,0.0505678021955366,0.0604877427865164,3.57898895587594e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0707046712843198,0.00322269304399878,0.0643881929180822,0.0770211496505574,3.71928759454926e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,39866,0.0957260813664096,0.004367627734,0.0871655310077696,0.10428663172505,6.19200291474403e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.181021724807195,0.0082631444052661,0.164825961772873,0.197217487841517,7.80403427920978e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN2,Nectin-2,39846,0.0587073462326081,0.00268537966073897,0.0534440020975597,0.0639706903676565,2.02087240457299e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OCLN,Occludin,37411,0.089485472183249,0.0040978958506224,0.0814535963160291,0.0975173480504689,6.34705941998917e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39477,0.159019615971282,0.00729250062031081,0.144726314755473,0.173312917187091,7.18856524237755e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,0.0446254641890676,0.00205183186186145,0.0406038737398191,0.048647054638316,2.18049879551236e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS9,Galectin-9,39859,0.0651125797337694,0.00299593616131363,0.0592405448575947,0.0709846146099441,3.05835088596773e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,0.0730180623316799,0.00337331354991724,0.0664063677738421,0.0796297568895176,1.98319165628207e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40030,-0.0723554403433627,0.0033435840621854,-0.0789088651052461,-0.0658020155814793,2.12825058520481e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.145529063699003,0.00678064470222833,0.132239000082636,0.158819127315371,1.62256752060921e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,39955,0.0701945245241907,0.00328017388154895,0.0637653837163547,0.0766236653320266,3.33982204440629e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,0.0562284853023048,0.00262739251002352,0.0510787959826587,0.0613781746219509,3.42569775495562e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0558387001408332,0.0026160811817397,0.0507111810246234,0.060966219257043,1.07521920155124e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0965847652684926,0.00453045317774295,0.0877050770401164,0.105464453496869,3.47181192263948e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0565337690736888,0.00267047294377295,0.0512996421038938,0.0617678960434838,3.93825471250226e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYNU,Kynureninase,40058,0.0915714108531124,0.00433408398788554,0.0830766062368567,0.100066215469368,9.09764343441102e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0660622072701432,0.00313291064002167,0.0599217024157007,0.0722027121245857,2.22232525323981e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40003,0.0657150663496124,0.00313312828445597,0.0595741349120787,0.0718559977871461,2.16859600397963e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,39868,0.0510084961891319,0.00243190367151664,0.0462419649929593,0.0557750273853045,2.20186744260124e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37088,0.0758563547651307,0.0036131247939588,0.0687746301689715,0.08293807936129,2.70859007463327e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,39866,0.111244423981629,0.00532276085743207,0.100811812701062,0.121677035262196,1.01832025135188e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MENT,Protein MENT,37124,-0.0444255885811236,0.00212459277947351,-0.0485897904288917,-0.0402613867333555,1.49470923240209e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,39866,-0.0675078186731243,0.00324127021576641,-0.0738607082960265,-0.0611549290502221,4.42623400033708e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRN,Agrin,39931,0.0646505313029601,0.00310926149859676,0.0585563787657104,0.0707446838402097,8.85193260271451e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.163919380257925,0.00789192050919523,0.148451216059902,0.179387544455948,1.51159463853006e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,0.0629015368803917,0.00303372375228803,0.0569554383259072,0.0688476354348762,4.85564067575833e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,39931,0.129702320379075,0.00628326709101614,0.117387116880683,0.142017523877467,1.85381325146696e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0389426890231806,0.0018876031504906,-0.0426423911981421,-0.035242986848219,2.40675568587709e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.241429812155896,0.0117073920292136,-0.264376300533154,-0.218483323778637,2.76130292515148e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0756894642258018,0.00366866793275223,0.0684988750776075,0.0828800533739962,3.87622191112673e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.106908043945784,0.00519170655076305,0.0967322991062882,0.117083788785279,5.43011226790649e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFASC,Neurofascin,40058,0.0543727752056795,0.00264213443691792,0.0491941917093204,0.0595513587020386,6.49999914335992e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0621167191282499,0.00303158552788385,0.0561748114935976,0.0680586267629023,4.00859266740598e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.106044183376585,0.00520239471488316,0.0958474897354142,0.116240877017756,3.60692849359786e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,39720,0.0537350899625203,0.0026397722294638,0.0485611363927712,0.0589090435322693,5.95540905807475e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40030,0.0545724893646454,0.00268215365143441,0.0493154682078339,0.0598295105214568,6.83217611477027e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37437,0.0549118141795417,0.0026994833272692,0.0496208268580941,0.0602028015009894,1.22929960017686e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0745900016405843,0.00367267833014357,0.0673915521135029,0.0817884511676657,1.42533864492461e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0567345113597437,0.00279763651093813,0.051251143798305,0.0622178789211824,2.64811261656405e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,39826,0.193216861919397,0.00954056081156636,0.174517362728727,0.211916361110067,4.59005018052876e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,0.0718012733090654,0.00355496046943965,0.0648335507889637,0.0787689958291671,1.30979115434438e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0575318524824052,0.00284780099447034,0.0519501625332433,0.0631135424315671,1.99510471014379e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELE,E-selectin,40052,0.0958157602370358,0.00475006036469109,0.0865056419222412,0.10512587855183,2.18093112861428e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSO,Cathepsin O,40058,0.0576176795204908,0.00285704164317898,0.05201787789986,0.0632174811411216,2.38493453350485e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40030,0.24796643635948,0.0123043436460249,0.223849922813271,0.272082949905689,3.16559934416569e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40009,-0.0409645843459037,0.002033681449691,-0.044950599987298,-0.0369785687045093,3.84370104589422e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.104358709062811,0.00518760941497348,0.0941909946094633,0.114526423516159,6.65540226962265e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,39974,0.0487730898251037,0.00243183699003157,0.0440066893246418,0.0535394903255656,2.13682077782002e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.150251121522412,0.0075797643279743,0.135394783439582,0.165107459605241,2.08467673696563e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,39486,0.0544890674905539,0.00275070576962921,0.0490976841820807,0.0598804507990272,2.83656154177176e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,39913,0.0498356218694925,0.00252364890425143,0.0448892700171597,0.0547819737218253,8.78196009665547e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FETUB,Fetuin-B,39908,0.0634688243301378,0.0032173728646171,0.0571627735154883,0.0697748751447874,1.30679122053473e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37051,0.0489940477309819,0.00249034327254585,0.044112974916792,0.0538751205451718,5.96496081065639e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.037246180239318,0.0019019059467684,0.033518444583652,0.0409739158949841,2.08624050331869e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40030,-0.0308646205430761,0.00157921061217435,-0.0339598733429379,-0.0277693677432144,4.29813252026382e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,0.0710615631188204,0.00363720323966322,0.0639326447690805,0.0781904814685603,5.04245085410085e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0943325124538968,0.00483848942789468,0.0848490731752233,0.10381595173257,1.10170784480782e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.134008280207158,0.00687491852749356,0.120533439893271,0.147483120521045,1.21296895405394e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0498995979903004,0.00256587764879887,0.0448704777986546,0.0549287181819462,2.77459730870787e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELN,Elastin,37437,0.0625260099725469,0.00321441242176963,0.0562257616258784,0.0688262583192154,3.79791229611367e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG2,Desmoglein-2,39858,-0.0494261565576207,0.00254799471579183,-0.0544202262005727,-0.0444320869146687,7.16146151331692e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,39858,0.0766986390095268,0.00395822972655233,0.0689405087454842,0.0844567692735693,1.06825424809513e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AREG,Amphiregulin,39788,0.0865244900568214,0.00446530889118785,0.0777724846300932,0.0952764954835496,1.07757908818777e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,0.0474869792037374,0.00244802996399145,0.0426888404743142,0.0522851179331607,1.08824421988131e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,39865,0.0573154234982816,0.0029644639286253,0.0515050741981761,0.0631257727983872,2.40499023630122e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0677341684980291,0.00351232276237514,0.0608500158837738,0.0746183211122843,6.12764588416163e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,39866,0.0840448333302111,0.00436377423622713,0.075491835827206,0.0925978308332163,9.83565330491848e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.152919167305693,0.00794431753700026,0.137348304933173,0.168490029678214,1.27013575501187e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0623251782532668,0.00324415973770342,-0.0686837313391655,-0.055966625167368,2.38110378514844e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0709141605300724,0.00370596990384851,0.0636504595185293,0.0781778615416155,1.04021311442263e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.109615781354335,0.00572997137894122,0.0983850374516101,0.12084652525706,1.10331703651976e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.0636070853000185,0.00332508546071318,0.0570899177970206,0.0701242528030163,1.1405262031709e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,39858,-0.0666278628461282,0.00349963985268891,-0.0734871569573985,-0.0597685687348579,6.25577251334765e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0486938457102523,0.00255820983756326,0.0436797544286283,0.0537079369918763,6.84581720510556e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37124,0.0494826043877127,0.00259815598859365,0.0443902186500692,0.0545749901253563,8.32365302899485e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.0946955127271674,0.00500866737810957,0.0848785246660726,0.104512500788262,1.04684341021675e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,-0.0589651463399015,0.00312716817349408,-0.0650943959599499,-0.0528358967198531,1.84986607509857e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40058,0.0741314487658186,0.00393631109191417,0.0664162790256668,0.0818466185059703,2.79033574385754e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.110364160323608,0.00586061219932637,0.0988773604129288,0.121850960234288,2.94684176133723e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0916641511688574,0.00486720450422345,0.0821244303405795,0.101203871997135,2.97786119126927e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.0765939035297669,0.00406783952299747,0.0686209380646919,0.0845668689948419,3.02644285233357e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOD,Apolipoprotein D,36780,-0.0783094440590677,0.00415745242227575,-0.0864580508067282,-0.0701608373114073,4.24978190408758e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOT,Angiomotin,37124,0.0746109387506577,0.00396212120378718,0.0668451811912349,0.0823766963100806,4.37100029756549e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37124,0.114550578553182,0.00608896097186388,0.102616215048329,0.126484942058035,6.11130096312334e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0499772359141935,0.00267902755916266,0.0447263418982347,0.0552281299301523,7.5067317260121e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,39866,0.0717405204811769,0.00386373918227983,0.0641675916839084,0.0793134492784454,3.70097425043638e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0471540157552246,0.00254207554418144,0.0421715476886289,0.0521364838218202,5.16321884873631e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,39866,0.0945144125387537,0.00509867726743007,0.0845210050945908,0.104507819982917,6.46150801580609e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,39866,0.0935713170578232,0.00505142263260415,0.0836705286979191,0.103472105417727,8.2289651483005e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.101018139528637,0.00546134459770747,0.0903139041171301,0.111722374940143,1.86321712781761e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0637591186969043,0.00345216359341461,0.0569928780538117,0.070525359339997,2.16547171619353e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.087614333311143,0.00475113080948751,0.0783021169245475,0.0969265496977385,3.72942777208815e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,39749,0.0878634012489346,0.00476847208975077,0.0785171959530231,0.0972096065448461,4.91979953481944e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.187289156822361,0.0101830623039386,0.167330354706641,0.20724795893808,9.0050665407771e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37386,0.0488174628819479,0.0026519654443509,0.0436196106110202,0.0540153151528757,9.24788150592988e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,39995,0.0659316022971336,0.00358534198807639,0.0589043320005039,0.0729588725937633,9.29715365157728e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,0.0922929021665719,0.00502497694711309,0.0824439473502302,0.102141856982914,1.41327570401432e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,-0.045073380785759,0.00245476003272785,-0.0498847104499056,-0.0402620511216124,2.11227064175214e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39464,0.103054695696994,0.00564964538255853,0.0919813907471796,0.114128000646809,1.41943026102798e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40058,0.133782683678564,0.00734269402920467,0.119391003381323,0.148174363975806,1.94304393803259e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UMOD,Uromodulin,40012,-0.091593687038376,0.00504017380728115,-0.101472427700647,-0.081714946376105,4.53384926389948e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0366603115010407,0.00202415653304118,0.03269296469628,0.0406276583058014,1.35471103994296e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS2,Trypsin-2,39931,0.0886983451902815,0.00491598817470902,0.0790630083678518,0.0983336820127111,4.61513736295325e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0600151593438649,0.00332879688661958,0.0534907174460905,0.0665396012416392,5.92655566981157e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,39858,0.0620255013912041,0.00344565761378297,0.0552720124681895,0.0687789903142188,9.74473537177504e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.117515268634999,0.00654532683430338,0.104686428039765,0.130344109230234,3.14790361770157e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0445751390888198,0.00248683445738398,0.0397009435523472,0.0494493346252924,5.03305137555538e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,39993,0.0975419782196866,0.00545170808551347,0.0868566303720802,0.108227326067293,6.5900125424728e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40011,0.0460130810136105,0.00257299222612257,0.0409700162504102,0.0510561457768107,7.69400632709157e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,-0.108225234267925,0.00605165778750945,-0.120086483531444,-0.0963639850044067,7.80025358505957e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHK,Ketohexokinase,37043,0.11121047394803,0.00621450882745346,0.0990300366462217,0.123390911249839,8.80381317811239e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100P,Protein S100-P,39585,0.0891811724210981,0.00502687162527387,0.0793285040355613,0.0990338408066349,9.68567376492605e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.109849758263003,0.00619086028054453,0.0977156721131354,0.12198384441287,1.17361549159364e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37382,0.121809634221638,0.00686806784725833,0.108348221241011,0.135271047202264,1.36362914139649e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37437,0.0747947291533801,0.00421993578867482,0.0665236550075774,0.0830658032991827,1.65364388908936e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOA,Elongin-A,39788,0.0865623514349473,0.00488908627941416,0.0769797423272955,0.096144960542599,1.76875774024684e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,39858,0.095671342098498,0.00541275065042725,0.0850623508236606,0.106280333373335,2.96401174347687e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,39738,0.0623277184626279,0.00353595519644613,0.0553972462775935,0.0692581906476623,6.94024336293974e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,39963,0.115308781622611,0.00655543297187538,0.102460132997736,0.128157430247487,1.29149322929966e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,37453,-0.046106657726566,0.0026207829169395,-0.0512433922437674,-0.0409699232093645,1.60709634685738e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.0879036282991228,0.00500336700502866,0.0780970289692667,0.097710227628979,1.84683781668616e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0966349903068165,0.00550923311476988,0.0858368934018676,0.107433087211765,4.1619337019122e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,39904,0.0559402324954259,0.00319372837225188,0.0496805248858123,0.0621999401050396,4.6755156391659e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD27,CD27 antigen,39913,0.0651503256079613,0.00372043282961226,0.0578582772619212,0.0724423739540013,5.019154112378e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0672295469673833,0.00383945126980143,0.0597042224785725,0.0747548714561941,5.15780297951625e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HJV,Hemojuvelin,37411,0.0746773580474274,0.00426193559816958,0.066323964275015,0.0830307518198398,5.46604097640593e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37124,0.0484046177702209,0.00276515628664778,0.0429849114483913,0.0538243240920506,7.55846201003021e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,39788,0.122012231150872,0.00698012940508373,0.108331177516908,0.135693284784837,8.74012546997851e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.113137792589716,0.00648232550628772,0.100432434597393,0.12584315058204,1.42232945989221e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40052,0.0958367685696837,0.00549616200829129,0.0850642910334328,0.106609246105935,1.78509873594803e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,39931,0.0491141766894106,0.00283087286876888,0.0435656658666236,0.0546626875121976,8.08195058376728e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCA,Calcitonin,39713,0.100991546020327,0.0058327494028801,0.0895593571906823,0.112423734849972,1.49463697842344e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0575486213407505,0.00332588157098846,-0.0640673492198879,-0.0510298934616131,1.78824689778752e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EZR,Ezrin,40009,0.0397393139192677,0.0022994102060892,0.0352324699153328,0.0442461579232025,2.5209685424594e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXN,Paxillin,39489,0.0853984627532968,0.0049422582903575,0.075711636504196,0.0950852890023975,2.78276968318873e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_E,,39866,0.0452715835690525,0.00262076377337266,0.040134886573242,0.0504082805648629,2.93382898724237e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,0.128507711803655,0.00745330708208805,0.113899229922763,0.143116193684548,5.0960202741224e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,39991,0.0632235067189413,0.00368169797164627,0.0560073786945146,0.0704396347433679,1.63372951459633e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,0.103891290325959,0.00604993563596672,0.0920334164794644,0.115749164172454,1.65296471307388e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37424,0.0464780399131507,0.0027047182734527,0.0411767920971834,0.051779287729118,1.72270028282256e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0585625812577423,0.00342146193076022,0.0518565158734523,0.0652686466420324,4.58661771414749e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFI,Complement factor I,37453,0.0327947028193956,0.0019170403723848,0.0290373036895214,0.0365521019492698,6.2908893364495e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40009,0.0684130469305447,0.0040128410370889,0.0605478784978504,0.0762782153632389,1.31677968558044e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDK,Midkine,39843,0.082174738205823,0.00484144757280433,0.0726855009631266,0.0916639754485195,4.72063037351096e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18,Interleukin-18,39795,0.073936843358386,0.00435787837007362,0.0653954017530417,0.0824782849637303,5.32099002878658e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0730197338926294,0.00430455381337895,0.0645828084184067,0.0814566593668522,7.27368801455538e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.169287008069943,0.00999775475508914,0.149691408749968,0.188882607389918,9.37438717054169e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,0.123428528518654,0.00728502731601857,0.109149874979258,0.137707182058051,1.01697054985447e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,0.0981327998926372,0.00580103136846549,0.0867627784104448,0.10950282137483,1.21557038044738e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,39749,0.054225295457087,0.00321249443127835,0.0479288063717815,0.0605217845423926,2.27010010704179e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,39875,0.0759272775866033,0.00451586015262857,0.0670761916874513,0.0847783634857553,6.73119130648131e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,39931,0.104851221598957,0.00624049906088843,0.0926198434396154,0.117082599758298,8.14133134290404e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37296,0.0446386045425122,0.00265650321521821,0.0394318582406845,0.0498453508443399,1.00361518806714e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37388,0.0608526652764758,0.00363154355873579,0.0537348399013537,0.067970490651598,2.15148141160961e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.139551743713415,0.00833496912801292,0.12321520422251,0.15588828320432,2.23903500720022e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0705228000652603,0.00421776847152601,0.0622559738610693,0.0787896262694513,3.15699124988685e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,0.106698131269515,0.00639520210471471,0.0941635351442742,0.119232727394756,5.64890788176731e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,0.0952430602290432,0.0057137454228731,0.0840441192002119,0.106442001257874,7.34656590079036e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40008,0.0930585401611786,0.00559658974937637,0.082089224252401,0.104027856069956,1.4265534462721e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0661249826364506,0.0039781114304341,0.0583278842327997,0.0739220810401014,1.57882694906946e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,39933,0.102534340348858,0.00617087432225492,0.090439426677238,0.114629254020477,1.74255335782248e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMA,Granzyme A,40058,0.0537575187023812,0.00323978408507108,0.0474075418956418,0.0601074955091205,2.51406252908521e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,39555,0.0600728038743534,0.00363151080003039,0.0529550427062938,0.067190565042413,5.98676841959852e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40009,0.0350559335575389,0.00212026852384009,0.0309002072508123,0.0392116598642655,6.64059498461974e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSM,Oncostatin-M,39785,0.113099976912518,0.00684178947073757,0.0996900695498721,0.126509884275163,7.08214089383256e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,0.0357157750375831,0.00216125502649921,0.0314797151856446,0.0399518348895215,9.72277097766435e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,39644,-0.0849688346814022,0.00515674993688579,-0.0950760645576984,-0.0748616048051061,1.71139886654654e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40009,0.122328267892345,0.00745503899852186,0.107716391455243,0.136940144329448,5.06127684990949e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0452631058100486,0.00275880294424514,-0.0506703595807691,-0.0398558520393281,5.26539042611276e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG2,Secretogranin-2,39949,0.0487771756388309,0.00298185723807246,0.0429327354522088,0.0546216158254529,1.15615610305579e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,0.172887534269312,0.0105730752260798,0.152164306826195,0.193610761712428,1.32312812761124e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37043,0.0819532418047418,0.00501050537493091,0.0721326512698772,0.0917738323396064,1.51229194435482e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0855703556130874,0.00524468870066067,0.0752907657597925,0.0958499454663823,2.30262534084816e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,39866,0.0909575559511027,0.00558391387725864,0.0800130847516758,0.10190202715053,3.52239303134311e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40009,0.0829971371406163,0.00509934080086914,0.0730024291709127,0.0929918451103198,4.31088240407739e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0423576506206207,0.00260426005984378,0.0372533009033269,0.0474620003379145,5.35591530508907e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.047761330539079,0.00294227354945989,0.0419944743821376,0.0535281866960203,1.05956275056506e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,0.0497286303033457,0.00306735545487521,0.0437166136117903,0.0557406469949011,1.19707463902576e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,39866,0.0972370680122519,0.00601584469332636,0.0854460124133323,0.109028123611172,2.64072164035993e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37124,0.0645644931236313,0.00399467038279153,0.0567349391733599,0.0723940470739027,3.32410067597437e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,0.144713093270275,0.008970912404059,0.12713010495832,0.162296081582231,4.40914868069236e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,0.0607818481053667,0.00377106820149845,0.0533905544304298,0.0681731417803037,5.45536861011514e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37368,0.0678442608334285,0.00421388897136829,0.0595850384495467,0.0761034832173104,8.77042807116291e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.0517712413196096,0.00322296384160031,0.045454232190073,0.0580882504491462,1.30303501327e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,39798,0.0467850663469399,0.00291549917690443,0.0410706879602072,0.0524994447336726,1.6919021929585e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,39803,0.046104401620772,0.0028739026535972,0.0404715524197215,0.0517372508218226,1.81873136305111e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREG1,Protein CREG1,39660,0.0576622780643369,0.00359997789173158,0.050606321396543,0.0647182347321308,2.72886462395691e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBKS,Ribokinase,39504,0.0759398567794,0.00475443935429554,0.0666211556449808,0.0852585579138193,5.61176463155437e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.113281351683372,0.00709991696621869,0.099365514429583,0.12719718893716,7.23422974621944e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40030,0.0701469579088809,0.00439873559298392,0.0615254361466324,0.0787684796711294,8.09413227585529e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0929403985637968,0.00582359014819408,-0.104354635254257,-0.0815261618733364,8.3495705788742e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAXX,Protein PAXX,37124,0.0705441647018242,0.00442379346024462,0.0618735295197447,0.0792147998839036,1.01289072996332e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.0527059099449047,0.00331094668514552,0.0462164544420195,0.0591953654477899,1.27479483198562e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0499547478367768,0.00314427291708524,0.0437919729192897,0.0561175227542638,2.08595909545184e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.091180681945557,0.00573784508258441,0.0799345055836916,0.102426858307422,2.36195885254532e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,39669,0.070343058201989,0.00443240005362005,0.0616555540968937,0.0790305623070843,2.77192739691611e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37437,0.0349640165815269,0.00220269218528749,0.0306467398983634,0.0392812932646904,3.1059012176967e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40009,0.0565231680217017,0.00356550708086288,0.0495347741432104,0.0635115619001929,3.56766930992651e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37124,0.176858284153705,0.0111721547674957,0.154960860809414,0.198755707497997,6.24993698339385e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO3,Beta-enolase,37043,0.0918351742602689,0.00581026935449934,0.0804470463254501,0.103223302195088,9.2373847113158e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.074321381059936,0.0047108973292309,0.0650880222946434,0.0835547398252286,1.18306185071509e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,39984,0.0356654661540522,0.00226089894437788,0.0312341042230716,0.0400968280850328,1.20706413882066e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37382,0.167448114213236,0.0106173740220987,0.146638061129922,0.188258167296549,1.53545849891448e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLN,Promotilin,39866,0.134548122251497,0.00853755144935596,0.117814521410759,0.151281723092235,1.54381512573299e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0422100341802689,0.00268521993388906,0.0369470031098464,0.0474730652506915,2.89799433843765e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.114153173289241,0.00727641815800045,0.0998913936995602,0.128414952878922,5.54147464089114e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFM,Afamin,37453,0.0285251858060287,0.00182519783404925,0.0249477980512922,0.0321025735607652,1.38832554861638e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40002,0.0740484217056991,0.00475140887744104,0.0647356603059146,0.0833611831054835,2.30902380376523e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40058,0.0640979280144364,0.00411623916693908,0.0560300992472358,0.072165756781637,2.79320017893322e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0584106788433517,0.00375271871231157,0.051055350167221,0.0657660075194823,3.16202743073721e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0838526550596015,0.0053916345346634,0.0732850513716613,0.0944202587475418,4.63890299620683e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37043,0.0468538151442561,0.00301487101509808,0.0409446679546638,0.0527629623338483,5.519764391374e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37043,0.0651824654708077,0.00419745346684781,0.056955456675786,0.0734094742658295,6.61862009190032e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,0.148667891870663,0.00959463051917461,0.12986241605308,0.167473367688245,9.49543530744717e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,0.0422624715749816,0.00272834743757253,0.0369149105973394,0.0476100325526237,9.94986335733076e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.042950375552703,0.00277638060699306,0.0375086695629966,0.0483920815424094,1.33912603145574e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0718614598306704,0.00465415867924328,0.0627393088193536,0.0809836108419872,2.10736711315617e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40052,0.0875218192351171,0.0056712926734001,0.0764060855952529,0.0986375528749813,2.37548274952773e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.091726364126772,0.00595317080899592,-0.103394578912404,-0.08005814934114,3.45684942538356e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0557103450138769,0.00361579227086302,0.0486233921629854,0.0627972978647684,3.51038083835346e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,39913,0.0794849703514073,0.00516329788905929,0.0693649064888511,0.0896050342139635,4.28609408156532e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XCL1,Lymphotactin,40030,0.0808069917470668,0.00526051501982178,0.0704963823082161,0.0911176011859175,7.05792471673994e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSS,Cathepsin S,36543,0.0359173928048657,0.00233633904700966,0.0313381682727268,0.0404966173370046,7.39614659192598e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAL,Galanin peptides,39931,-0.0946937756333479,0.00617193331569774,-0.106790764932115,-0.0825967863345803,9.38326067403819e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40030,0.0387164380620325,0.00252485546720905,0.0337677213463028,0.0436651547777622,1.06239538307784e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,0.0994738643952381,0.00648944240198661,0.0867545572873443,0.112193171503132,1.15445522646345e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0546312856732602,0.0035631547548362,0.0476475023537813,0.0616150689927392,1.28598286096365e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0433934512507307,0.00283599392058522,0.0378349031663837,0.0489519993350778,2.1228685152493e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40009,0.0875137041949745,0.00572565578246185,0.0762914188613493,0.0987359895285998,2.25646166632077e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,0.0314691802405503,0.00206007006000591,0.0274314429229387,0.0355069175581619,2.56830248676568e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,39846,0.0423747129536584,0.00277699791704884,0.0369317970362427,0.0478176288710742,3.33621819256266e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0342950279067969,0.00225216880032421,0.0298807770581614,0.0387092787554324,5.37303030693631e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,39931,0.0570158365377119,0.00375370193869133,0.0496585807378769,0.0643730923375469,9.53259552385199e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.0390112244839339,0.00257313414680852,-0.0440545674116786,-0.0339678815561892,1.46204255421757e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,39817,-0.0924738578942809,0.0061011769499781,-0.104432164716238,-0.0805155510723238,1.56244016306267e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,0.124956800657706,0.00829242572867112,0.10870364622951,0.141209955085901,6.88365703680389e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,39749,0.05273875461877,0.00350254837220862,0.0458737598092411,0.0596037494282989,6.94228462869318e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,39868,0.0912170749618166,0.00607591196781994,0.0793082875048895,0.103125862418744,1.33574918047336e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0403340294888839,0.00269326986221771,0.0350552205589372,0.0456128384188306,2.3155839638261e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,0.06680054760831,0.0044644479293365,0.0580502296668104,0.0755508655498095,2.82507075392226e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0276182310897548,0.00184582112612519,0.0240004216825494,0.0312360404969601,2.88896254312334e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37437,0.0988048854066315,0.00660717353172444,0.0858548252844516,0.111754945528811,3.66656685408816e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,0.0482231781926255,0.00322856385525873,0.0418951930363184,0.0545511633489326,4.76659957022422e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.082379699890572,0.00552003774889695,0.071560425902734,0.09319897387841,4.98273080526599e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,0.122137446109525,0.00818394395036758,0.106096915966804,0.138177976252245,5.0576015067247e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,39788,0.0513359661151448,0.00344434229358656,0.0445850552197152,0.0580868770105745,6.69004373649422e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39455,0.0562205701887585,0.00377634694233796,0.0488189301817761,0.0636222101957409,8.72325450663036e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD83,CD83 antigen,39866,0.0468128567647155,0.00314778269189198,0.0406432026886072,0.0529825108408237,1.08027551457539e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,0.0630997908959965,0.00424581141679029,0.0547780005190875,0.0714215812729055,1.25421883305492e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,0.0974710196835389,0.00655931574840642,0.0846147608166623,0.110327278550415,1.28924880966343e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,0.0361359134957706,0.00243679361284743,0.0313597980145896,0.0409120289769516,2.00447686815361e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.072952690832723,0.00494255187566171,0.063265289156426,0.0826400925090199,5.65697703450143e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0484860446512465,0.00328830574463954,0.042040965391753,0.05493112391074,7.06152881218313e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37445,-0.0732956648949298,0.00496918395363216,-0.0830352654440489,-0.0635560643458108,7.33785185111163e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,37453,0.0436788167263913,0.00296400583562293,0.0378693652885703,0.0494882681642122,8.9457662294215e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37437,0.129410625545812,0.00878473994431719,0.11219253525495,0.146628715836674,9.64764064516224e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0569788013011512,0.00388196997069067,0.0493701401585974,0.0645874624437049,1.87083954011442e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0399667293923746,0.00272465368928273,0.0346264081613805,0.0453070506233688,2.12294442779425e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0919961445175747,0.0062734173466946,0.0797002465180533,0.104292042517096,2.24570334138633e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,0.0653901110723314,0.0044686894393571,0.0566314797711915,0.0741487423734713,3.60704903707179e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,0.127977813916572,0.00875527252224875,0.110817479772965,0.14513814806018,4.44196710859311e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,39931,0.0585182754215144,0.00400861855620693,0.0506613830513488,0.06637516779168,5.85397497854935e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,0.063981994614338,0.00438323488832089,0.0553908542332291,0.072573134995447,5.93079949271822e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6,Interleukin-6,39788,0.0987726794299696,0.00679609213928863,0.0854523388369639,0.112093020022975,1.49244115672317e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40009,0.0807792854898823,0.00556364149545322,0.069874548158794,0.0916840228209706,1.82456569644471e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0583179955976206,0.00401872685016373,0.0504412909712997,0.0661947002239415,2.03072110715446e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN4,CCN family member 4,40030,0.0556533658653783,0.00384577146047067,0.0481156538028558,0.0631910779279008,3.62563328893792e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAB2,Stabilin-2,37437,0.0389486867951896,0.00269882662780268,0.0336589866046964,0.0442383869856829,7.26197201246643e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40009,0.0460303979920797,0.00319149513368609,0.039775067530055,0.0522857284541044,7.26937419005973e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0720610990176977,0.00499627032441883,0.0622684091818368,0.0818537888535586,7.28457626297973e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39489,0.0896837989182935,0.0062250347873341,0.0774827307351187,0.101884867101468,9.325171726876e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,0.038427334634144,0.0026694904616145,0.0331951333293796,0.0436595359389085,1.08839330989071e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,39666,0.0499899234454385,0.0034749499681029,0.0431790215079569,0.0568008253829202,1.25179832537636e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0519089229482912,0.00360998916839261,0.0448333441782417,0.0589845017183407,1.3633804097197e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPH,Hephaestin,37437,0.0364722239098852,0.00253508453321929,0.0315034582247754,0.041440989594995,1.37418364221492e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH1,Cadherin-1,39315,0.0556094842929937,0.00386739032457334,0.0480293992568299,0.0631895693291574,1.398974020516e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0468275955536575,0.0032624278565825,0.0404332369547558,0.0532219541525592,1.96042140630616e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0867891362661346,0.00604916323412728,0.0749327763272452,0.0986454962050241,2.41987718552343e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,39908,0.0784594878090188,0.00547700425306533,0.0677245594730108,0.0891944161450269,2.93480419937373e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAST,Gastrin,37388,0.159486794775887,0.0111759213467004,0.137581988936354,0.181391600615419,7.18308973695288e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,0.0645642097080578,0.00453009658377598,0.0556852204038569,0.0734431990122588,9.29965978812848e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39477,0.100989202438474,0.00710774354235489,0.0870580250954584,0.11492037978149,1.56308519686033e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMD,Osteomodulin,39931,-0.0592664873801685,0.00417429906003015,-0.0674481135378276,-0.0510848612225094,1.77669564744805e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,39931,0.137460342098541,0.00970380673290435,0.118440880902049,0.156479803295034,2.80092056342869e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,-0.065999738463043,0.00466009140984224,-0.0751335176263337,-0.0568659592997522,3.27255551883934e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37437,0.054749312041039,0.00386660668366622,0.0471707629410532,0.0623278611410248,3.41928065351796e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,0.169124305599983,0.0119513497874526,0.145699660016576,0.19254895118339,3.45540192707077e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.115798292695648,0.00818396809880293,0.0997577152219945,0.131838870169302,4.02731370393569e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.0954203680240482,0.00674894433341035,0.082192437130564,0.108648298917533,4.68769458174781e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,39868,-0.0693971337712597,0.00491552517636085,-0.0790315631169269,-0.0597627044255924,5.48155014769161e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37124,0.0393448714302971,0.00278895466307077,0.0338785202906784,0.0448112225699158,7.21549245798304e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0959158056556725,0.00680473837970303,0.0825785184314545,0.10925309287989,8.5576743541523e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37376,0.0861745282266747,0.00611917444542196,0.0741809463136477,0.0981681101397018,1.00447738300106e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.077584798423987,0.00551780519504364,0.0667699002417014,0.0883996966062725,1.22450206915617e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0439647183739891,0.00312873221203136,0.0378324032384076,0.0500970335095706,1.38396233743923e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0429734593890785,0.00306113629080789,0.0369736322590951,0.048973286519062,1.65784099741507e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40030,0.0512277476960066,0.00365835789708517,0.0440573662177196,0.0583981291742935,2.7135092961977e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSN,Gelsolin,37383,-0.0251836011206521,0.00179901571341039,-0.0287096719189365,-0.0216575303223678,3.23695236713519e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.104241997128564,0.0074483234305533,0.0896432832046797,0.118840711052449,3.38202133694038e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BECN1,Beclin-1,37043,0.0816353607816365,0.00583693924461485,0.0701949598621913,0.0930757617010816,3.92266355105091e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0348813043527123,0.00249613024395721,0.0299888890745562,0.0397737196308685,4.08815942973753e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.039565263944309,0.00283209349126611,0.0340143607014274,0.0451161671871906,4.29354197134516e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,0.0479365964535659,0.00343265745354592,0.0412085878446159,0.0546646050625159,4.63161835950098e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0643443150448979,0.00461999561915765,0.0552891236313489,0.0733995064584469,7.86812980994619e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0667113272061489,0.00479285287567034,0.057317335569835,0.0761053188424627,1.0063074546981e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0518301115643249,0.00372701171074703,-0.0591350545173891,-0.0445251686112607,1.03712114642362e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN2,CCN family member 2,39880,0.0780709079403602,0.00561858108735197,0.0670584890091504,0.0890833268715701,1.21469658590582e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,0.0752702655090226,0.00543190708381492,0.0646237276247454,0.0859168033932999,2.05369940992412e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD302,CD302 antigen,39788,0.0386469450152544,0.00278947471188704,0.0331795745799558,0.044114315450553,2.13156700460307e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.0924894706034968,0.00667470592803131,0.0794070469845555,0.105571894222438,2.29377996410906e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,39858,0.0598018967212334,0.00431907661342281,0.0513365065589247,0.0682672868835421,2.39221946855412e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0754023665262352,0.00545177945110158,0.0647168788020762,0.0860878542503943,2.94744514704381e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37348,0.0585013777622064,0.00423087971467064,0.0502088535214519,0.0667939020029608,3.44024029685172e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH9,Myosin-9,37437,0.148053478647,0.0107328440178032,0.127017104372106,0.169089852921895,5.3669347030309e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0664246661763344,0.00482081525843898,0.056975868269794,0.0758734640828748,5.98285377288307e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39489,0.0804838818518159,0.00584591582453662,0.0690258868357241,0.0919418768679076,7.10899559973705e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0663987396045207,0.00482443516461822,0.056942846681869,0.0758546325271724,7.55022325580303e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.059293310289601,0.00431492647413335,0.0508360544002996,0.0677505661789023,1.00467318422284e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COCH,Cochlin,37437,0.060511960614982,0.00440567575993892,0.0518768361255017,0.0691470851044622,1.20764011274743e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0547398004476471,0.00398803828995683,0.0469232453993318,0.0625563554959625,1.23425002648306e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0485824451154744,0.00354268915037822,0.0416387743807331,0.0555261158502157,1.48238110353746e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EREG,Proepiregulin,39713,0.105110497938461,0.00766635061258039,0.0900844507378037,0.120136545139119,1.53333262638652e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,0.0653527022266587,0.00477255608502891,0.0559984923000021,0.0747069121533154,1.92746044447083e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0333614220211797,0.00243718144637371,0.0285845463862873,0.0381382976560722,2.06122464703341e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSTB,Cystatin-B,39619,0.0556927122077983,0.00407076953941169,0.0477140039105514,0.0636714205050452,2.29833515111462e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0682191933486275,0.00498656623666866,0.058445523524757,0.0779928631724981,2.57699055532487e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REN,Renin,39868,0.0864583946089794,0.00633029418401219,0.0740510180083155,0.0988657712096433,3.12474701791126e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0648205103397285,0.00474688335587444,0.0555166189622146,0.0741244017172425,3.27644901518027e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,39885,0.0615288328812774,0.0045126889868742,0.052683962467004,0.0703737032955508,4.28064684980427e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0536935692615491,0.00394656066845041,0.0459583103513863,0.0614288281717119,6.36946897867975e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPO,Erythropoietin,39866,0.100785196535417,0.00741337357049759,0.0862549843372415,0.115315408733592,7.31723906906702e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,39749,0.0847795975167819,0.00623981019684503,0.0725495695309656,0.0970096255025981,8.20233195761455e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,0.104277955142653,0.00767579076610022,0.0892334052410962,0.119322505044209,9.34171059463135e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.0926308823786006,0.00683115986102003,0.0792418090510013,0.1060199557062,1.18894027852014e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,39788,0.095861616702395,0.00707462367631876,0.0819953542968103,0.10972787910798,1.34592549873175e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37437,0.0466528746775812,0.00344131326012031,0.0399079006877454,0.053397848667417,1.34836605957349e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORT1,Sortilin,39846,0.04854147605984,0.00358262410072607,0.0415195328224169,0.0555634192972631,1.36020837427044e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37056,0.110565936500473,0.00816218890583746,0.0945680462450319,0.126563826755915,1.58259546397213e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RETN,Resistin,39790,0.0528145334714466,0.00391603268201889,0.0451391094146896,0.0604899575282036,3.15152866506543e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN5,CCN family member 5,39858,0.0498443883380532,0.0036962782776364,0.0425996829138859,0.0570890937622206,3.21815255093902e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0650860057059734,0.00483642255718859,0.0556066174938838,0.074565393918063,4.65419249965671e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD63,CD63 antigen,39720,0.066506581302029,0.00494471543818779,0.0568149390431809,0.076198223560877,5.16396781464461e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP1,Neuropilin-1,39949,-0.035789891115218,0.0026630461228677,-0.0410094615160387,-0.0305703207143973,5.90485613999989e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37437,0.0732284246273658,0.00546640975594818,0.0625142615057073,0.0839425877490242,1.1550332139841e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40030,0.0835555101663753,0.00624779108925964,0.0713098396314264,0.0958011807013242,1.41701188942333e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSL,Cathepsin L1,39868,0.0306791123989821,0.00229446601002253,0.026181959019338,0.0351762657786263,1.47600138421516e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37043,0.0658016639054359,0.00491955970017735,0.0561593268930883,0.0754440009177835,1.54446325350066e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,39686,0.0646391070271452,0.0048356142060612,0.0551613031832652,0.0741169108710251,1.55755943558601e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37124,0.0375716722222151,0.00281172937470934,0.0320606826477848,0.0430826617966454,1.8293697000923e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.042456429454746,0.0031801392353122,0.0362233565535341,0.0486895023559579,1.93508739777157e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0359701873718636,0.00269495617241744,0.0306880732739254,0.0412523014698018,2.0147270339446e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,39858,0.0317774603717574,0.00238211423316663,0.0271085164747508,0.036446404268764,2.22541216674974e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.038671463086391,0.00289908615426266,0.0329892542240361,0.0443536719487458,2.24053782926424e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0399430287733925,0.00300331259555536,0.0340565360861039,0.045829521460681,3.77666943188483e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37056,0.0570684628740985,0.00429922744296499,0.0486419770858871,0.0654949486623099,5.89843176800149e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFH,Complement factor H,36763,0.0301143707773393,0.00227224595607717,0.0256607687034281,0.0345679728512506,7.87871828762276e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0334305645750028,0.0025249124559597,0.0284817361613217,0.0383793929886838,8.29915966154633e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0554728754965781,0.00419210519563626,0.047256349313131,0.0636894016800252,9.2101373472879e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.107402079928585,0.0081209724055141,0.0914849740137778,0.123319185843393,1.01558415736314e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39314,0.11670768262213,0.00882440377695776,0.0994118512192926,0.134003514024967,1.02672096613008e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,0.0511056786461223,0.00386519442112525,0.0435298975807168,0.0586814597115278,1.05175357005312e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40052,-0.0203683898908019,0.00154072239059548,-0.023388205776369,-0.0173485740052347,1.07970883449609e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,39749,0.0664843922308731,0.00503226727746135,0.0566211483670489,0.0763476360946974,1.21675821721042e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,39913,0.037786545327037,0.00286085854863206,0.0321792625717181,0.0433938280823558,1.26789442200195e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POSTN,Periostin,37437,-0.047293216569475,0.00358277142421134,-0.0543154485609292,-0.0402709845780208,1.53338814085981e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,0.0779666847523964,0.00590703040107249,0.0663889051662944,0.0895444643384985,1.58554919772555e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,39788,0.0868201519813128,0.00661414494724476,0.073856427884713,0.0997838760779125,3.70996687966569e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,39900,0.0632834424960712,0.0048252869884861,0.0538258799986384,0.0727410049935039,4.2957242903714e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0558786642597134,0.00426896354027676,0.0475114957207709,0.0642458327986558,6.0116397525766e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0643281651563363,0.00491346490417534,0.0546977739441526,0.07395855636852,6.39158668575315e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,39843,0.0488299545486706,0.00374012286943469,0.0414993137245786,0.0561605953727626,9.30717259291025e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.100587363418138,0.00770182231133836,0.0854917916879151,0.115682935148361,9.53955140126019e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0749696902958877,0.00574445624798353,0.06371055604984,0.0862288245419355,9.99467712981589e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,-0.136942241021277,0.0104959864197805,-0.157514374404047,-0.116370107638507,1.1678284456387e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0549717200569935,0.00421510813088705,0.0467101081204549,0.0632333319935321,1.22415201662143e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.122326326038306,0.00938584126861748,0.103930077151815,0.140722574924796,1.37379742041431e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37437,0.0999940268783125,0.00767830667459356,0.0849445457961091,0.115043507960516,1.5419583086851e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,0.0399697874296312,0.0030699688426618,0.0339526484980141,0.0459869263612483,1.61937612625138e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0525861564098458,0.00403958605080285,0.0446685677502722,0.0605037450694194,1.65425221926051e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSF,Cathepsin F,39913,0.0503982394495815,0.00388389165960512,0.0427858117967555,0.0580106671024076,2.60124621897489e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0649071989526282,0.00500267312778956,-0.0747124382830957,-0.0551019596221607,2.66365826737621e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0453170441072153,0.00349934745021821,0.0384583231047876,0.052175765109643,3.69796587289126e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.034659494217857,0.00267775269988781,0.0294110989260769,0.0399078895096371,4.34803935065208e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.0807144969388785,0.00624444175811269,0.0684753910929776,0.0929536027847793,5.04290010720245e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40058,0.094250074814214,0.00729294302543023,0.0799559064843708,0.108544243144057,5.1154015531773e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,39836,0.113760803707596,0.00881913200180499,0.0964753049840582,0.131046302431134,7.01851517035956e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,39749,0.110549910135452,0.00857136952643036,0.0937500258636487,0.127349794407256,7.19423536167284e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD209,CD209 antigen,39885,-0.0481542813127662,0.00373501395698409,-0.0554749086684551,-0.0408336539570774,7.63452406120508e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN3,Contactin-3,39858,0.0404161454290807,0.00313818665856353,0.0342652995782962,0.0465669912798653,9.1248561135554e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39489,0.0427824797903044,0.00332344765989178,0.0362685223769165,0.0492964372036923,9.94185426127514e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.0895315397531797,0.00696151061210312,0.0758869789534576,0.103176100552902,1.14370118456326e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37424,-0.0463905632708249,0.0036121736780184,-0.053470423679741,-0.0393107028619089,1.5608927985855e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,39913,0.0683433488502827,0.00533740455883163,0.0578820359149727,0.0788046617855927,2.35371081148966e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.110147995460159,0.00860642364740769,0.0932794051112394,0.127016585809078,2.56211186609508e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40058,0.0611107520291871,0.00479293091378875,0.0517166074381612,0.070504896620213,4.68710089778374e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40030,0.0459422996046586,0.00360341626388553,0.038879603727443,0.0530049954818743,4.72228086068126e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0415334169738355,0.00326564581659083,0.0351327511733175,0.0479340827743535,7.07294750490549e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,39985,0.0874914953204061,0.00688808401652505,0.073990850648017,0.100992139992795,8.66422339271209e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0358568658926749,0.00282364627867464,0.0303225191864726,0.0413912125988772,9.71512865152369e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,-0.0309114092686301,0.00244026911733132,-0.0356943367385995,-0.0261284817986608,1.347907167294e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0754691138605351,0.00596684268492095,0.0637741021980901,0.0871641255229802,1.71370676433251e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37445,0.0273065931478539,0.00216288837973284,0.0230673319235775,0.0315458543721303,2.45733799688264e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40058,0.063483544383047,0.00503295052648176,0.0536189613511428,0.0733481274149513,2.63288549417212e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,39788,0.138026267083234,0.0109581295998137,0.116548333067599,0.159504201098869,3.31411015782961e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0679895471533285,0.00539579554522204,0.0574137878846933,0.0785653064219636,3.37753380696196e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0308019455892861,0.00245224626603151,0.0259955429078644,0.0356083482707079,5.12837134618543e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANG,Angiogenin,39843,0.0407512638499664,0.00324917795713364,0.0343828750539845,0.0471196526459483,6.48932446523474e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,0.103232188971262,0.00823581822041543,0.0870899852592482,0.119374392683277,7.11027928685894e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0432209346519184,0.00345728887062636,0.0364446484654907,0.0499972208383461,1.07237855980858e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0736751862122883,0.00590459590011346,0.062102178248066,0.0852481941765107,1.44883219029295e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37169,0.154833236216662,0.0124069599719886,0.130515594671564,0.179150877761759,1.52594540707475e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.0985471545240958,0.0079085030525216,0.0830464885411534,0.114047820507038,1.91016195358648e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0424787321728906,0.0034111760838407,0.0357928270485629,0.0491646372972184,1.97163899716517e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCOF1,Treacle protein,37437,0.0364353387828165,0.002938086104815,0.0306766900173791,0.0421939875482539,3.99633914963497e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD48,CD48 antigen,39908,0.0344967330433788,0.00278315405090162,0.0290417511036116,0.039951714983146,4.03558962807748e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAG1,Dystroglycan,39931,0.0578036399712514,0.00466623659638544,0.048657816242336,0.0669494637001669,4.40855085510173e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSG,Basigin,40040,0.0231704273436913,0.00187050596453333,0.019504235653206,0.0268366190341767,4.41862229952418e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37056,0.110769612024308,0.00893877504230134,0.093249612941397,0.128289611107218,4.52240684281393e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0498825662844142,0.00403008253155548,0.0419836045225654,0.0577815280462629,4.98928605891991e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.0466533370352414,0.0037720169058517,0.0392601838997721,0.0540464901707108,5.62400312083669e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN1,Ficolin-1,37430,0.0671481770325412,0.00543816522495695,0.0564893731916255,0.0778069808734568,7.7217539475269e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,0.0468458538402831,0.00379890171703957,0.0394000064748856,0.0542917012056807,8.90586660241946e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN1,Contactin-1,40052,-0.0315369025258058,0.00256145859603075,-0.036557361374026,-0.0265164436775855,1.11461633144237e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSC2,Desmocollin-2,39673,0.0393995745717324,0.00320255381505542,0.0331225690942237,0.045676580049241,1.26371872971991e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0455584931655819,0.00370480340388701,0.0382970784939633,0.0528199078372004,1.34801373108378e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40058,0.0540308856507346,0.00439424874830816,0.0454181581040506,0.0626436131974186,1.36068801321156e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,39749,0.0496758502371877,0.00405360970903666,0.0417307752074759,0.0576209252668996,2.26571810216552e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,0.0723941177043543,0.00591061386900164,0.0608093145211111,0.0839789208875975,2.47008732331676e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELP,P-selectin,39931,0.0676216263029009,0.00552280254913596,0.0567969333065945,0.0784463192992074,2.56989266689674e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,39913,0.0333587753785767,0.00273038079024809,0.0280072290296905,0.038710321727463,3.54982784412406e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.102085442963047,0.00836013777732455,0.0856995729194909,0.118471313006603,3.84984519665473e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0542651830260989,0.00444370052950991,0.0455555299882595,0.0629748360639383,4.113838918163e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0595468618415258,0.00487693877382686,0.0499880618448252,0.0691056618382265,4.16197087410884e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMN,Protein amnionless,39587,0.0559294726082316,0.00458539467420591,0.046942099046788,0.0649168461696752,4.57882516552819e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.034868584742373,0.00285873932398639,0.0292654556673596,0.0404717138173863,4.85616637885422e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.114300417004438,0.00938767332377912,0.0959005772898314,0.132700256719046,5.93592451048646e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0459290736185933,0.00377261158069604,-0.0533233923167576,-0.0385347549204291,6.01693084168824e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,39913,0.0646076073716417,0.00531382499239652,0.0541925103865445,0.0750227043567389,7.29291240165769e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.116501738273662,0.00958277923578635,0.0977194909715209,0.135283985575803,7.35883869014298e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0457041581734611,0.00375808261576145,0.0383383162465687,0.0530700001003536,7.53953766345979e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,0.0603051065053324,0.00496263980307066,0.0505783324913139,0.0700318805193509,7.90776111820704e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,0.0994226652913048,0.00819280134444108,0.0833647746562003,0.115480555926409,9.72923143716184e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,0.0506075906780163,0.00417649774325337,0.0424216551012397,0.0587935262547929,1.20173386993247e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37382,0.114574038158388,0.00945736584979441,0.0960376010927906,0.133110475223985,1.31659790558236e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0739330164886968,0.0061107539967258,0.0619559386551142,0.0859100943222793,1.50066855205627e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COLEC12,Collectin-12,39862,0.0288412578221879,0.00238791313303883,0.0241609480814318,0.033521567562944,1.92921177024295e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,39789,0.0873117118115379,0.00723531649587614,0.0731304914796206,0.101492932143455,2.19482264773308e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40002,0.0311591952914106,0.00258779693009756,0.0260871133084194,0.0362312772744018,3.00966427743088e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.0952675950155005,0.00791389822212895,0.0797563545001278,0.110778835530873,3.1124908738278e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0538127280723335,0.00447779463833658,0.0450362505811938,0.0625892055634732,3.98457686596785e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,39788,0.0377600924510389,0.0031434330112415,0.0315989637490055,0.0439212211530722,4.25266530193325e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37382,0.112396009798013,0.00935401912313041,0.0940621323166777,0.130729887279349,4.32644321503003e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37357,0.0369128868375497,0.00307280343244954,0.0308901921099486,0.0429355815651508,4.48924054571484e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,0.0225959532137572,0.00188421306963263,0.0189028955972773,0.0262890108302372,5.40704938817349e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39248,0.0338969457256001,0.00282656434295575,0.0283568796134068,0.0394370118377934,5.47190298187564e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.0790123312734676,0.00659005569338532,0.0660958221144324,0.0919288404325029,5.55918248209955e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0287768005426653,0.00240113952050746,0.0240705670824707,0.03348303400286,5.91010700647895e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.126283293940602,0.0105421122994603,0.10562075383366,0.146945834047544,6.72620624631728e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37437,-0.0671507218651755,0.005613329893097,-0.0781528484556456,-0.0561485952747054,8.14295290699196e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,39882,0.0714613992050838,0.00598914941019599,0.0597226663610996,0.0832001320490679,1.11134593006574e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,0.110403778426042,0.00926148884219447,0.092251260295341,0.128556296556743,1.26478091488681e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,0.148514685627436,0.0124625183276772,0.124088149705188,0.172941221549683,1.32574835336988e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0426966231029421,0.00358454294814189,0.0356709189245839,0.0497223272813002,1.42672926205765e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37445,0.0317047229937924,0.00266144524518024,0.0264882903132391,0.0369211556743456,1.47794199166203e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,39826,0.0301532315104808,0.00253421001945793,0.0251861798723432,0.0351202831486183,1.65389970598302e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,0.0731620439627114,0.00615749627712393,0.0610933512595485,0.0852307366658743,2.03032025601902e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA2,Annexin A2,36879,0.0800797423730326,0.00673731130059329,0.0668746122238697,0.0932848725221955,2.05835626348043e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPSE,Heparanase,37306,0.10782228185313,0.00908648667232312,0.0900127679753769,0.125631795730884,2.56998058011785e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0546912072015403,0.0046101780892603,0.0456552581465901,0.0637271562564904,2.6576830248523e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37368,0.114036194899447,0.00961684193382936,0.0951871847091414,0.132885205089752,2.82869204515614e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0328082477746352,0.00276835618736127,0.0273822696474072,0.0382342259018633,3.06372646314128e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0484250908447459,0.00409367863184412,0.0404014807263314,0.0564487009631604,3.74746987558381e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAN,Brevican core protein,39749,-0.0378693274011844,0.00320175101423452,-0.0441447593890841,-0.0315938954132848,3.82975695080656e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37382,0.121381246778045,0.0102710028831772,0.101250081127018,0.141512412429072,4.53891196269927e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NADK,NAD kinase,39868,0.0606152689776299,0.00513442225246892,0.0505518013627908,0.070678736592469,4.95488249336064e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.116802196587636,0.00989397749287194,0.097410000701607,0.136194392473665,5.25695533464407e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0246191510696516,0.00208919369094472,0.0205243314353999,0.0287139707039032,6.80311070386011e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39477,0.0707938734939783,0.00601313314461295,0.0590081325305369,0.0825796144574197,7.31509684889327e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0584359027257541,0.00496622886181412,0.0487020941565985,0.0681697112949098,7.8423707542142e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37390,0.124350686584662,0.010576888172012,0.103619985767519,0.145081387401806,9.29571317216474e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,0.137423501820053,0.0116881831127856,0.114514662918993,0.160332340721113,9.3132093739617e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,39776,0.043962646715469,0.00374136125264497,0.0366295786602849,0.0512957147706532,9.50215817537064e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,39747,0.0257391521490444,0.00219523141163966,0.0214364985822307,0.0300418057158581,1.2805867179272e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0603614605790374,0.00514620849744463,0.0502748919240459,0.0704480292340289,1.28374038168224e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A4,Protein S100-A4,39913,0.0639547673548204,0.00546519664233488,0.053242981935844,0.0746665527737968,1.66763250257608e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,39866,0.0946311408498559,0.00808828396052168,0.0787781042872334,0.110484177412478,1.71673657694638e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,39749,0.0584402096523146,0.00500754102655911,0.0486254292402587,0.0682549900643704,2.42286804077703e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC1,Syndecan-1,39868,0.0445271178376972,0.00382126743308129,0.0370374336688579,0.0520168020065365,2.98124581207158e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.0688275103017246,0.00591336028287976,0.0572373241472802,0.0804176964561689,3.49725212110319e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,37453,0.0191988372286002,0.00164965851064204,0.0159655065477418,0.0224321679094586,3.70848315557856e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0215295361243471,0.00185291907102606,0.017897814745136,0.0251612575035582,4.38937982598581e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,39972,0.0761121224714062,0.00655998252273158,0.0632545567268523,0.0889696882159601,5.31608289320159e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,39788,0.0616767373887469,0.00531637162058535,0.0512566490123996,0.0720968257650942,5.40841394957901e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37333,0.039025827933192,0.00336352301934308,0.0324333228152795,0.0456183330511044,5.60648312477388e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37388,0.0306113561216733,0.0026385239215136,0.0254398492355067,0.03578286300784,5.66179784649116e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37437,0.0330137319613784,0.00284725264271018,0.0274331167816665,0.0385943471410904,6.11455040226201e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD248,Endosialin,37437,-0.0443703637269607,0.00382829837377951,-0.0518738285395685,-0.0368668989143528,6.46667713050243e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,-0.043582255371206,0.00376218461370709,-0.0509561372140719,-0.0362083735283401,6.60825307370159e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37388,0.0738517338999897,0.00638570672006602,0.0613357487286603,0.0863677190713191,8.63536563764593e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,0.0214665523100708,0.00185759038474948,0.0178256751559618,0.0251074294641797,9.57329264187139e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TALDO1,Transaldolase,37415,0.0498793695589757,0.00431929362947197,0.0414135540452106,0.0583451850727407,1.05129932236344e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40052,0.060244309141748,0.00522644803914567,0.0500004709850225,0.0704881472984735,1.27265030808921e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,39585,0.0639563822533847,0.00555389757281494,0.0530707430106675,0.074842021496102,1.46008628617687e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39477,0.0610363270633886,0.00531209330367179,0.0506246241881919,0.0714480299385853,1.96134591562496e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.08076128619539,0.00702810318365857,0.0669862039554192,0.0945363684353608,2.03894233330343e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,0.0322655197010819,0.00281539369593958,0.0267473480570404,0.0377836913451235,2.74944203263951e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37021,0.0744442444118061,0.00649357954605333,0.0617168285015416,0.0871716603220706,2.77611193711713e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0722502835971243,0.00630747531886829,0.0598876319721424,0.0846129352221061,3.09962960025686e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL11,Eotaxin,40058,0.0419660098734056,0.00367369695614926,0.0347655638393531,0.0491664559074582,4.16729902966989e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0601210739030958,0.00526386898045682,0.0498038907014004,0.0704382571047912,4.27834878420656e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40009,0.0713424866225506,0.00625121440045288,0.059090106397663,0.0835948668474383,4.7172872218945e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,39879,-0.0214254712837804,0.00187838603124225,-0.0251071079050152,-0.0177438346625455,5.07723855688909e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0358028627930078,0.00314190620116351,0.0296447266387273,0.0419609989472883,5.75966884136345e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP7,Matrilysin,39563,0.0540533961285824,0.00474654117246699,0.0447501754305471,0.0633566168266177,6.29194153358288e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0512173265100626,0.0045014724363033,0.0423944405349081,0.060040212485217,7.01826666497715e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,39790,0.047535354263064,0.00417825640260264,0.0393459717139628,0.0557247368121652,7.11271676075635e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,0.0615973796404942,0.00542015800926263,0.0509738699423395,0.072220889338649,8.2252197953113e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40009,0.0294806505267218,0.00259784162982957,0.0243888809322558,0.0345724201211877,9.81953773523222e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.154302784022196,0.01361306684363,0.127621173008681,0.180984395035711,1.19916738885042e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,39829,0.0725171317249105,0.00640816831393827,0.0599571218295914,0.0850771416202295,1.41146618762604e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39476,0.0759838507833558,0.00671667021328231,0.0628191771653225,0.0891485244013892,1.47925829502395e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBN,Nibrin,39587,0.0561008477587246,0.00495962397156084,0.0463799847744654,0.0658217107429839,1.49691507481717e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,-0.0290680278684092,0.00257086420920729,-0.0341069217184555,-0.0240291340183629,1.57336919535668e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,0.0779867552923138,0.00691128431893086,0.0644406380272094,0.0915328725574183,2.02782032464286e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0614755669716246,0.00544829626559059,0.050796906291067,0.0721542276521822,2.05887948226012e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.068744866288632,0.00609354850284465,0.0568015112230565,0.0806882213542075,2.09019103073216e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEP,Leptin,39868,0.0734178339973388,0.00651894882346971,0.0606406943033382,0.0861949736913395,2.59879950037627e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0286534400321449,0.00254589315016404,0.0236634894578234,0.0336433906064664,2.82642390105562e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40040,0.0567594345744003,0.00504642899573353,0.0468684337427625,0.066650435406038,3.06068384523351e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.0828942509524218,0.00737204208182327,0.0684450484720482,0.0973434534327954,3.32129040272452e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAD,Chondroadherin,37124,-0.0548014422128239,0.00487364095619157,-0.0643537784869593,-0.0452491059386884,3.34271672523956e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40009,0.125073053787841,0.0111283636348492,0.103261461063536,0.146884646512145,3.3624735092545e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,39843,0.0654644088978985,0.0058302248926151,0.0540371681083729,0.0768916496874241,3.80041476869811e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0359208276676473,0.00319974252841535,-0.0421923230233414,-0.0296493323119533,3.89690176025954e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0544435091576622,0.00485488873448638,0.0449279272380689,0.0639590910772555,4.48662617256371e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0337047348357769,0.00300627817735478,0.0278124296081615,0.0395970400633923,4.81113421039381e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,-0.0564983549654435,0.00504496775709028,-0.0663864917693405,-0.0466102181615466,5.28861234760526e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,0.0786428387820167,0.00703852860060588,0.0648473227248291,0.0924383548392042,7.08579850383712e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,39858,0.0574239679088874,0.00514301655893909,0.0473436554533668,0.067504280364408,7.69528804310859e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15,Interleukin-15,39866,0.0348264413128524,0.00312337840948791,0.0287046196302561,0.0409482629954487,9.114479357141e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0453864794758539,0.00406967759485693,0.0374099113899343,0.0533630475617735,9.2981208529131e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40058,0.0590161364405285,0.00530087914962157,0.0486264133072703,0.0694058595737868,1.09808710525582e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBIN,Erbin,39788,0.110024809928715,0.00988728299054414,0.0906457352672486,0.129403884590182,1.17034979964787e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.121872177378826,0.0109587172360864,0.100393091596097,0.143351263161555,1.32496053564494e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.0687027500173478,0.00617938013736611,0.0565911649481102,0.0808143350865854,1.36148369374701e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.0802849935348891,0.00722184628566953,0.0661301748149769,0.0944398122548014,1.39061024426172e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0433992386948495,0.00390510791558633,0.0357452271803003,0.0510532502093987,1.43446121555928e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0681229608779096,0.00614040262976677,0.0560877717235667,0.0801581500322524,1.78873851021277e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,0.0848411910362867,0.00765347398244463,0.0698403820306952,0.0998420000418781,1.88710791917416e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39477,0.055611059802225,0.00501760922251429,0.045776545726097,0.065445573878353,1.93275223669797e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37377,0.0807100962959012,0.00728478664502643,0.0664319144716494,0.094988278120153,2.09584279465652e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD160,CD160 antigen,40058,0.0477814323640844,0.00431748220982101,0.0393191672328352,0.0562436974953336,2.29299462452791e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,39866,0.0704288655998011,0.00636403185011616,0.0579553631735735,0.0829023680260288,2.30607527884001e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0361417529899848,0.00326737388175079,0.0297377001817533,0.0425458057982164,2.45972180176724e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,0.0583527060007167,0.00527646045338519,0.0480108435120818,0.0686945684893517,2.52435740035306e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.100486213737491,0.00910353584993224,0.0826432834716238,0.118329144003358,3.16002437838443e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,39866,-0.0491497569125361,0.00445281884937425,-0.0578772818573096,-0.0404222319677626,3.17109720726803e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0595251252051195,0.00539420330366537,0.0489524867299354,0.0700977636803036,3.26453603118989e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.0752328007036224,0.00682029748801225,0.0618650176271184,0.0886005837801264,3.4467237471149e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,39794,0.0895733518275663,0.00813135627865287,0.0736358935214066,0.105510810133726,4.05100229027693e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPPK1,Epiplakin,37043,0.0794551212607154,0.007213705043096,0.0653162593762472,0.0935939831451835,4.31469819282866e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0283922583776736,0.0025801955180462,0.0233350751623031,0.0334494415930442,4.61650872616135e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0330161685726949,0.00300389287296454,-0.0389037986037054,-0.0271285385416844,5.30692559003451e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40058,0.100209046166294,0.00911755120177035,0.0823386458108242,0.118079446521764,5.31504545827934e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM1,Isthmin-1,39866,0.0421615984111516,0.00383685189301348,0.0346413687008452,0.0496818281214581,5.45963172776213e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40003,0.0637283524437804,0.00580864252208763,0.0523434131004887,0.0751132917870722,6.58926095838333e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,39843,0.0875399201364929,0.00798826363522599,0.0718829234114499,0.103196916861536,7.59431056107462e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,0.0613492140133832,0.00560686346721927,0.0503597616176335,0.072338666409133,9.502214462969e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.0807294557434113,0.00738719744775097,0.0662505487458194,0.0952083627410032,1.05879273196536e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0290214166502378,0.0026573606506221,0.0238129897750185,0.0342298435254572,1.14427431731947e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.103260960864554,0.00945280578856382,0.0847334615189689,0.121788460210139,1.15629497421546e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F10,Coagulation factor X,37445,0.0279921854297489,0.00256449530047907,0.0229657746408099,0.0330185962186878,1.26871460199309e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0476991513795132,0.0043721814174544,0.0391296758013026,0.0562686269577238,1.30322861038042e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,0.0244925432821014,0.00224547509161363,0.0200914121025387,0.0288936744616641,1.38112272372758e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,39931,0.080217564302984,0.00736449132422966,0.0657831613074938,0.0946519672984741,1.56236655227639e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.0560134039655133,0.00514262927019804,0.0459338505959251,0.0660929573351014,1.57489157668896e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.114146527103855,0.0104768554497861,0.0936118904222743,0.134681163785436,1.58237057656827e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0369973951638488,0.00339681091609805,0.0303396457682966,0.043655144559401,1.58403474294022e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.0704753113781593,0.00647275149354247,0.057788718450816,0.0831619043055025,1.6507925791396e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,0.0677631538364737,0.00623048943684956,0.0555513945402485,0.0799749131326988,1.87115046271079e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0616438407426653,0.00566792590395056,0.0505347059709222,0.0727529755144084,1.88365197343501e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRN,Progranulin,39787,0.0257997169123755,0.00237690796397406,0.0211409773029864,0.0304584565217647,2.37142426959975e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGMN,Legumain,39931,0.0375103761134694,0.00345639196400942,0.0307358478640109,0.0442849043629279,2.41489370285843e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN5,Contactin-5,39897,-0.0375208682299161,0.00346223674794129,-0.044306852255881,-0.0307348842039511,2.85223986207099e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37241,0.0244887374236571,0.00226213208212352,0.020054958542695,0.0289225163046192,3.37818106373349e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.0718599139099479,0.00664013578654574,0.0588452477683182,0.0848745800515775,3.5208018010129e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0343496187381679,0.00318473602951268,0.028107536120323,0.0405917013560127,4.97023361712295e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,39809,0.0284041561757515,0.00263582522764158,0.023237938729574,0.033570373621929,5.52377290952399e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37445,-0.0495781577586039,0.00460706296639278,-0.0586080011727338,-0.0405483143444741,6.72636708092668e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS8,Galectin-8,40009,0.0633134817612877,0.00588685074326302,0.0517752543044922,0.0748517092180832,6.91794323711643e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0545283666448083,0.00506867777353823,0.0445937582086733,0.0644629750809432,6.98355205709207e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFC1,Cryptic protein,39477,0.0483980601548085,0.00450323227509114,0.0395717248956299,0.0572243954139872,7.56634118619802e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,37453,0.0312630272751367,0.00291183070276482,0.0255558390977176,0.0369702154525557,8.77832316343586e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,0.0873346998806005,0.00814876186611611,0.071363126623013,0.103306273138188,1.03856190605674e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGRN,Neugrin,37388,0.0220764382301056,0.00205932024845654,0.0180401705431308,0.0261127059170804,1.04681093676407e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39477,0.0420603292628755,0.00393084284747572,0.0343558772818231,0.0497647812439279,1.25763243730473e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,39730,-0.0289754881117533,0.00271354040567052,-0.0342940273068676,-0.0236569489166391,1.58565346320893e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37368,0.0371477144334794,0.00348248608182477,0.0303220417131028,0.0439733871538559,1.85070544635156e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,39866,0.0760040641630393,0.00713597009311502,0.0620175627805339,0.0899905655455447,2.11815335844817e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,39836,0.0923380521448133,0.00867355079112201,0.0753378925942142,0.109338211695412,2.23273401604526e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,0.02610817745011,0.00245596871825182,0.0212944787623364,0.0309218761378835,2.62927125056936e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0378158477943555,0.00355785378059254,0.0308424543843942,0.0447892412043169,2.67783966773315e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0642859563096058,0.00604961376451991,0.0524287133311468,0.0761431992880648,2.84938104376715e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTN,Pleiotrophin,39585,0.0513136178242578,0.00483757448530579,0.0418319718330585,0.0607952638154572,3.37907894213427e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.0987435233407374,0.00931756902149997,0.0804810880585975,0.117005958622877,3.74729696797254e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37373,0.0608584751318489,0.00574929325404721,0.0495898603539164,0.0721270899097814,4.40683247260244e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0338040391459913,0.0031949274312362,0.0275419813807683,0.0400660969112142,4.47034462563827e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0270099567039375,0.00255673922750131,0.0219987478180349,0.0320211655898401,5.30614251723081e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40058,0.0856199312133012,0.00811237005726975,0.0697196859010525,0.10152017652555,5.89511957379589e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,36991,0.0403346587604622,0.00382236797051336,0.032842817538256,0.0478264999826684,6.29673927979227e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTR,Transthyretin,37309,0.0256675799891112,0.00243540174801115,0.0208941925630093,0.030440967415213,7.17510507329132e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,0.139543211350628,0.013250789229671,0.113571664460473,0.165514758240783,7.56535689015475e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,39856,0.043283077606928,0.00411619416459314,0.0352153370443255,0.0513508181695306,8.91247535316165e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.0957509121198651,0.00910669242650396,0.0779017949639174,0.113600029275813,9.015634210277e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH15,Cadherin-15,39973,0.0541216009990337,0.00515992070552827,0.0440081564161983,0.0642350455818691,1.17590800402124e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.0449375152932658,0.00428553745886176,0.0365378618738968,0.0533371687126349,1.2129416864457e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,0.040087033879558,0.00382720401409758,0.0325857140119267,0.0475883537471893,1.4274922219238e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.058504882519818,0.00558760685714533,0.0475531730798132,0.0694565919598229,1.42992986012035e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0376853576938939,0.00359903051850977,0.0306312578776148,0.044739457510173,1.47917842229746e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,39564,0.0413789260711951,0.00395475063359644,0.0336276148293461,0.0491302373130442,1.54845278004071e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.0788888115818014,0.00755083311252388,0.0640891786812546,0.0936884444823482,1.82144560112416e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,0.0494991900523368,0.00473993828646555,0.0402089110108643,0.0587894690938093,1.96913254302745e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37388,0.0636212888610046,0.00609401475424513,0.0516770199426842,0.0755655577793251,2.03432583451806e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0233756665099987,0.00224190224535777,0.0189815381090975,0.0277697949109,2.25424355015028e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,39906,-0.0387163172622487,0.00371478653964161,-0.0459972988799462,-0.0314353356445512,2.36537146282004e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,0.065517769229951,0.00628754705192768,0.0531941770081728,0.0778413614517293,2.49938917328424e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL8,Interleukin-8,39750,0.0662911639047915,0.00636551316273024,0.0538147581058402,0.0787675697037427,2.57900402300645e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3,Galectin-3,39901,0.0295129467151157,0.00283499638413879,0.0239563538022037,0.0350695396280277,2.68107447596936e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL32,Interleukin-32,39866,-0.0429086334936408,0.0041223183209801,-0.0509883774027618,-0.0348288895845198,2.72059896583022e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39477,0.0377156340509414,0.00364266021770669,0.0305760200242363,0.0448552480776465,4.84319065784607e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37039,0.0491829620056672,0.00475256858316866,0.0398679275826566,0.0584979964286778,5.28756416640589e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID1,Nidogen-1,39892,0.0374815266733938,0.00362339720109377,0.03037966815925,0.0445833851875376,5.32284538181661e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40030,0.0592591631962753,0.00574934603827305,0.0479904449612602,0.0705278814312905,7.81071739598277e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSE,Cathepsin E,37124,0.0526589064600856,0.00511170074362158,0.0426399730025873,0.0626778399175839,8.58941133372712e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0699453146889224,0.00679604735502231,0.0566250618730787,0.0832655675047661,9.1529477723289e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0707384159804617,0.00687691850586598,0.0572596557089644,0.084217176251959,9.69106370619886e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0409437134750117,0.00398007982823161,0.0331427570116777,0.0487446699383456,9.93090471310593e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,39805,0.112712240645881,0.0109711026128925,0.0912088795246112,0.13421560176715,1.10695969372575e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGN,Biglycan,39448,-0.118163085330272,0.0115098784908365,-0.140722447172311,-0.0956037234882321,1.19849272942883e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,0.052088449545995,0.00507448252115012,0.0421424638045408,0.0620344352874492,1.21462808852617e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,39777,0.028014443325034,0.00273142707800054,0.022660846252153,0.0333680403979151,1.32198094738525e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.0665144606550576,0.00648924166698173,0.0537955469877734,0.0792333743223418,1.41636407762367e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,39913,0.0818936207595678,0.00799112575540939,0.0662310142789654,0.0975562272401702,1.4371377919225e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37124,0.0534311672829315,0.00521577809830354,0.0432082422102566,0.0636540923556065,1.55181377205796e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37445,0.0614077738770878,0.00599488367912983,0.0496578018659934,0.0731577458881823,1.55652441856222e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,39868,0.0344285822537292,0.00336661580819131,0.0278300152696742,0.0410271492377841,1.79486948006251e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,39913,0.0667347600279042,0.00653383897275326,0.0539284356413078,0.0795410844145006,2.04450152938162e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40009,-0.0360901479685686,0.00353392383275642,-0.0430166386807712,-0.029163657256366,2.0682640238975e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST7,Cystatin-F,39882,0.0906158431069661,0.00887595114270958,0.0732189788672553,0.108012707346677,2.14321189314971e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAYN,Layilin,39713,0.0316940385826207,0.00310520860676338,0.0256078297133645,0.037780247451877,2.20070449281437e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40011,0.0567481267193492,0.00556106446553611,0.0458484403668984,0.0676478130718,2.24342778659186e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,0.0757200311452338,0.00742022413818863,0.0611763918343841,0.0902636704560835,2.31848596854507e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTD,Biotinidase,37453,0.0202358112053449,0.00198458372763614,0.0163460270991781,0.0241255953115117,2.51450749382871e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA9,Serpin A9,39715,0.0713015274360117,0.00699718538537466,0.0575870440806773,0.085016010791346,2.61065136454772e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN2,Ficolin-2,39810,0.0398435159064028,0.00391030808228147,0.0321793120651311,0.0475077197476745,2.62603709717167e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,0.0846766553896756,0.00831452844337234,0.0683801796406658,0.100973131138685,2.85454105057856e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37340,0.0465762004039592,0.00457372103385164,0.03761170717761,0.0555406936303084,2.87806037652022e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0209869464188483,0.00206235911229976,-0.0250291702789558,-0.0169447225587408,3.01142031509854e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40052,0.0230118891413378,0.00226185752080391,0.0185786484005622,0.0274451298821135,3.06749532028545e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARC,SPARC,39913,0.0690384510359866,0.0067866686201284,0.055736580540535,0.0823403215314383,3.11083067355706e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37371,0.0834835666374362,0.00821456782589017,0.0673830136986914,0.0995841195761809,3.54765994673893e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PF4,Platelet factor 4,37385,0.0947808434211306,0.00933057050361561,0.076492925234044,0.113068761608217,3.72341799507386e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,0.0524811691024011,0.00518234671938285,0.0423237695324107,0.0626385686723915,5.15129963539229e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,0.040665089922565,0.00401730334472473,0.0327911753669045,0.0485390044782255,5.3672635683114e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS1,Galectin-1,39868,0.0325656187538547,0.00322786619153864,0.026239001018439,0.0388922364892705,7.29028541576703e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0591102223870317,0.00586352149248773,0.0476177202617558,0.0706027245123077,7.89623531795982e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,39788,0.0870900108137918,0.00864176241610968,0.0701521564782169,0.104027865149367,8.16277312953169e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,39718,0.0439335729526956,0.00436236287834239,0.0353833417111445,0.0524838041942467,8.74603826397018e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0558918699703142,0.00555155648804844,0.0450108192537393,0.0667729206868892,9.02646350226242e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0233406642014457,0.00231936459940305,0.0187947095866157,0.0278866188162757,9.71272180049586e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0405401021416813,0.00403089557261659,0.0326395468193528,0.0484406574640098,1.00288280682874e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.0674354670282696,0.00670497797203706,0.0542937102030769,0.0805772238534622,1.03114884492865e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37437,0.0729798582467043,0.00725639602560645,0.0587573220365157,0.087202394456893,1.03259978182553e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.070680585953451,0.00702785088228012,0.0569059982241819,0.08445517368272,1.03467421347898e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,37453,0.0534777622861417,0.00532070536793145,0.0430491797649961,0.0639063448072874,1.10154430696813e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,39858,0.0320573481930457,0.00319120605351236,0.0258025843281615,0.0383121120579299,1.12992343294581e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,39858,0.0539929191510776,0.00538030557203061,0.0434475202298976,0.0645383180722576,1.25270231085555e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0366740422646444,0.0036548671119678,0.0295105027251875,0.0438375818041013,1.2642818834311e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,0.122026238621522,0.0121626177601467,0.0981875078116347,0.14586496943141,1.28235598897132e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGN,Mimecan,39858,0.038141974703064,0.00380179414359579,0.0306904581816162,0.0455934912245117,1.28675276245082e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.0878179923242839,0.00876436357254503,0.0706398397220956,0.104996144926472,1.50572399674128e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,39866,0.0785440553745593,0.00786108190333524,0.0631363348440222,0.0939517759050963,1.94479687624959e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,39984,0.0570842814008667,0.00571619200634557,0.0458805450684294,0.068288017733304,2.04423973569369e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,39749,0.0339594063246876,0.00340131687457735,0.027292825250516,0.0406259873988592,2.09513972167843e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0629111048578139,0.00630729607020764,0.050548804560207,0.0752734051554209,2.3852765169032e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM3,Dynamin-3,37411,0.0529528256949296,0.00531278495401464,0.0425397671850609,0.0633658842047983,2.55556006640732e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,39866,0.0880551289720411,0.00885186065411942,0.070705482089967,0.105404775854115,3.01643736064758e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37056,0.0323708811896294,0.00325495148619838,0.0259911762766805,0.0387505861025782,3.19676269321705e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0410189844623084,0.00412728463699473,-0.0491084623508181,-0.0329295065737988,3.30507690872608e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,0.0580533902017345,0.00584229702650358,0.0466024880297875,0.0695042923736816,3.45818687889428e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,39866,0.0821834135819957,0.00827991493638489,0.0659547803066813,0.0984120468573101,3.75675785186892e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0284263660606599,0.00286442051369171,0.0228121018538242,0.0340406302674957,3.81441612891006e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.0792066217883438,0.00800209608119955,0.0635225134691927,0.0948907301074949,5.09128510438827e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39477,0.0560803046221362,0.0056823220116647,0.0449429534792734,0.067217655764999,6.60239532213449e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.022064960121397,0.00223596737189171,0.0176824640724893,0.0264474561703048,6.65668684022151e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNG,Interferon gamma,39587,0.108655719499374,0.0110170828865244,0.087062237041786,0.130249201956962,7.05352150024994e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40034,0.0220600093245344,0.00223723944530546,0.0176750200117357,0.0264449986373331,7.17191338033999e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.100853061030146,0.0102376505844699,0.0807872658845855,0.120918856175707,7.86597370589653e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37043,0.0385747070431199,0.00391598414818596,0.0308993781126754,0.0462500359735644,8.17003530088929e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,0.069144914655457,0.00702024800499726,0.0553852285656624,0.0829046007452517,8.22890814326768e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37437,0.0614190562394439,0.00624301403242324,0.0491827487358944,0.0736553637429935,9.1978838828016e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,0.0610626839167726,0.00620932432687541,0.0488924082360968,0.0732329595974484,9.57273236976548e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0541866219868064,0.00551447387272649,0.0433782531962625,0.0649949907773503,1.0100337107325e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37039,0.043104821390958,0.00438872911802344,0.034502912319632,0.0517067304622839,1.08620050184963e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,39858,0.0730206842776928,0.00744265926165898,0.0584330721248412,0.0876082964305444,1.16856744483765e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37388,0.0241572870520246,0.00246399952812175,0.019327847976906,0.0289867261271433,1.28588575680154e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,0.0715124612373458,0.0072960651233404,0.0572121735955986,0.085812748879093,1.28756450838437e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,0.0313207568176084,0.00319652381025875,0.0250555701495012,0.0375859434857155,1.32438536767716e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,39931,0.100233318720845,0.0102297056873614,0.0801830955736171,0.120283541868074,1.32517252160304e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0296388533936575,0.00302795283653705,0.0237040658340449,0.0355736409532701,1.50688155861071e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0282737409830978,0.0028918389236463,0.0226057366927511,0.0339417452734446,1.63294170729647e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10,Interleukin-10,39587,0.0745488393739623,0.00762587018247929,0.0596021338163028,0.0894955449316217,1.65802248977838e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,0.023969212418344,0.00245259358020298,0.0191621290011461,0.0287762958355418,1.74368876475098e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37388,0.0578730558529927,0.00592448120889733,0.0462610726835539,0.0694850390224314,1.8244582873377e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0525519459543844,0.00538931701603883,0.0419888846029483,0.0631150073058205,2.1032535952123e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37021,0.0443231123538771,0.00454590899919192,0.0354131307154609,0.0532330939922932,2.19383575058967e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,0.0321949207236496,0.00330703865041452,0.0257131249688371,0.038676716478462,2.46576339359572e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,39998,0.0383988386218261,0.00394481457676178,0.030667002051373,0.0461306751922792,2.48731322923652e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXIN1,Axin-1,39866,0.0894083072218115,0.00919103673319203,0.0713938752247551,0.107422739218868,2.64659063896303e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPL,Periplakin,37056,0.030216032055469,0.00310605683178839,0.0241281606651637,0.0363039034457742,2.7188655512976e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.0659572750127797,0.00678477455117282,0.052659116892481,0.0792554331330784,2.82455320398025e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP10,Caspase-10,39489,0.0668174192568837,0.00687581969814906,0.0533408126485116,0.0802940258652559,2.9289876113116e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,-0.030027987369839,0.00309022435586146,-0.0360848271073275,-0.0239711476323506,3.02710020773665e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0268045240544506,0.00276074350474362,0.0213934667851531,0.0322155813237481,3.25441380571306e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FST,Follistatin,39908,0.0480903899715425,0.00495515527346197,0.038378285635557,0.0578024943075279,3.30009974888567e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.0684435701567655,0.00705322598937667,0.0546192472175872,0.0822678930959438,3.34195657776657e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0357695931671663,0.00368754388687788,0.0285420071488857,0.042997179185447,3.47822988904223e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.0699883005544857,0.00721630217612444,0.0558443482892818,0.0841322528196896,3.62364557351401e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,39749,0.0579131522521108,0.00597322047513369,0.0462056401208487,0.0696206643833728,3.63079300200234e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTBDN,Retbindin,39788,0.0273224488720954,0.00282381104538501,0.0217877792231408,0.03285711852105,4.39763270062501e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40030,0.103921367482135,0.0107450046314658,0.0828611584044618,0.124981576559808,4.56852025103692e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37037,0.0400163202894872,0.00413958727049866,0.0319027292393098,0.0481299113396646,4.94027417591502e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0582122578085868,0.0060260678627764,0.0464011647975451,0.0700233508196285,5.24434386805229e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.0723983478031501,0.00749960189208402,0.0576991280946654,0.0870975675116348,5.58426101216511e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0537761834146074,0.00557059602728061,0.0428578152011374,0.0646945516280773,5.61337985242766e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,39782,0.0383758242196253,0.00397756727382456,0.0305797923629291,0.0461718560763214,5.75292028696815e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39477,0.0271546094742892,0.00281572486727701,0.0216357887344263,0.0326734302141522,6.00511158029262e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,-0.0278641677224101,0.00288944452707557,-0.0335274789954782,-0.022200856449342,6.00925241406545e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39477,0.0538658322150937,0.00558683945384986,0.042915626885548,0.0648160375446395,6.14380261842681e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39489,0.0438336322096188,0.00454949554305128,0.0349166209452383,0.0527506434739993,6.55636720474878e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,-0.0265200013579894,0.00275538131444955,-0.0319205487343105,-0.0211194539816683,7.18962253116393e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0714601390902573,0.00743304761341079,-0.0860289124125425,-0.0568913657679722,8.00279674493467e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,0.0778662748819415,0.00810260073063863,0.0619851774498898,0.0937473723139932,8.51389151622599e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0225877600548068,0.00235258945456715,-0.0271988353857584,-0.0179766847238552,9.02784415619091e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,0.0817480357702191,0.0085236024859512,0.0650417748977548,0.0984542966426835,1.02485608708109e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40052,0.03947119735194,0.00412063883169733,0.0313947452418132,0.0475476494620668,1.11956490662347e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,37453,0.0171776790947652,0.00179367543502834,0.0136620752421096,0.0206932829474207,1.17151385628908e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,0.0737760431833341,0.00773841310846596,0.0586087534907408,0.0889433328759274,1.77932050809819e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,0.0531731738958344,0.00558119454843906,0.0422340325808938,0.064112315210775,1.84776202312435e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,39496,0.0344743675889458,0.00362539071887897,0.027368601779943,0.0415801333979485,2.19602214497443e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,0.0725338150924227,0.00762642543250181,0.0575860212447192,0.0874816089401263,2.21408445445195e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0541244879551103,0.00569720670545119,0.042957962812426,0.0652910130977947,2.44076914100593e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C3,Complement C3,36816,0.0424167298401632,0.0044661481691282,0.0336630794286719,0.0511703802516544,2.52500233631646e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37411,0.0713479649634301,0.00752051268551711,0.0566077600998165,0.0860881698270436,2.76533153828114e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37411,0.0967322910251019,0.0102033796314043,0.0767336669475496,0.116730915102654,2.9474737236955e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0731714611385893,0.00772882136871088,0.058022971255916,0.0883199510212626,3.35232328700915e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,-0.041153002506296,0.00435016882364532,-0.0496793334006409,-0.0326266716119512,3.57597762197561e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,0.0237667283407537,0.00251323255553067,0.0188407925319136,0.0286926641495938,3.60963839378588e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0364653443956684,0.00385755956133321,0.0289045276554553,0.0440261611358815,3.74011858971192e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,39871,-0.0248138183366394,0.00262513637063201,-0.0299590856230781,-0.0196685510502006,3.76003968816534e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID2,Nidogen-2,39858,0.0661454016251567,0.00700116834532536,0.052423111668319,0.0798676915819944,3.92937879772713e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39453,0.0409240227517132,0.00433146523551004,0.0324343508901135,0.0494136946133129,3.93062490167111e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37388,0.0505047106018105,0.00535235080171147,0.040014103030456,0.060995318173165,4.49623567049948e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,0.0790355649169418,0.0083782045282985,0.0626142840414768,0.0954568457924069,4.49995239482599e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.0772029229638438,0.00818437199645427,0.0611615538507934,0.0932442920768942,4.62551857339946e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37124,0.0461885927058321,0.00490050880659922,0.0365835954448976,0.0557935899667666,4.99152597494146e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0562981819048177,0.00598067698278837,0.0445760550185525,0.0680203087910829,5.57094163433976e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL19,Interleukin-19,39419,0.0621931993055782,0.00660988162610109,0.0492378313184201,0.0751485672927363,5.68763603918075e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.053987052967613,0.00574218054397924,0.0427323791014137,0.0652417268338123,6.08502167874885e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39405,0.107144360394341,0.0114047476677665,0.0847910549655187,0.129497665823163,6.51825523578264e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,39868,0.0350799694502707,0.00373576225316839,0.0277578754340606,0.0424020634664807,6.77018336696459e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0657371274504084,0.00700512956382409,0.0520070735053132,0.0794671813955036,7.17616229182144e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37388,0.0342253111651274,0.00365070565627272,0.0270699280788328,0.0413806942514219,8.0010003591409e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0630865654125214,0.00673966188400271,0.0498768281198761,0.0762963027051667,8.97329438729753e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0509535561516395,0.00544676667280588,0.04027789347294,0.061629218830339,9.4798177688129e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0554803647444049,0.00593164822320884,0.0438543342269156,0.0671063952618942,9.80763674630359e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0233665569599202,0.00250024355801664,-0.0282670343336328,-0.0184660795862076,1.0531078321668e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.048540448113148,0.00519407632176813,0.0383600585224825,0.0587208377038136,1.05975626929631e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,39739,0.0521846789551377,0.0055982293665257,0.0412121493967473,0.063157208513528,1.29310583146209e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0453448400755867,0.00486655224335073,0.0358063976786192,0.0548832824725541,1.34494886534702e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37124,0.0517402833597977,0.00557130414889547,0.0408205272279625,0.0626600394916328,1.8319110569201e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,39713,0.0574541858799252,0.00620377967218912,0.0452947777224345,0.0696135940374158,2.27616536119462e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOST,Sclerostin,39846,0.0341306233760875,0.00368646399751579,0.0269051539409565,0.0413560928112184,2.33391607541772e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH3,Cadherin-3,40009,0.0308787611223633,0.00333664418083307,0.0243389385279305,0.0374185837167961,2.41799969372903e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOE,Apolipoprotein E,37453,0.0648260300152504,0.00701404278907489,0.0510785061486636,0.0785735538818372,2.76557218755901e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0582792898446152,0.00631743195559487,0.0458971232116492,0.0706614564775811,3.17450662102586e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40024,0.0611675496921853,0.00663216919188653,0.0481684980760877,0.0741666013082829,3.24259363782428e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37388,0.0409780365931526,0.00445098828521596,0.0322540995541293,0.0497019736321758,3.85743849687707e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0346284310183208,0.0037776693751771,0.0272241990429737,0.0420326629936679,5.45534238208555e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0395675859058261,0.00432299789101103,0.0310945100394445,0.0480406617722078,6.20679611271951e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,39858,0.0231141695465011,0.00252561327109718,0.0181639675351507,0.0280643715578516,6.25585884411168e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0499094363999826,0.00545663794826304,0.039214426021387,0.0606044467785782,6.57207199797342e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.0235438700956061,0.00257556909429448,0.0184957546707889,0.0285919855204232,6.90518466095545e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,0.0677299290588717,0.00742012966451031,0.0531864749164315,0.0822733832013119,7.96110583950561e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0856846281071601,0.00939054683627395,0.0672791563080632,0.104090099906257,8.04540322706545e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39173,0.0185158802897977,0.00203217393880984,0.0145328193697304,0.022498941209865,9.12474724276877e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40011,0.0468052452026285,0.00514145864621514,0.0367279862560469,0.0568825041492102,9.74941800624306e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0247836777579458,0.002732531349921,0.0194279163121006,0.0301394392037909,1.328958987273e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40052,-0.0262690716044833,0.00290014517647871,-0.0319533561503816,-0.020584787058585,1.47942289596604e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASC3,Protein CASC3,37039,0.0367809433850013,0.00406616326304916,0.0288112633894249,0.0447506233805776,1.69412458321497e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GET3,ATPase GET3,37437,0.0489766886531383,0.00541711701126833,0.0383591393110524,0.0595942379952243,1.75849580844791e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0459279824844651,0.00508126549899071,0.0359687021064433,0.0558872628624869,1.80275994456586e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,39843,-0.0273800024085382,0.00303117108183649,-0.0333210977289377,-0.0214389070881387,1.86080711521924e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0510054467898947,0.00565143815027601,0.0399286280153537,0.0620822655644357,2.0374786461695e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,39866,0.0800539159313297,0.00887771136730368,0.0626536016514145,0.0974542302112449,2.14015338816755e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.0901671194602879,0.0100104655880409,0.0705466069077278,0.109787632012848,2.34598989792355e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.048100938966398,0.00534301000005652,0.0376286393662872,0.0585732385665088,2.49804865569832e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37368,0.0185728800902322,0.00206573372010115,0.014524041998834,0.0226217181816305,2.77335491481301e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0592419611634363,0.00659336428651734,0.0463189671618623,0.0721649551650102,2.93055637348886e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,0.0913674733558511,0.0101743974950055,0.0714256542656402,0.111309292446062,3.001439145541e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPO,Myeloperoxidase,39858,0.0392156397544407,0.00436708098821056,0.030656161017548,0.0477751184913334,3.00842055866998e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POF1B,Protein POF1B,37056,0.0393263992110248,0.00437930353180446,0.030742964288688,0.0479098341333615,3.06881613177728e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37437,0.0878987986188595,0.00979901972930445,0.0686927199494228,0.107104877288296,3.34389611882271e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0310051308456339,0.00345774849387307,0.0242279437976426,0.0377823178936251,3.45839290210907e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.0892446599169526,0.00997997167663735,0.0696839154307434,0.108805404403162,4.31081324317883e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.0844547574871711,0.00945323837137935,0.0659264102792676,0.102983104695075,4.55043730546133e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.0568509748141279,0.00636959670870659,0.044366565265063,0.0693353843631928,5.00637416500565e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,39885,0.0202621145610981,0.00227415749858297,0.0158047658638754,0.0247194632583207,5.65655966996386e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,39585,0.0345722501791351,0.00388051581186903,0.0269664391878718,0.0421780611703984,5.69460469148376e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,39868,0.0483189903632079,0.00542663398248677,0.0376827877575338,0.0589551929688819,5.95287702466019e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.032760171988415,0.0036809055201757,0.0255455971688706,0.0399747468079593,6.17413602863557e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPN,Asporin,37437,-0.0232091627909549,0.0026094716200035,-0.0283237271661617,-0.018094598415748,6.6189423364311e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0264384808463515,0.00297406542680906,-0.0322676490828972,-0.0206093126098057,6.85914627987139e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37382,0.0512291651257188,0.00576291619839341,0.0399338493768677,0.0625244808745699,6.90956950278383e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0407572324878256,0.00458936549294248,0.0317620761216584,0.0497523888539929,7.46545396390921e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SBSN,Suprabasin,37420,-0.0291430150255693,0.00328470714906812,-0.0355810410377428,-0.0227049890133958,8.04942241423662e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,39868,0.0223794933759039,0.00252656251488544,0.0174274308467284,0.0273315559050794,9.0127805516983e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,39715,0.0602605840958503,0.00680341438423774,0.0469258919027444,0.0735952762889563,9.04397058869296e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.0979649894565541,0.0110649103225698,0.0762777652243173,0.119652213688791,9.51246981321386e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0576224783391072,0.0065139149508821,0.0448552050353783,0.0703897516428361,1.00210065693645e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37388,0.064781188379842,0.00732990405902334,0.0504145764241562,0.0791478003355277,1.09410204122225e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZN,Kazrin,37382,0.0889972355722892,0.010080355235422,0.069239739310862,0.108754731833716,1.18692441576411e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39477,0.0830541610615465,0.00943327238804312,0.064564947180982,0.101543374942111,1.45167920253018e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.0634556074528768,0.00721000625136438,0.0493239952002027,0.077587219705551,1.49270864923506e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A12,Protein S100-A12,39615,0.0633630870041425,0.00720794690406962,0.049235511072166,0.0774906629361189,1.63713265180587e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.075164943549056,0.00855107461456476,0.058404837304509,0.0919250497936029,1.64426916572896e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0325912806760862,0.00370858984453153,-0.039860116771368,-0.0253224445808044,1.67319239389552e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,39821,0.0574527628095997,0.00654506296259049,0.0446244394029224,0.0702810862162771,1.82958416417397e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.0946767954625144,0.010792800929929,0.0735229056398534,0.115830685285175,1.92734388132053e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN1,Pantetheinase,37445,0.0615419722110341,0.00702005231223318,0.0477826696790571,0.0753012747430111,2.05783165037961e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0168450929026124,0.00192150437199093,0.0130789443335102,0.0206112414717146,2.05841793970408e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0311311962014523,0.00355160118571012,0.0241700578774604,0.0380923345254441,2.08716704705984e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37388,0.0500036598377505,0.00571225512556943,0.0388076397916344,0.0611996798838666,2.3058327054317e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37388,0.0696856815523029,0.00796370624734869,0.0540768173074994,0.0852945457971063,2.37477823945644e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37021,0.0675967911353638,0.00772621058134272,0.0524534183959321,0.0827401638747955,2.41135422343287e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0493856953242476,0.00565190339996554,0.0383079646603151,0.06046342598818,2.60912807376142e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0425525465161677,0.00486999662376591,0.0330073531335865,0.0520977398987489,2.65621348701986e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,0.0422255215125022,0.00483525032697986,0.0327484308716216,0.0517026121533827,2.77936279867065e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,39866,0.0681637264718431,0.00782504531235821,0.052826637659621,0.0835008152840652,3.30322292484806e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK2,Docking protein 2,39868,0.102928799029046,0.0118225012707418,0.0797566965383921,0.1261009015197,3.44508114641843e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,0.0657358582539936,0.00755111270400355,0.0509356773541467,0.0805360391538406,3.53325273138354e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,-0.0201365862625363,0.00231469483163568,-0.0246733881325422,-0.0155997843925303,3.65275811475806e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37056,0.0269787983591235,0.00310070067450947,0.0209014250370849,0.033056171681162,3.68011671871538e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37043,0.0648751413839721,0.0074634004681679,0.050246876466363,0.0795034063015812,3.96269511136226e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGT,Angiotensinogen,37445,0.0188643050794035,0.00217254437494472,0.0146061181045118,0.0231224920542951,4.28807869178277e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40058,0.0290896117232225,0.00335212786544984,0.0225194411069409,0.0356597823395042,4.40706713542499e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,39822,0.0339639453017008,0.00392166756001612,0.0262774768840692,0.0416504137193324,5.13624790855435e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2,Complement C2,39908,0.0197564288021953,0.00228148901587337,0.0152847103310835,0.0242281472733071,5.18524535126828e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,0.0565138420199609,0.00653569786021183,0.0437038742139457,0.0693238098259761,5.77783827606217e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.0655300616099272,0.0075785741126337,0.0506760563491652,0.0803840668706893,5.79758485832954e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37056,0.0382928827648604,0.00442833321371426,0.0296133496659805,0.0469724158637404,5.87942701378141e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,0.0211200841484567,0.00244414805123156,0.0163295539680428,0.0259106143288705,6.08096163807093e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0511043457680449,0.0059241263136241,0.0394930581933417,0.0627156333427482,6.9109199406064e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,0.0602574993894254,0.00699218548172077,0.0465528158452527,0.0739621829335981,7.57029834946591e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0334794453681862,0.00388581755704392,0.0258632429563801,0.0410956477799923,7.70815594831359e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0707581090607212,0.0082216545527239,0.0546436661373824,0.08687255198406,8.23808989290981e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN3,Perilipin-3,39868,0.0355778756384751,0.00413847376637816,0.0274664670563739,0.0436892842205762,8.94039432425101e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.0223595458273644,0.00260038284878273,0.0172627954437503,0.0274562962109786,8.94800363732151e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37411,0.0461808864318277,0.00537126749608621,0.0356532021394987,0.0567085707241567,9.01169577290892e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,0.024141901915556,0.00280903004458143,0.0186362030281764,0.0296476008029356,9.28187149871404e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,0.0714621995866296,0.00831844377592207,0.0551580497858223,0.0877663493874368,9.42144281779719e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNST,Consortin,39868,0.0893671119540259,0.0104100637022086,0.068963387097697,0.109770836810355,9.93499696990104e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0295508809717056,0.00344746719151897,0.0227938452763284,0.0363079166670828,1.11120624990902e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0400913238425433,0.0046777036868319,0.0309230246163528,0.0492596230687338,1.13898747824554e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,39771,0.0463122130249007,0.00540583368290724,0.0357167790064025,0.0569076470433989,1.15750967673655e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0300542624518987,0.00350975873057355,0.0231751353399746,0.0369333895638229,1.2198989284995e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,39866,0.0308591387700484,0.00360478972743625,0.0237937509042733,0.0379245266358234,1.22359811840253e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.0665854874624416,0.00778539970804919,0.0513261040346652,0.081844870890218,1.33129071354697e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40009,0.0236770447530878,0.0027774716164133,0.0182332003849177,0.0291208891212579,1.66623353322018e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0632800880715906,0.00743059658557817,0.0487161187638573,0.0778440573793238,1.82209259877325e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.0523684288564957,0.00616079200560768,0.0402932765255046,0.0644435811874867,2.06047383819034e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37043,0.0440152107321729,0.00517987662842295,0.0338626525404639,0.0541677689238819,2.14635057849053e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0194749994402688,0.00229288900543714,-0.0239690618909256,-0.014980936989612,2.17582377764581e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN2,Centrin-2,39489,0.055380849525899,0.00652263643789757,0.0425964821076198,0.0681652169441783,2.23919975876389e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD2,Polycystin-2,37021,0.0488931441554741,0.00576047945380403,0.0376026044260182,0.06018368388493,2.33178984575501e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0396447919926147,0.00467378255606328,0.0304841781827307,0.0488054058024987,2.40174716248662e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37382,0.0272898308790389,0.00321807909065899,0.0209823958613473,0.0335972658967305,2.48013491568048e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37178,0.0296948407732212,0.00350201257853194,0.0228308961192986,0.0365587854271438,2.50082987391772e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0355181204492301,0.00419060384681209,0.0273045369094784,0.0437317039889818,2.58151029524368e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFB,Complement factor B,37220,0.0270235091533334,0.00319757578385195,0.0207562606169836,0.0332907576896832,3.17803691414617e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0589348426213488,0.00697649235014621,0.0452609176150623,0.0726087676276354,3.22982589131989e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX8,Syntaxin-8,39866,0.0396898968617983,0.00470155893270598,0.0304748413536946,0.048904952369902,3.38782742970847e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK10,Kallikrein-10,39856,0.0320012024279401,0.00379471641314964,0.0245635582581669,0.0394388465977134,3.65051016479925e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0509598912282765,0.00604149953173848,0.0391185521460691,0.062801230310484,3.65565406269075e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37368,0.067603259757411,0.00801931355171964,0.0518854051960405,0.0833211143187815,3.80218097959541e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0212050631922287,0.00251758882679981,0.0162705890917011,0.0261395372927563,4.05461582256888e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES2,Cocaine esterase,39788,0.0438788734026112,0.00521803168872985,0.0336515312927007,0.0541062155125217,4.47838910678623e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLB,Beta-klotho,39489,-0.059545001081599,0.00708871876223371,-0.0734388898555771,-0.0456511123076209,4.84594501357194e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0487051008899648,0.00580188720755575,0.0373334019631556,0.0600767998167741,5.14402508072496e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37368,0.0321020071651458,0.00383103044680882,0.0245931874894005,0.039610826840891,5.8377542382586e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0432629867897456,0.00516513910857924,0.0331393141369303,0.053386659442561,6.02394039419192e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0380863282841446,0.00455078250773237,0.0291667945689892,0.0470058619993001,6.27186701783981e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0247448108779808,0.00296544026459481,0.018932547959375,0.0305570737965866,7.7387958340533e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,-0.019902660065973,0.00238593953344411,-0.0245791015515235,-0.0152262185804226,7.9102587724004e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37124,0.0446862641725779,0.00535741803469557,0.0341857248245745,0.0551868035205812,8.08806134348538e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40058,0.0214719325064458,0.00257550654299761,0.0164239396821704,0.0265199253307211,8.22727436169043e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,39866,0.0676515479885319,0.008122078647103,0.0517322738402101,0.0835708221368538,8.78116386844393e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,39804,0.0373092285793874,0.0044800868388367,0.0285282583752675,0.0460901987835073,8.89885974724567e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0510391292277418,0.00613697922666098,0.0390106499434863,0.0630676085119973,9.76143037231262e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.0631043174838375,0.0075895294526179,0.0482288397567064,0.0779797952109686,9.95178661337674e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAP,Prosaposin,37347,0.0225137276978989,0.00270987709124278,0.017202368599063,0.0278250867967347,1.06529825144446e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,0.0196130317252286,0.00236087201327375,0.014985722579212,0.0242403408712451,1.06913420575787e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLVRB,Flavin reductase,39858,0.0516056641791394,0.00621473893840214,0.0394247758598713,0.0637865524984076,1.08861437880122e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0378316501604223,0.00455721883408897,0.0288995012456079,0.0467637990752367,1.12489983094958e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,0.0236891897007825,0.0028544028965699,0.0180945600235055,0.0292838193780595,1.14702143935606e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,39858,0.0419537693798959,0.00505789400052284,0.0320402971388712,0.0518672416209207,1.17432067337235e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37382,0.0570920232610139,0.00689273319862145,0.0435822661917158,0.0706017803303119,1.31400173815018e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0338363340951971,0.00408510819269517,0.0258295220375146,0.0418431461528796,1.31716347273469e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37043,0.018389701011278,0.00222083843918918,0.0140368576704672,0.0227425443520888,1.34377496147268e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.0728918194074342,0.00882851819840384,0.0555879237385627,0.0901957150763057,1.64312186829079e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.117786817600943,0.014282454778723,0.0897932062346456,0.14578042896724,1.77373837046511e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0519348720759697,0.00630277187939188,0.0395814391923616,0.0642883049595778,1.87938188115824e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37382,0.0540546280191952,0.00656142849538108,0.0411942281682483,0.0669150278701421,1.90715617245892e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREH,Trehalase,37437,0.0600711582779285,0.00729265061740775,0.0457775630678093,0.0743647534880477,1.92275348332554e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,0.0553788064555487,0.00672479290726297,0.0421982123573133,0.0685594005537841,1.96221866395519e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LARP1,La-related protein 1,37368,0.050946580037044,0.00619951205960137,0.0387955364002253,0.0630976236738627,2.25951021380313e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.0812014054093966,0.0099160135279613,0.0617660188945924,0.100636791924201,2.87065895208774e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40052,0.0440049378168004,0.00537500570513909,0.0334699266347278,0.054539948998873,2.87692961879575e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,0.0540977275929682,0.00661465388995479,0.0411330059686568,0.0670624492172796,3.0889203526675e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39477,0.0778237879777591,0.00952259452849662,0.0591595027019057,0.0964880732536124,3.24937187544513e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37043,0.0714724548641101,0.00874467736928766,0.0543328872203062,0.0886120225079139,3.2742250101857e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40009,0.023577640236844,0.00288627899032135,0.0179205334158142,0.0292347470578739,3.34125495128008e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,39858,-0.0248257266560456,0.00304006471069992,-0.0307842534890175,-0.0188671998230738,3.41845239855137e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,39720,0.0406024216535207,0.004981273099219,0.0308391263790515,0.0503657169279899,3.87622125356244e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40030,0.0211194307958309,0.00259812961470898,0.0160270967510013,0.0262117648406605,4.65054512878184e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0437850151481602,0.00538878210531775,0.0332230022217374,0.054347028074583,4.7950992758081e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLG,Plasminogen,37162,0.0178091358467449,0.0021930882131697,0.0135106829489322,0.0221075887445575,5.04597884620158e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40009,0.0499192585474632,0.00615306574704978,0.0378592496832456,0.0619792674116808,5.29478043136743e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0355742121681938,0.00438731355917584,0.0269750775922092,0.0441733467441785,5.57777521337214e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,0.0208652215628422,0.00257527700180871,0.0158176786392971,0.0259127644863873,5.78630229293997e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37124,0.0545159608895725,0.0067283748266235,0.0413283462293904,0.0677035755497545,5.85747639208937e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI3,Elafin,39594,0.0412209595092351,0.00510161682907632,0.0312217905242456,0.0512201284942247,6.94463148280819e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.0211753361128074,0.00262429823678988,0.0160317115686992,0.0263189606569156,7.68486354670542e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40058,0.0385751188790116,0.00478583124169958,0.0291948896452804,0.0479553481127428,8.13941995730278e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,39839,0.0736271099095345,0.00914080622992965,0.0557111296988724,0.0915430901201966,8.52038139829368e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.0878679341206366,0.0109148670089203,0.0664747947831528,0.10926107345812,8.83538448485844e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,0.0722401118477048,0.0089771593699216,0.0546448794826585,0.0898353442127512,9.0790973231029e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0284496059924222,0.00353472511479295,0.0215215447674281,0.0353776672174164,9.08698727879518e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0307866633965652,0.00382612924275499,0.0232874500807654,0.038285876712365,9.22789244258442e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCA2A,Guanylin,39796,0.0249832974528027,0.00310949292784658,0.0188886913142234,0.031077903591382,1.00472783336022e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0509581595208714,0.00634255458365304,0.0385267525369114,0.0633895665048313,1.00771773036464e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37056,0.0426317560842779,0.0053089827933632,0.032226149809286,0.0530373623592698,1.05588850557245e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0338557868168054,0.00421618658624228,0.0255920611077705,0.0421195125258402,1.05736955958763e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0597231244276901,0.00745513737925065,0.0451110551643589,0.0743351936910214,1.2328565292888e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0312635744040943,0.00390326719128948,0.0236131707091669,0.0389139780990217,1.24441297431943e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37124,0.0518939161439394,0.0064978030535822,0.0391582221589183,0.0646296101289605,1.50355480148337e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39477,0.0407074325529697,0.00509835426040666,0.0307146582025726,0.0507002069033667,1.5094650960379e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0365117800962459,0.00457276951282735,0.0275491518511043,0.0454744083413875,1.5259039852294e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0276536722479833,0.00346605265200986,0.020860209050044,0.0344471354459226,1.60078652068037e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.055779882131629,0.00699453481678758,0.0420705938907253,0.0694891703725326,1.65095158342024e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37138,-0.0163404817752416,0.00205203696852595,-0.0203624742335525,-0.0123184893169308,1.81428956953678e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,36962,0.0381576293877132,0.00479406509217798,0.0287612618070444,0.047553996968382,1.87115386453506e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,39793,0.0613398689694324,0.00771183217175095,0.0462246779128005,0.0764550600260642,1.92644818113208e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0241357049318386,0.00303436204789886,0.0181883553179568,0.0300830545457203,1.95025195913493e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0265302141610485,0.00333715584957529,0.019989388695881,0.0330710396262161,1.99004491012874e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0388810015968077,0.00489290730857544,0.0292909032719998,0.0484710999216156,2.04682500682552e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.024214262135851,0.00304805616662679,0.0182400720492625,0.0301884522224395,2.08440422114027e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40052,0.0148506084248287,0.00187100334986123,0.0111834418591007,0.0185177749905567,2.20178152615256e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37422,0.0356232267274154,0.00449273235468524,0.0268174713122323,0.0444289821425985,2.37957886069759e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37124,-0.0250583113533114,0.00316131797861348,-0.0312544945913938,-0.018862128115229,2.43256115322395e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39477,0.0338012339501278,0.00426822982642035,0.0254355034903439,0.0421669644099117,2.54913535061884e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37124,0.0529680172981433,0.00668731535871961,0.0398608791950529,0.0660751554012338,2.54963022574896e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,0.0171469493473883,0.00216651017268186,0.0129005894089319,0.0213933092858448,2.64348022419362e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,0.0367475526779287,0.00464450525135365,0.0276443223852756,0.0458507829705819,2.72775980623324e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,0.0238646729016329,0.00301883884906708,0.0179477487574615,0.0297815970458044,2.84517695197869e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.0933134759860388,0.0118301578488453,0.070126366602302,0.116500585369776,3.28051074990591e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40058,-0.00684665789821423,0.000868577855969296,-0.00854907049591405,-0.00514424530051441,3.40901619971245e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0555737991031611,0.00705165392575515,0.0417525574086811,0.0693950407976412,3.5027800810928e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.036238103660919,0.00460619536668089,0.0272099607422244,0.0452662465796135,3.85556852628574e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37043,0.0358998901797539,0.0045679112592146,0.0269467841116933,0.0448529962478146,4.16645495147626e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37382,0.0634266673149981,0.00808040920229847,0.0475890652784931,0.0792642693515031,4.49209881000419e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0364727696358568,0.00464727020792341,0.027364120028327,0.0455814192433867,4.54401353474019e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOC,Brother of CDO,39585,-0.0176604071637993,0.00225312269598573,-0.0220765276479313,-0.0132442866796672,4.86214638199873e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37056,0.0312830929554783,0.00399355562228069,0.0234557239358082,0.0391104619751485,5.1105023973324e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,39749,0.073366001803978,0.00936986592491063,0.0550010645911531,0.0917309390168028,5.18526452260807e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0223769754036608,0.00286047272555417,0.0167704488615746,0.027983501945747,5.48590903595401e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F12,Coagulation factor XII,37453,0.0313734544278419,0.0040144834839398,0.0235050667993199,0.0392418420563639,5.89541563210717e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37382,0.0514046708540213,0.00657783999754024,0.0385121044588424,0.0642972372492002,5.90883473313831e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0181279378722034,0.00232352987810057,0.0135738193111263,0.0226820564332805,6.4756585289671e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,0.0382081124679771,0.00489807050246802,0.0286078942831398,0.0478083306528145,6.60889060866171e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,39866,0.0296724148173232,0.00380702419358848,0.0222106473978897,0.0371341822367566,6.88248846096362e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0384121896249903,0.0049343458550624,0.028740871749068,0.0480835075009126,7.42667663006085e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37039,0.0993182699451574,0.0127805487789737,0.0742683943383689,0.124368145551946,8.35861716429641e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0432117167807287,0.00556466658345532,0.0323049702771563,0.0541184632843011,8.63476490782396e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0285132583095482,0.00367128983970942,0.0213175302237177,0.0357089863953786,8.64251398863939e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0249501650280686,0.00321325760918438,0.0186521801140672,0.03124814994207,8.66700130915459e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,0.0168172031596163,0.00216652745800398,0.0125708093419285,0.0210635969773041,8.84568412205331e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37021,0.0320921376543133,0.00413865584766477,0.0239803721928904,0.0402039031157363,9.53866011695088e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37411,0.0568787144154714,0.00734229623089869,0.0424878138029099,0.0712696150280328,1.00975973159287e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0462909317076066,0.00598518713665063,0.0345599649197714,0.0580218984954418,1.11558472159102e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0359449457572381,0.00464991562480426,0.0268311111326217,0.0450587803818544,1.13856272750089e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN2,Matrilin-2,39885,0.0221544038804099,0.00286880287744981,0.0165315502406083,0.0277772575202116,1.20759607642948e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPOCK1,Testican-1,39749,-0.0188995684775633,0.00244732659445185,-0.023696328602689,-0.0141028083524377,1.20808549903889e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,0.0600793518075969,0.00778529317971124,0.0448201771753629,0.0753385264398309,1.26066156277931e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,39587,0.0689367974325411,0.00893780651031263,0.0514186966723283,0.0864548981927538,1.30288878447569e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,39587,0.0357042131343117,0.00462938374275722,0.0266306209985076,0.0447778052701159,1.30720898655287e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39489,0.0383196934950897,0.00497020814470638,0.0285780855314652,0.0480613014587142,1.33494284573985e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37368,0.036284019124584,0.00470817891372322,0.0270559884536865,0.0455120497954815,1.38212627926133e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX4,Syntaxin-4,39788,0.0440254548754432,0.00571527309359095,0.0328235196120049,0.0552273901388814,1.40564365237457e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37073,0.0490229687622318,0.00637056214267743,0.036536666962584,0.0615092705618795,1.5122894087269e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37124,0.0369027623244046,0.00479625622178823,0.0275021001296997,0.0463034245191095,1.52558421578285e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.0771610191761574,0.010035486078653,0.0574914664619974,0.0968305718903173,1.57063479510746e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.02717291423451,0.00353480990211625,0.0202446868263621,0.0341011416426578,1.60900781217512e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40011,0.0228038344414213,0.00296870233678643,0.0169851778613199,0.0286224910215227,1.66331634842242e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,0.0263132579614871,0.00342600563935966,0.0195982869083422,0.0330282290146321,1.6757655495651e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBD,Thrombomodulin,39868,0.0201076563475442,0.00262192504091965,0.0149686832673417,0.0252466294277467,1.83211651488333e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0166988174344845,0.00217814644179475,0.0124296504085668,0.0209679844604022,1.8700608647234e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.0694413058346156,0.00905972620662573,0.0516842424696291,0.087198369199602,1.89486165516777e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2,Brorin,39684,0.0284634713261116,0.00371400355023197,0.0211840243676569,0.0357429182845662,1.90910702922343e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37382,0.0249273246468143,0.00325318612482394,0.0185510798421594,0.0313035694514692,1.94830420282626e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,0.0251216203288772,0.00328213577307572,0.0186886342136488,0.0315546064441057,2.05878135224559e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,39858,0.0177801399186653,0.00232323062566942,0.0132266078923532,0.0223336719449773,2.07189534130925e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNXB,Tenascin-X,39858,-0.0189719335047593,0.00247943603763054,-0.0238316281385151,-0.0141122388710034,2.09584800567758e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0321526856175257,0.00420264828390658,0.0239154949810688,0.0403898762539826,2.11722143978802e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37388,0.0687850989287495,0.00899090140802987,0.0511629321690109,0.086407265688488,2.13663867823193e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,39587,0.0358624202789527,0.0046930888687382,0.0266639660962259,0.0450608744616796,2.26982795376837e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37445,0.0351792929359391,0.00460304215847959,0.0261573303053191,0.0442012555665591,2.27082964906592e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.0397220039010165,0.0051975593141435,0.0295347876452952,0.0499092201567378,2.27474893635839e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,39585,0.0341857959160061,0.00447809159877238,0.0254087363824122,0.0429628554495999,2.40596797915697e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,0.0430797972952713,0.00564914574398263,0.0320074716370653,0.0541521229534772,2.56165308582694e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,39831,0.0194549064916381,0.00255246678161371,0.0144520715996753,0.024457741383601,2.63762957357016e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0401029515715931,0.0052633507419668,0.0297867841173382,0.050419119025848,2.69399760082804e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37043,0.0456667865903313,0.00600991491967769,0.033887353347763,0.0574462198328995,3.19583775887257e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,39858,0.0202906399117406,0.00267216345653624,0.0150531995369296,0.0255280802865516,3.28939267493941e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,39585,0.0270049922217589,0.00355642274817389,0.020034403635338,0.0339755808081797,3.29335461233413e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0639489622871566,0.00842211757659093,0.0474416118370384,0.0804563127372748,3.33083412049156e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,0.0259052265729785,0.00341826880849352,0.0192054197083312,0.0326050334376258,3.7232697722868e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0163444545542688,0.00215804915911754,0.0121146782023984,0.0205742309061391,3.86087516615926e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37388,0.0479742549533643,0.00633832119809128,0.0355511454051054,0.0603973645016232,4.00638440197806e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,0.0649065454360247,0.00857556925765026,0.0480984296910302,0.0817146611810192,4.01721488193735e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37056,0.0329059515674101,0.00434913611044239,0.024381644790943,0.0414302583438772,4.10070978256829e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,0.0457344937169328,0.00604571811148982,0.0338848862184127,0.0575841012154528,4.13529593513664e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0241136840247105,0.0031960288924143,0.0178494673955784,0.0303779006538425,4.82770168510704e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0249791061101217,0.00331708383724197,0.0184776217891275,0.031480590431116,5.3274391282001e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.027086465689694,0.00359805863550786,0.0200342707640986,0.0341386606152894,5.42316631934831e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN3,Centrin-3,37382,0.0575370549952186,0.00765132597841359,0.042540456077528,0.0725336539129093,5.82765542966641e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37388,0.078562394156719,0.0104494775508365,0.0580814181570795,0.0990433701563585,5.89768099212655e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0430311172919718,0.00572767839956717,0.0318048676288201,0.0542573669551234,6.09881957798911e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0484821875022355,0.00645373702611906,0.0358328629310421,0.0611315120734289,6.18573757339365e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,36961,0.0404123288242077,0.0053903958581733,0.029847152942188,0.0509775047062273,6.94356660022499e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,39866,0.0476531586392169,0.00635985873828562,0.0351878355121771,0.0601184817662567,7.09359640053727e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0247956258101305,0.00331531027766665,0.0182976176659038,0.0312936339543571,7.86689439968981e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.0620827941705271,0.00830197529607484,0.0458109225902204,0.0783546657508338,8.01930781113804e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.0683895403534156,0.00915252590848422,0.0504505895727865,0.0863284911340446,8.29620374068886e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0308328714175119,0.00412872384432027,-0.0389251701523796,-0.0227405726826442,8.57040073904515e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.037861881988914,0.00507859442351582,0.027907836918823,0.047815927059005,9.44104601076171e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,0.0653893277232146,0.00877446130580015,0.0481913835638463,0.0825872718825829,9.73182998073702e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,39826,0.0489870462949304,0.00657485635497825,0.0361003278391731,0.0618737647506878,9.76197984054782e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,0.0571936205959843,0.00768070473375703,0.0421394393178205,0.0722478018741481,1.00836789679496e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.0691062619330582,0.00929981589277286,0.0508786227832234,0.087333901082893,1.13279432111824e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAX,Protein max,39489,0.0753993274830867,0.0101584791275526,0.0554887083930836,0.0953099465730898,1.21022549075638e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40058,0.028698380789451,0.0038696446473345,0.0211138772806754,0.0362828842982266,1.26409111542764e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.046429941665563,0.00626067191212391,-0.0587008586133258,-0.0341590247178001,1.26660537919301e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0175857322243462,0.00237302170435588,-0.0222368547648837,-0.0129346096838086,1.33243551852714e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39489,0.0443828270027612,0.00599541407005153,0.0326318154254602,0.0561338385800622,1.40136156030697e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD226,CD226 antigen,37056,0.0300885098129334,0.00406382183642675,0.0221234190135369,0.0380536006123298,1.40156868617811e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,39575,-0.0214213959135143,0.00289460042336519,-0.0270948127433101,-0.0157479790837185,1.42568401412913e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0431512424174211,0.00583620832576232,0.0317122740989269,0.0545902107359153,1.50025755603873e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37382,0.0257088044305363,0.0034771992433831,0.0188934939135054,0.0325241149475672,1.51373917416852e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37445,0.0445816661873181,0.00603090058112973,0.0327611010483038,0.0564022313263323,1.52850630232945e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37437,0.0586707760046166,0.00794196710897914,0.0431045204710175,0.0742370315382157,1.58416900472143e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0232185951785218,0.00314565874716732,0.0170531040340739,0.0293840863229698,1.64652579094401e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRKL,Crk-like protein,39881,0.076190209229513,0.0103237724728092,0.055955615182807,0.0964248032762191,1.65958234412834e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.0183373136042493,0.00248774674738644,-0.0232132972291268,-0.0134613299793719,1.79089556484115e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37437,0.0588828977545556,0.00799009624420545,0.0432223091159129,0.0745434863931982,1.8118018210337e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37368,0.0291989468692159,0.00396401893225211,0.0214294697620017,0.03696842397643,1.86017608148289e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0306095113895484,0.00415725673295246,-0.0387577345861352,-0.0224612881929615,1.88655570678229e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37411,0.0483574828941462,0.00657129032964866,0.0354777538480348,0.0612372119402576,1.96096785308986e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,0.0318305001899026,0.00432901872424761,0.0233456234903773,0.040315376889428,2.03689822310033e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS27,Serine protease 27,39818,0.0284443378627651,0.00387032499094412,0.0208585008805146,0.0360301748450156,2.08829653709665e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37249,0.0783863673053627,0.0106704775343208,0.057472231338094,0.0993005032726314,2.15881024482869e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0390730318457884,0.00532112501746547,0.0286436268115561,0.0495024368800207,2.21107828190404e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39489,0.0362716336044087,0.00494668812564146,0.0265761248781515,0.045967142330666,2.36952203716205e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB2,Calretinin,39489,0.0206056249184093,0.00281037484054055,0.0150972902309498,0.0261139596058688,2.37877796071857e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,0.085945035440498,0.0117200521804321,0.062973733166851,0.108916337714145,2.378883706273e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,0.0619758031264341,0.008470423552234,0.0453737729640554,0.0785778332888127,2.68777995032633e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,0.0692446790230217,0.0094671986203195,0.0506889697271955,0.087800388318848,2.73920077021804e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,39749,0.0573156994150824,0.00784054485363185,0.041948231501964,0.0726831673282008,2.79507319922625e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.0775787442488534,0.0106155682399874,0.0567722304984781,0.0983852579992286,2.83854459647375e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37056,0.0301071305033597,0.00414394526789892,0.0219849977782778,0.0382292632284416,3.93021316625325e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37388,0.0319595191217031,0.00440151136765888,0.0233325568410917,0.0405864814023145,4.05120891793778e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39438,0.030330936559237,0.00418834950446611,0.0221217715304834,0.0385401015879905,4.63680928357271e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0376594705081451,0.00520244239065279,0.0274626834224656,0.0478562575938246,4.77065391153492e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0402697234452803,0.00556456926304206,0.0293631676897178,0.0511762792008427,4.84750636823687e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.027013408689924,0.00374304340468789,0.0196770436167358,0.0343497737631123,5.55582890688044e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0254656244492816,0.00353221689699291,0.0185424793311755,0.0323887695673877,5.92079860307039e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A11,Protein S100-A11,39703,0.0315604029338661,0.00438127265850762,0.0229731085231911,0.040147697344541,6.13369109816087e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0371589301718408,0.00515898482229101,0.0270473199201504,0.0472705404235312,6.21262066457676e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.0704552496209104,0.00978583420164405,0.0512750145856881,0.0896354846561328,6.30184603602486e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,39585,0.0587245148535512,0.00816521464748086,0.0427206941444887,0.0747283355626136,6.67084334433477e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0381712331034671,0.00531652160188796,0.0277508507637667,0.0485916154431675,7.29925667834536e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,-0.0313927941796791,0.00437498947505938,-0.0399677735507955,-0.0228178148085627,7.51854712864365e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0192106386574659,0.00267817306636596,0.0139614194473886,0.0244598578675432,7.65444657009748e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37021,0.0272105672329029,0.0037944078557824,0.0197735278355694,0.0346476066302364,7.82979476950262e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,39568,0.0288274119416684,0.00402185724812906,0.0209445717353354,0.0367102521480013,7.96697883074294e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,39729,-0.0231506532113776,0.00323058486250525,-0.0294825995418879,-0.0168187068808673,8.05669419902294e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,39862,-0.0150060792901585,0.0020963167648432,-0.0191148601492512,-0.0108972984310659,8.52271812679831e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.036327082447826,0.00507512099081786,0.026379845305823,0.046274319589829,8.55846980182446e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH1,Somatotropin,39846,-0.124447077725021,0.0174111689554046,-0.158572968877614,-0.0903211865724283,9.21630356133914e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.0649245871555689,0.00908215737862052,0.0471235586934727,0.0827256156176651,9.21642103554175e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,39990,0.0319192636859503,0.00446590017036182,0.0231660993520411,0.0406724280198595,9.22706106117601e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDN1,Endothelin-1,37043,0.0194565316853595,0.00272262391911909,0.0141201888038861,0.0247928745668329,9.38748866959738e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.0517622742147789,0.00724672469719542,0.0375586938082759,0.065965854621282,9.53501785608764e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA10,Annexin A10,39489,0.0539037601336734,0.00754867384294419,0.0391083594015028,0.068699160865844,9.6859734753644e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,39808,0.0714551742525648,0.010007675354045,0.0518401305586366,0.0910702179464931,9.7331030280708e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37043,0.0633605539133768,0.00888197482323227,0.0459518832598415,0.080769224566912,1.02873937145513e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,0.0411918517697606,0.0057773777517906,0.029868191376251,0.0525155121632701,1.04792000089709e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39421,0.0317951094903829,0.00445940317256838,0.0230546792721489,0.040535539708617,1.04857921650686e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,39908,0.0177384617145604,0.00248880426879161,0.0128604053477289,0.022616518081392,1.06711202583368e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0663257597891158,0.00931470542169332,0.0480689371625969,0.0845825824156347,1.12118109559576e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0467812987385044,0.00657281178107685,0.0338985876475938,0.059664009829415,1.15517985858841e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP1,Caspase-1,39489,0.045839989275277,0.00644167354680812,0.0332143091235331,0.0584656694270209,1.1579636125744e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,0.0429535163738288,0.00604033400715702,0.031114461719801,0.0547925710278565,1.19975516997787e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0247610952515565,0.00348230301510654,0.0179357813419477,0.0315864091611653,1.20468851642304e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,0.0353930278925406,0.00498338467865431,0.0256255939223781,0.045160461862703,1.28077922573129e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0811786395430864,0.0114400193620923,0.0587562015933856,0.103601077492787,1.33784864347636e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,-0.0291070538907652,0.00411367409293674,-0.0371698551129212,-0.0210442526686092,1.54853671943401e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,-0.0232326723247744,0.00328596053814986,-0.0296731549795481,-0.0167921896700007,1.6100896288058e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37318,-0.0194445449348992,0.00274978772743981,-0.0248341288806813,-0.0140549609891172,1.61075712610868e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.0714135340088476,0.0101077524717635,0.0516023391641911,0.091224728853504,1.66965276471507e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON2,Spondin-2,39775,0.0228531107381844,0.00323474547276382,0.0165130096115673,0.0291932118648015,1.67408298727758e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.0739743507824509,0.0104884161454044,0.0534170551374582,0.0945316464274435,1.83667462007378e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.03187069238976,0.0045230517880596,0.0230055108851632,0.0407358738943568,1.92623918303805e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0462317242408935,0.00656686486759758,0.0333606691004022,0.0591027793813847,1.99831307171315e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.0145152283853976,0.00207042396962235,0.0104571974049378,0.0185732593658574,2.48287589376379e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37411,0.0347207410454761,0.00495261550757249,0.0250136146506341,0.0444278674403182,2.48554728418945e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEXN,Nexilin,37445,0.0467949645244279,0.00667525598932825,0.0337114627853446,0.0598784662635113,2.49189059946274e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.0617163914129961,0.00880821371838286,0.0444522925249656,0.0789804903010265,2.55579495410328e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,0.0599078125996717,0.00855516428176998,0.0431396906074025,0.0766759345919409,2.63262339685521e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,39754,0.0406206230576428,0.00580489488389508,0.0292430290852084,0.0519982170300771,2.70687074296943e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0439569095887671,0.00628261172477805,0.0316429906082021,0.056270828569332,2.74940087645853e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,36991,0.0373346225500645,0.00533691137697207,0.0268742762511992,0.0477949688489298,2.77028595102548e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37056,0.038331610131804,0.00548112530317928,0.0275886045375726,0.0490746157260354,2.81258399426434e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,0.0311438715445756,0.00445983458849252,0.0224025957511302,0.0398851473380209,2.99956994936499e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37368,0.0219412360263487,0.00314296668692323,0.0157810213199792,0.0281014507327182,3.06642869901925e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.0522879729826058,0.00749153234452913,0.0376045695873287,0.0669713763778829,3.07624302809008e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0455278923001543,0.00652229869656558,0.0327441868548858,0.0583115977454228,3.08156306012453e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0414164892542498,0.00593373132177134,0.029786375863578,0.0530466026449216,3.09353923258641e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,39913,0.048953475391567,0.00701790936763556,0.0351983730310013,0.0627085777521327,3.16667923873297e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,39713,0.0203301095481,0.00291598946106789,0.014614770204407,0.0260454488917931,3.2493031054135e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40009,0.0195946400021532,0.00281480773720813,0.0140776168372253,0.0251116631670811,3.50194745061376e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0293800361137375,0.00422764430188335,0.0210938532820461,0.0376662189454289,3.83806738780499e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0285735782190944,0.00411482920628648,0.0205085129747729,0.0366386434634159,3.9885326919907e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0227124947462705,0.00327222709972145,0.0162989296308165,0.0291260598617245,4.07128827530782e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37039,0.0331384918742479,0.00477586367972198,0.0237777990619928,0.042499184686503,4.14090595198693e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,0.025821548023057,0.00372385620749505,0.0185227898563667,0.0331203061897473,4.24320590673362e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,0.0181321728663235,0.00261608096644605,0.0130046541720893,0.0232596915605578,4.33642912335648e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPF,Centromere protein F,37169,0.0362730284564783,0.00523425792050813,0.0260138829322824,0.0465321739806742,4.40437669916129e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37056,0.0262798302503173,0.00379251104455591,0.0188465086029877,0.0337131518976469,4.42243837802136e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",37453,0.0109205391853837,0.00157790313144864,0.00782784904774435,0.014013229323023,4.68834302540802e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,0.0767913957202868,0.0111107816465496,0.0550142636930495,0.0985685277475241,5.01242640477012e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,0.0618560710941752,0.00895150594813364,0.0443111194358333,0.0794010227525171,5.02932138325033e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,0.0367902085574402,0.00532463024698283,0.0263539332733539,0.0472264838415266,5.08374583049186e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37124,0.0578663572662341,0.00838561263696416,0.0414305564977843,0.0743021580346838,5.41078590580889e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMH,Granzyme H,39585,0.0499618208953619,0.00724706949706871,0.0357575646811072,0.0641660771096166,5.62799952644782e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40009,0.0166571942738446,0.00241813765305489,0.011917644473857,0.0213967440738322,5.84896286418207e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37382,0.0381855586901246,0.00554677223475842,0.0273138851099981,0.0490572322702511,6.06404672147509e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IST1,IST1 homolog,37287,0.0665304531015134,0.00966706432215025,0.0475830070300989,0.0854778991729279,6.15600262800603e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,0.0187446174972659,0.00273394200288585,0.0133860911716096,0.0241031438229221,7.3278301017589e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37124,0.072607248555274,0.0105895672617549,0.0518516967222344,0.0933628003883135,7.36973670148462e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40058,0.0514468715467941,0.00750736563288958,0.0367324349063305,0.0661613081872577,7.50006347103792e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,39788,0.0594270762563763,0.00868552841335579,0.0424034405661989,0.0764507119465536,8.08953523320051e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSB,Cathepsin B,39847,-0.0338447672415646,0.0049481984350579,-0.0435432361742781,-0.0241462983088512,8.2169208221775e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.0516202050518834,0.00757010589913024,0.0367827974895882,0.0664576126141787,9.55909223626883e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,0.0273082296708518,0.00400563545911919,0.0194571841709782,0.0351592751707254,9.60052963627843e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK11,Kallikrein-11,39779,0.0191336214403144,0.0028070974571634,0.0136317104242741,0.0246355324563546,9.68645585791109e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17C,Interleukin-17C,39587,0.0436889917521167,0.00640976382421979,0.0311258546566459,0.0562521288475875,9.70085041723023e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,0.0292818515896559,0.00429777717028121,0.0208582083359047,0.037705494843407,9.94507233897193e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39489,0.0354205728905635,0.00520053184786164,0.0252275304687547,0.0456136153123723,1.00491104216236e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN4,Nectin-4,39913,0.0192751525865978,0.00283477161341102,0.0137190002243122,0.0248313049488834,1.08651559675338e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0499764357135799,0.00735377847770221,0.0355630298972835,0.0643898415298762,1.12053174826327e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37388,0.0464919614005103,0.00685379810404881,0.0330585171165746,0.0599254056844459,1.2227011323212e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,39931,0.0608320232246837,0.00897618148185503,0.0432387075202478,0.0784253389291195,1.26918115167196e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39403,0.0555586579296476,0.00820103975070307,0.0394846200182696,0.0716326958410256,1.29241395881839e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,39859,0.0617161058310311,0.00913196732140072,0.0438174498810857,0.0796147617809765,1.44492542118258e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0280827642368893,0.00415615686942016,0.0199366967728258,0.0362288317009528,1.45918180157199e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37124,0.0486378741137642,0.0072026127019372,0.0345207532179673,0.0627549950095611,1.51048083764108e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39489,0.0241649825709586,0.00358123240442305,0.0171457670582894,0.0311841980836278,1.55515220645298e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0424555297176549,0.00629548418535833,0.0301163807143526,0.0547946787209572,1.60556975942584e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.0398034578689511,0.00590488783125942,0.0282298777196827,0.0513770380182196,1.64113336863089e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0441276494201237,0.00655926347085778,0.0312714930172424,0.0569838058230049,1.79702308027734e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,39908,0.037888997827724,0.00563658769075104,0.0268412859538519,0.048936709701596,1.8531914898533e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.0695405313114796,0.0103453864492913,0.0492635738708687,0.0898174887520906,1.8656163857424e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.0700540250806014,0.0104299311199509,0.0496113600854977,0.0904966900757051,1.93373868053117e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37445,-0.0396246937772049,0.00590697640585411,-0.0512023675326789,-0.0280470200217308,2.04954430947904e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39489,0.0315878341405517,0.00471005751484163,0.0223561214114621,0.0408195468696413,2.06234312274779e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,39587,0.0519124320821319,0.00774322373606327,0.0367357135594479,0.0670891506048159,2.09347086054217e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0247287184003941,0.00368869484311628,0.0174988765078862,0.0319585602929021,2.11080488745455e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37388,0.0464817376229233,0.00694089859080137,0.0328775763849526,0.060085898860894,2.21460219796915e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,0.0204586398604897,0.00305773160908257,0.0144654859066879,0.0264517938142915,2.2932971853771e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0330059678515116,0.00493446931740276,0.0233344079894022,0.042677527713621,2.33770179992997e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAT,Catalase,37252,0.0342608836332253,0.00512441586095507,0.0242170285457534,0.0443047387206973,2.38748486914941e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,39788,0.0487763573072448,0.00729855538653463,0.0344711887496369,0.0630815258648527,2.4184074488954e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37043,-0.0275624152785818,0.00412448352548593,-0.0356464029885342,-0.0194784275686294,2.44118031223651e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZU1,Azurocidin,39344,0.0493141666095759,0.00738324366711677,0.034843009022027,0.0637853241971247,2.48432678903512e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,-0.0167403405124878,0.00250695630934237,-0.0216539748787989,-0.0118267061461768,2.50858613039017e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.0663793885643794,0.0099464268548855,0.0468843919288039,0.085874385199955,2.57578887472369e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.0557180071254992,0.00835083974007594,0.0393503612349503,0.072085653016048,2.62099912936133e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,36942,-0.0401946536478153,0.00602940846833919,-0.0520122942457601,-0.0283770130498705,2.72609053482254e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.0588927653408583,0.0088404631276268,0.0415654576107098,0.0762200730710069,2.81357817763066e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH17,Cadherin-17,39868,0.0426689462916872,0.0064073180669024,0.0301106028805585,0.0552272897028159,2.8388050213752e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37043,0.0447980945879587,0.00672712635443284,0.0316129269332703,0.057983262242647,2.85999998315161e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,0.0396356766193952,0.00595444428854187,0.0279649658138532,0.0513063874249373,2.91222018021044e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0191077105283702,0.00287212119873449,0.0134783529788506,0.0247370680778898,2.96948367827803e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,0.0367505723160576,0.00552450252822898,0.0259225473607288,0.0475785972713864,2.97815710647925e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0217672956102828,0.00327789842782339,0.015342614691749,0.0281919765288166,3.22334183061025e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,-0.0111477737754784,0.00167881952004593,-0.0144382600347684,-0.00785728751618833,3.23258450997991e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37124,-0.0182020126457466,0.00274203356806169,-0.0235763984391475,-0.0128276268523456,3.30014064786099e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37437,0.0542085667347632,0.0081901552292863,0.038155862485362,0.0702612709841643,3.75856618395312e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,-0.0162865706634087,0.0024644380740448,-0.0211168692885365,-0.0114562720382809,4.00126920132736e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37411,0.0307761706194465,0.00465951156232954,0.0216435279572805,0.0399088132816124,4.12290240597171e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA3,Annexin A3,39985,0.0444215770587915,0.00673698365929236,0.0312170890865785,0.0576260650310046,4.42354346081512e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA11,Annexin A11,39829,0.0424958010565701,0.00644970501168117,0.029854379233675,0.0551372228794652,4.57269805557024e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0318211389477862,0.00483152478588151,0.0223513503674585,0.041290927528114,4.68340134408965e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0192192751580096,0.00291955187414326,0.0134969534846888,0.0249415968313303,4.75408193968968e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASN,Vasorin,39642,-0.0173815457174604,0.00264311091445802,-0.0225620431097981,-0.0122010483251226,4.97884056355876e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.0566672932190504,0.00863655712389441,0.0397396412562174,0.0735949451818834,5.52723002697239e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.0164381495862368,0.0025061343022203,0.011526126353885,0.0213501728185886,5.57756708525382e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,39913,0.0136608560926095,0.0020884440914717,0.00956750567332498,0.017754206511894,6.28867074347685e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37368,0.045060821983103,0.00689594368583313,0.03154477235887,0.0585768716073359,6.61574255679436e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0216198409027971,0.00330980124544346,0.0151326304617279,0.0281070513438662,6.68593048312085e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0369112150133729,0.00565838333531695,0.0258207836761517,0.0480016463505941,7.0856430259201e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.0562044608122014,0.00863127813741063,0.0392871556628766,0.0731217659615263,7.69096497478503e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,36991,0.0274033023930688,0.00420950384214026,0.0191526748624739,0.0356539299236637,7.79531973718115e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.0144205721508565,0.00221562291083536,0.0100779512456192,0.0187631930560938,7.81329935083018e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0295653547054841,0.00454373496875315,0.020659634166728,0.0384710752442403,7.90064431346673e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,39931,0.0210827048575891,0.00324421813953264,0.0147240373041051,0.0274413724110731,8.34851538682297e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39456,0.0573156407255944,0.00882057940045583,0.0400273051007009,0.0746039763504878,8.3892908115545e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.0454769675493461,0.0070079556827035,0.0317413744112472,0.0592125606874449,8.87414452724511e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.056654626861576,0.00874463829022776,0.0395151358127296,0.0737941179104224,9.57465572634643e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,39908,0.0191385530524341,0.00295780752425233,0.0133412503048995,0.0249358557999686,1.00494650657374e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,39913,0.0393771771205429,0.00608831158520689,0.0274440864135373,0.0513102678275484,1.02403405669907e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLN,Mesothelin,39766,0.0327079927887992,0.00506589605573989,0.022778836519549,0.0426371490580494,1.10251648852343e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,0.0476259047512335,0.00737662488198382,0.0331677199825452,0.0620840895199217,1.10997691104727e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0146995305854948,0.00227936364964619,0.0102319778321883,0.0191670833388013,1.1584140983968e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40030,0.0267369264454591,0.00414674937054202,0.0186092976791968,0.0348645552117215,1.16791448283113e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,0.0430673652205829,0.00668047624064062,0.0299736317889273,0.0561610986522385,1.18144869779727e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0516465870138255,0.00802325788907681,0.035921001551235,0.0673721724764161,1.25234498598587e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39477,0.0301223064106525,0.00468222601886308,0.0209451434136809,0.0392994694076242,1.28470519949539e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,0.0222524391656816,0.00346058992761052,0.0154696829075649,0.0290351954237982,1.31678607387209e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,39791,0.066635930560009,0.010368549882428,0.04631357279045,0.0869582883295679,1.34075968937681e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,39585,0.0277683494935453,0.00432603241334446,0.0192893259633902,0.0362473730237005,1.41197971395124e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.0613768365373938,0.00956657794981551,0.0426263437557554,0.0801273293190322,1.44773265408213e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,39812,0.0294413333789457,0.00459465589317398,0.0204358078283247,0.0384468589295667,1.51838640956921e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37056,0.0401622514908318,0.00627048495912535,0.0278721009709461,0.0524524020107175,1.55502595128073e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX7,Syntaxin-7,37056,0.0306340024159678,0.00478795683197417,0.0212496070252985,0.0400183978066372,1.62596361506508e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.0691641846782539,0.0108339577363966,0.0479296275149166,0.0903987418415912,1.77229724849355e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMD,Dystrophin,37043,0.031915157175664,0.00502434681473401,0.0220674374187854,0.0417628769325427,2.19371618355605e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,0.0138624072638969,0.00218606860568637,0.00957771279675164,0.0181471017310422,2.35144715614028e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.035853379338304,0.00566122806454614,0.0247573723317936,0.0469493863448145,2.46545989098624e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,39855,0.0477410991180393,0.00754007001983975,0.0329625618791534,0.0625196363569252,2.49018041328775e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.049549392343534,0.007826565790909,0.0342093233933524,0.0648894612937157,2.50352180597216e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,39866,0.0433394238823696,0.0068542559451405,0.0299050822298942,0.056773765534845,2.63341522819197e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,-0.0248895437089132,0.00393810245446158,-0.0326082245196579,-0.0171708628981685,2.68138537334819e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPART,Spartin,37124,0.0478525929520622,0.00757299966272821,0.0330095136131149,0.0626956722910095,2.71956011779202e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37043,0.0317668394665015,0.00503341165434834,0.0219013526239788,0.0416323263090243,2.85756322213687e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37382,0.0368514506388993,0.00584073038963777,0.0254036190752093,0.0482992822025894,2.88868256839879e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.052180132115089,0.00827026221667509,0.0359704181704058,0.0683898460597722,2.88918902047432e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0301705246950557,0.00478322221628061,0.0207954091511457,0.0395456402389656,2.92250613433551e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0152364936613986,0.00241765606854345,0.0104978877670535,0.0199750995557438,3.01151221792302e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,39866,0.0350800700454606,0.00556746309646911,0.0241678423763811,0.04599229771454,3.03642911954519e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.0528330510878647,0.008384205535506,0.0364000082382729,0.0692660939374564,3.04132800014935e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40058,0.0391246687755084,0.00621269486609185,0.0269477868379684,0.0513015507130485,3.10208194509199e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37043,-0.0399607614589417,0.00634639775216209,-0.0523997010531794,-0.027521821864704,3.13887570521047e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37345,0.0537577608571462,0.00854796277085011,0.03700375382628,0.0705117678880124,3.29471128959874e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37169,0.020425582299685,0.00324864314110339,0.0140582417431223,0.0267929228562476,3.32870933398509e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37021,0.0408639261168185,0.00650095714655923,0.0281220501095624,0.0536058021240746,3.36396019315311e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37437,0.0326956070990681,0.00520746323174787,0.0224889791648422,0.0429022350332939,3.5202504949175e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN3,CCN family member 3,40042,0.0195850297951881,0.00312241654474498,0.0134650933674879,0.0257049662228883,3.64564478228205e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,0.0292679327915568,0.00466697996409424,0.0201206520619321,0.0384152135211816,3.68953300273975e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0283797074569356,0.00452626719295816,0.0195082237587377,0.0372511911551336,3.70545759946425e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0295368801340669,0.00471059193502406,0.0203041199414197,0.0387696403267141,3.71296308726958e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0355832092928721,0.00568261684461013,0.0244452802774362,0.0467211383083079,3.92447961492185e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,0.029591410991239,0.0047308766643771,0.0203188927290599,0.0388639292534182,4.07704250848527e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0252070666082829,0.00403212858461762,0.0173040945824324,0.0331100386341334,4.16964211453782e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0308543860692662,0.00493977598041959,0.0211724251476438,0.0405363469908886,4.33416807826155e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39489,0.0370722461839047,0.00593968988776721,0.025430454003881,0.0487140383639284,4.44729964298934e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,0.0146443627994796,0.00234742749451593,0.0100434049102284,0.0192453206887308,4.55377001217797e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,39868,0.0400734851873116,0.00642714119929944,0.0274762884366847,0.0526706819379385,4.62986178351564e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0388189255931134,0.00623542214275701,0.0265974981933097,0.0510403529929172,4.92126027227079e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEPR,Leptin receptor,39868,-0.0185594434566451,0.00298159327776522,-0.0244033662810649,-0.0127155206322253,4.94581361226307e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,0.0198871599549089,0.00320248324997883,0.0136102927849504,0.0261640271248674,5.45638058667315e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.0503583689049736,0.00811231406822557,0.0344582333312515,0.0662585044786958,5.5358039690606e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,0.0200608590185094,0.00323654322617403,0.0137172342952083,0.0264044837418104,5.88016095820926e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,37453,0.0125728524528291,0.00202874581740307,0.00859651065071906,0.0165491942549391,5.90794329020997e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39489,0.0267975723403292,0.00432643908546849,0.0183177517328109,0.0352773929478474,6.015866357962e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.0216181095148649,0.00349575659625449,0.0147664265862061,0.0284697924435237,6.42551473380113e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNR,Tenascin-R,39749,-0.0250027958076566,0.00404781896327546,-0.0329365209756766,-0.0170690706396367,6.69825201462506e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37382,0.0419640245756035,0.00680097487967774,0.0286341138114351,0.0552939353397719,7.01077994871078e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN4,Contactin-4,39858,-0.0142021533998976,0.00230220638673858,-0.0187144779179052,-0.00968982888188995,7.04069146488321e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,39868,0.0456576410979306,0.00740229689826201,0.031149139177337,0.0601661430185241,7.08042441074422e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,39531,0.0353065627231787,0.00573132129915662,0.0240731729768317,0.0465399524695256,7.43887147286564e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,0.0480802710937117,0.00780447783796142,0.0327834945313074,0.0633770476561161,7.45784736384902e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.029102778592573,0.00472756602756542,0.0198367491785448,0.0383688080066012,7.67270082965257e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,0.0164270316787705,0.00267079015423504,0.0111922829764698,0.0216617803810712,7.90114166448209e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,0.0151104497654308,0.00245792941945035,0.0102929081033081,0.0199279914275534,8.0903083461332e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,39866,0.0507470172237525,0.00825599010884578,0.0345652766104148,0.0669287578370902,8.09915285964186e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,39713,-0.0280816489454373,0.00456972903965966,-0.0370383178631702,-0.0191249800277044,8.18005798460631e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0703901713151929,0.0114931247688323,0.0478636467682816,0.0929166958621042,9.34627517228968e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,0.0528603578303905,0.0086382221492896,0.0359294424177829,0.0697912732429981,9.61500488363394e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOB,Elongin-B,37021,0.0232258012701806,0.00380019615220447,0.0157774168118598,0.0306741857285013,1.01336001247139e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39434,-0.0534784986338827,0.00877349042783596,-0.0706745398724412,-0.0362824573953242,1.11692867877133e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37124,0.0219513701350906,0.00360440638484945,0.0148867336207857,0.0290160066493955,1.15923500650071e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.01937556246909,0.00318244417468088,-0.0256131530514646,-0.0131379718867155,1.1721813549488e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37411,0.0452321681327539,0.00743117166219891,0.0306670716748441,0.0597972645906638,1.18286984301796e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,39868,0.0406696394952679,0.00669054670274685,0.0275561679578841,0.0537831110326518,1.23930669475291e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROK1,Prokineticin-1,39866,0.0379387720458576,0.00624802915822685,0.025692634895733,0.0501849091959823,1.29085495216043e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0395372235058931,0.00651537741936035,0.0267670837639468,0.0523073632478394,1.32786633487919e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0257145030964518,0.00424364326593999,0.0173969622952094,0.0340320438976942,1.39574748486433e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.0499435098356077,0.0082512347091755,0.0337710898056238,0.0661159298655917,1.45557264704506e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37411,0.0391868729142779,0.00647371554187439,0.0264983904522041,0.0518753553763517,1.4572056110472e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.0560086918791149,0.00927758470296317,0.0378246258613071,0.0741927578969227,1.60487989427433e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0294947156027665,0.00489563312241311,0.0198992746828368,0.0390901565226962,1.73939307091082e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37039,0.039707260022683,0.00660666214698885,0.0267582022145849,0.0526563178307812,1.9020471403322e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37437,0.0153947811808243,0.00256220968223976,0.0103728502036343,0.0204167121580142,1.92157495724398e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0140627315647643,0.0023429359945508,0.00947057701544474,0.0186548861140839,1.98888888501763e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,39866,0.038569272283154,0.00643243536915234,0.0259616989596154,0.0511768456066926,2.06507267791135e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,39788,0.0499560502055927,0.00833160167194174,0.0336261109285868,0.0662859894825985,2.066411624288e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,39749,0.0586115922247795,0.00977904011337497,0.0394446736025645,0.0777785108469944,2.09691670479866e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,0.0127200266560801,0.00212240577433665,0.00856011133838024,0.0168799419737799,2.10968629958313e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,0.0154831194589184,0.00258658802143506,0.0104134069369056,0.0205528319809311,2.20586830041058e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0312123173938252,0.00521694002117437,0.0209871149523234,0.041437519835327,2.23852620118378e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0590276162060774,0.00986756090491635,0.0396871968324414,0.0783680355797135,2.25162222501199e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,39868,0.0253172152424454,0.0042355392348945,0.0170155583420522,0.0336188721428386,2.31640142312359e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.0284058430787269,0.00476044685697507,-0.0377363189183981,-0.0190753672390558,2.47749608014132e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37380,0.0270176793939591,0.0045307525456898,0.0181374044044071,0.0358979543835111,2.53551088290188e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,0.0159388098386656,0.00267288333420199,0.0106999585036297,0.0211776611737015,2.53563482901192e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.0479635743049904,0.00805141374164152,0.032182803371373,0.0637443452386078,2.62033051780947e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37056,-0.0171462344575929,0.00288162810115843,-0.0227942255358634,-0.0114982433793224,2.74619840675128e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,0.0393381539160083,0.00661538755165437,0.0263719943147657,0.0523043135172508,2.80730358549421e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39344,0.0343126701349603,0.00577486338377513,0.0229939379027611,0.0456314023671596,2.8808063640168e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,-0.0137636859197188,0.00231737490553203,-0.0183057407345616,-0.00922163110487601,2.9212040913311e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TF,Serotransferrin,37453,0.0125612595329049,0.00211619488732413,0.00841351755374959,0.0167090015120602,2.99583606480025e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37368,0.0220553371269205,0.00371736809311174,0.0147692956644215,0.0293413785894195,3.04632668846244e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0308074717148644,0.0051937066849758,0.0206278066123118,0.0409871368174169,3.06035221273865e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,36874,0.0464158854998004,0.00782579043094257,0.031077336255153,0.0617544347444478,3.0846771166937e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,39785,0.0502205187396228,0.00847164103523671,0.0336161023105588,0.0668249351686867,3.12839560492937e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP7,Caspase-7,37388,0.0483000089163491,0.00817061725760384,0.0322855990914456,0.0643144187412526,3.47326058288396e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,39687,0.0327380781999198,0.0055497922316671,0.0218604854258523,0.0436156709739873,3.73227436569941e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37437,0.0380261922026189,0.00645043498945118,0.0253833396232946,0.0506690447819433,3.83260891579194e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0215848875348503,0.00366306208177302,0.0144052858545752,0.0287644892151255,3.89510420522654e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.0119689965380816,0.00203132047086783,-0.0159503846609825,-0.00798760841518066,3.90332050796001e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0321468001706095,0.00546003873529136,0.0214451242494385,0.0428484760917806,3.99600490855786e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40030,-0.0190078605583501,0.00323469617323046,-0.0253478650578818,-0.0126678560588184,4.27930247443586e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,36654,0.0700702505897629,0.0119301993375718,0.0466870598881221,0.0934534412914037,4.37683128485822e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0161253468386782,0.00274792413548441,0.0107394155331288,0.0215112781442277,4.51112096684949e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0421554979645883,0.0071847496194826,0.0280733887104024,0.0562376072187742,4.53322977122444e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.0661977794514444,0.0112899165768652,0.0440695429607887,0.0883260159421001,4.62336551801833e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,39858,-0.0159382907757433,0.00271891398261281,-0.0212673621816644,-0.0106092193698222,4.66306499552391e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,39858,0.0688822196944846,0.0117843030635197,0.0457849856899861,0.0919794536989832,5.15644039722292e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0122342264989093,0.00209496368377197,0.00812809767871621,0.0163403553191023,5.32724504900102e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0300724407927011,0.00515512208052992,0.0199684015148625,0.0401764800705397,5.55480206058707e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,0.0371526133884374,0.00637950226732905,0.0246487889444725,0.0496564378324024,5.86747874745227e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0225269732169458,0.00387190380505302,0.0149380417590419,0.0301159046748497,6.08762458260054e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,0.0205848963199568,0.00354113283687945,0.013644275959673,0.0275255166802405,6.27549425031757e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,0.040092306258511,0.00690684561816915,0.0265548888468994,0.0536297236701225,6.5943295050191e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,39868,0.0719387919077099,0.0123948445258685,0.0476448966370077,0.0962326871784122,6.6003949044082e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0382653405738421,0.00660049315275756,0.0253283739944372,0.0512023071532469,6.86731859862028e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0273008044962592,0.00471299871096374,0.0180633270227703,0.0365382819697481,7.05800222280092e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0514431751423605,0.00888386591859253,0.0340307979419192,0.0688555523428019,7.17217334856516e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.0479987528522008,0.00829403162813416,0.0317424508610579,0.0642550548433438,7.3176942267721e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,0.026777146826405,0.00462945374826047,0.0177034174798145,0.0358508761729955,7.42936423791898e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.03327490756558,0.00575493859851283,0.0219952279124948,0.0445545872186651,7.54562884959132e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0490874340440233,0.00849057002429406,0.0324459167964069,0.0657289512916396,7.57145353810741e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.016766209401037,0.00290051207098447,0.0110812057419074,0.0224512130601665,7.61470141832048e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.0491598951899944,0.00851372652208613,0.0324729912067055,0.0658467991732832,7.9015115707897e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,0.0538431203107385,0.00934637238207583,0.0355242304418699,0.0721620101796071,8.55098819625445e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0198216045935044,0.00344930718970742,0.0130609625016779,0.026582246685331,9.30405356958251e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,39788,0.0460151812437238,0.00801205312018853,0.0303115571281543,0.0617188053592934,9.45734471728843e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,-0.0210828393801068,0.00367113908504036,-0.0282782719867859,-0.0138874067734277,9.48010194995152e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.0554335563185813,0.00965907491126822,0.0365017694924956,0.074365343144667,9.7268387486937e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40030,-0.0249959950329799,0.00435621287093604,-0.0335341722600145,-0.0164578178059452,9.75099612114602e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0284233657102622,0.00495587639292624,0.0187098479801268,0.0381368834403976,9.91496494787673e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17A,Interleukin-17A,39558,0.0234155266531556,0.00408753196325471,0.0154039640051764,0.0314270893011348,1.03164285238657e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN9,Septin-9,39788,0.0156517363027603,0.00273363838494335,0.0102938050682714,0.0210096675372493,1.04922495021822e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,36962,0.0312871993806938,0.00547147732975259,0.0205631038143788,0.0420112949470089,1.09985502183642e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37088,0.0575447950820096,0.0100739968662903,0.0377997612240806,0.0772898289399385,1.13919142905115e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB6,Serpin B6,39970,0.0331502896739544,0.00580618113400773,0.0217701746512993,0.0445304046966096,1.15316888423357e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0308000317691736,0.00540294224262258,0.0202102649736333,0.0413897985647139,1.21908913397689e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.0458999328662172,0.00805910160928556,0.0301040937120175,0.0616957720204169,1.25233485368041e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0408885436691385,0.00718071653847979,0.0268143392537182,0.0549627480845589,1.26508564677699e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0521463752385585,0.00916052329492576,0.034191749580504,0.070101000896613,1.27398267455108e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39478,0.03066203169718,0.00538654602072302,0.0201044014965629,0.0412196618977971,1.27564084359996e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,39587,0.0363284073856868,0.00638248117103574,0.0238187442904568,0.0488380704809169,1.27878510845424e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0408265611586432,0.0071747618759478,0.0267640278817855,0.0548890944355009,1.29088539195769e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37095,0.0783438647470638,0.0137693194396236,0.0513559986454016,0.105331730848726,1.29928322198135e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0154397416341128,0.00271401534533645,0.0101202715572533,0.0207592117109722,1.30587328548222e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37382,0.0168960468144828,0.0029703709001591,0.011074119850171,0.0227179737787947,1.31049441571016e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMS,Spermine synthase,36991,0.0354299558700614,0.00623401440601477,0.0232112876342724,0.0476486241058503,1.34907002080833e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0458773474833475,0.00807481516622853,0.0300507097575395,0.0617039852091554,1.35806517996029e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMTN,Smoothelin,37342,0.0529840622979206,0.0093282449325353,0.0347007022301515,0.0712674223656898,1.375093875306e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,0.0266379273309515,0.00469274824214705,0.0174401407763433,0.0358357138855597,1.39944696125362e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37364,0.0309476819140845,0.00546140961324919,0.020243319072116,0.0416520447560529,1.48626430342673e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH5,Cadherin-5,40052,-0.0166702439682328,0.00294232900781064,-0.0224372088235417,-0.010903279112924,1.48948385550863e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,0.028871618353009,0.00510204395763536,0.0188716121960437,0.0388716245099743,1.55062350944134e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37445,-0.0130978741799169,0.00231649451726333,-0.017638203433753,-0.00855754492608076,1.59746916213692e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37411,0.0319178614318361,0.00565864373201907,0.0208269197170787,0.0430088031465934,1.72898386495604e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37169,0.0289923430522722,0.00514072187289955,0.0189165281813891,0.0390681579231553,1.73772292765188e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.0445917416333005,0.00791200486169641,0.0290842121043756,0.0600992711622255,1.77020608731572e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MILR1,Allergin-1,39587,0.0269163773671486,0.00477874953162918,0.0175500282851554,0.0362827264491418,1.80640734482256e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLGN,Calmegin,37039,0.0238704643251176,0.00423795363913249,0.0155640751924179,0.0321768534578173,1.81201915333062e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,0.0493899457929258,0.00877089421784081,0.0321989931259578,0.0665808984598937,1.82602141187077e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,0.0324715243345705,0.00577923050621533,0.0211442325423885,0.0437988161267526,1.96248485789136e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,-0.0324992229289762,0.00579618955136562,-0.0438597544496528,-0.0211386914082996,2.09895331197498e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.024925804789438,0.00445024376056353,0.0162033270187335,0.0336482825601426,2.17385034345818e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0293077125058229,0.00523401261369371,0.0190490477829832,0.0395663772286625,2.19175147076978e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,39788,0.0512414059526188,0.00915308734673982,0.0333013547530088,0.0691814571522288,2.20080708588851e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,0.04167367111796,0.00745447720812495,0.0270628957900351,0.0562844464458849,2.31034745481596e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37021,0.0363315259564226,0.0065001509575726,0.0235912300795803,0.0490718218332649,2.32470251882615e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0207114499814098,0.00370786718135715,0.0134440303059498,0.0279788696568698,2.36488869902744e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,-0.0302219251566026,0.0054107815849452,-0.0408270570630951,-0.01961679325011,2.36781371138558e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,0.0315906785210765,0.00565558722394062,0.0205057275621529,0.0426756294800001,2.37187151524315e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0149437611385599,0.00267533255699628,0.00970010932684724,0.0201874129502726,2.372956543733e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37124,0.0237419045938479,0.00425112745557696,0.0154096947809171,0.0320741144067787,2.38501464176799e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RP2,Protein XRP2,39788,0.0224951581932983,0.00403045063931685,0.0145954749402372,0.0303948414463593,2.42618960987697e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37039,0.0438401178672598,0.00785913735651356,0.0284362086484932,0.0592440270860264,2.47755821820787e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.0603047000814752,0.0108208307623246,0.0390958717873189,0.0815135283756315,2.5447337184547e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0219235776255588,0.00393469187615275,0.0142115815482994,0.0296355737028182,2.5684664998657e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO1,R-spondin-1,39749,0.0189578159239544,0.00340455944148332,0.0122848794186471,0.0256307524292617,2.61312319666428e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.0499346700920086,0.00897553466293654,0.032342622152653,0.0675267180313642,2.69692228987522e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSPN,Persephin,39866,0.0505506028016727,0.00909370279860137,0.032726945316414,0.0683742602869314,2.75882919114521e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,39585,0.0260086874423857,0.00468324635873621,0.0168295245792628,0.0351878503055087,2.84444852069477e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0119179153037835,0.00214733739828663,0.00770913400314175,0.0161266966044253,2.90061911385568e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0156245663809772,0.00281520762191763,0.0101067594420186,0.0211423733199357,2.90141363540601e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C5,Complement C5,37453,0.00818069157518283,0.00147483387614712,0.00529001717793448,0.0110713659724312,2.96282492579519e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37043,0.0163070085541553,0.00295037678939735,0.0105242700469365,0.0220897470613742,3.31762313077536e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,37453,-0.0118805635164844,0.00215378394971906,-0.0161019800579337,-0.007659146975035,3.52867218836893e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0187376313430129,0.00339707169905012,0.0120793708128747,0.0253958918731512,3.53711497094742e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F3,Tissue factor,39931,-0.0144272031354316,0.00262250691780185,-0.0195673166943233,-0.00928708957654001,3.82754666949229e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,39617,0.0369095262188667,0.00671546891131712,0.0237472071526852,0.0500718452850483,3.94098024788412e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37388,0.0531707380548146,0.00969533514178895,0.0341678811769082,0.0721735949327209,4.22902098902761e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED8,Protein TMED8,37382,0.0549497708135556,0.0100370693788913,0.0352771148309287,0.0746224267961826,4.46112551117253e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.0144241968894039,0.00264299982355105,0.00924391723524388,0.019604476543564,4.89954024266128e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENR,Density-regulated protein,37056,0.0306076022173016,0.00560945942034329,0.0196130617534287,0.0416021426811744,4.94576988404715e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,0.0633724967829267,0.01161833614125,0.0406005579460767,0.0861444356197767,4.99654385457738e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7,Interleukin-7,39866,0.0342888815803223,0.00629381107548908,0.0219530118723637,0.0466247512882809,5.16822953503678e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,39587,0.029971459331213,0.0055021115189581,0.0191873207540551,0.0407555979083708,5.19185255573047e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37039,0.0361497222204315,0.00665479129109963,0.0231063312898762,0.0491931131509868,5.66723748117091e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,0.0167741465831462,0.00309044526709111,0.0107168738596476,0.0228314193066448,5.80741259489877e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0200573657058058,0.00369593809198445,0.0128133270455163,0.0273014043660953,5.81898623723018e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0165162537213825,0.00304638739538765,0.0105453344264227,0.0224871730163423,5.99323087857076e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,0.0119997568658667,0.00221519808633182,0.00765796861665636,0.0163415451150771,6.14722774948715e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,39788,0.0166567731793122,0.00307503989882054,0.010629694977624,0.0226838513810005,6.15669537462712e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40030,0.038208141069706,0.00708630124064774,0.0243189906380365,0.0520972915013756,7.07220599205642e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0171067846456426,0.00317453410637943,0.0108846977971389,0.0233288714941463,7.2166716364258e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,0.0624111723961937,0.0115930138292038,0.0396888652909542,0.0851334795014333,7.4288716861549e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.0137528530393482,0.00255737645669906,-0.0187653108944784,-0.00874039518421809,7.64992356748476e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39477,0.0229325879044234,0.00427555372719187,0.0145525025991273,0.0313126732097195,8.27167981565809e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,0.0376829909709445,0.00704086779559428,0.0238828900915797,0.0514830918503093,8.81731901948224e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,37453,0.0171101473176226,0.00319866390104539,0.0108407660715737,0.0233795285636716,8.97979595071746e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0209079364128209,0.00391102826481171,0.0132423210137899,0.0285735518118518,9.12364976438449e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,0.0155687275456531,0.00291620373351996,0.00985296822795399,0.0212844868633522,9.48948838324805e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0315928832039579,0.00591872591430588,0.0199921804119183,0.0431935859959974,9.56485602953148e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.0363683461718505,0.00682125615188485,0.0229986841141562,0.0497380082295448,9.86518510705841e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0400077333579584,0.00751124284319591,-0.0547297693306223,-0.0252856973852944,1.01543882402164e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0242704074544591,0.00455680319372404,0.01533907319476,0.0332017417141582,1.01683065029692e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40058,0.0313205405751335,0.00588405558659638,0.0197877916254046,0.0428532895248624,1.034576959531e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,39738,0.0247087922006067,0.00464447599198976,0.0156056192563068,0.0338119651449066,1.05152672631898e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.0504593017707521,0.00949443312026989,0.0318502128550232,0.0690683906864811,1.08577112429871e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,39908,0.0447183322747916,0.00843263415624361,0.0281903693285542,0.0612462952210291,1.15419473605031e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,39913,0.0401364551870322,0.00756981963769619,0.0252996086971476,0.0549733016769167,1.1595101961697e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.0502914469712658,0.00951731071036426,0.0316375179789518,0.0689453759635798,1.27946309760315e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FN1,Fibronectin,37453,0.0136386723451799,0.00258197804083126,0.00857799538515067,0.0186993493052092,1.29570454083169e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.0392791251924369,0.00743892437567218,0.0246988334161195,0.0538594169687544,1.30760578711718e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,-0.0222397663387942,0.00421917448970039,-0.0305093483386069,-0.0139701843389814,1.37355669289122e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0185780085700512,0.00352676513156005,0.0116655489121935,0.0254904682279089,1.39950046703096e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22,Interleukin-22,37368,0.0333143471343226,0.00633780691973651,0.0208922455716391,0.0457364486970062,1.49102031868233e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.05336239442522,0.0101572135723281,0.0334542558234569,0.073270533026983,1.51426813606936e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.0481649369007214,0.00917122070497327,0.0301893443189738,0.066140529482469,1.52949722791854e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37409,-0.0366343266409681,0.00697626353760367,-0.0503078031746713,-0.0229608501072649,1.53329251425523e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0216882783991471,0.00413894352923395,0.0135759490818485,0.0298006077164456,1.63007160150368e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0203986916284393,0.00389969064053114,0.0127552979729982,0.0280420852838803,1.71326449543833e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,39587,0.0144421116287794,0.00276285450042327,0.00902691680794975,0.019857306449609,1.74257203663449e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37382,0.0213490399030482,0.00408515062857154,0.013342144671048,0.0293559351350484,1.75783212396884e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0303677899535018,0.00581319032568004,0.0189739369151689,0.0417616429918347,1.77362267767422e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39456,0.0353493255980769,0.00677640330596239,0.0220675751183906,0.0486310760777631,1.84636868403649e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX6,Syntaxin-6,39477,0.0344000876826016,0.0065985843233336,0.0214668624088678,0.0473333129563355,1.87923371637803e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0370459001185194,0.00711026606446431,0.0231097786321694,0.0509820216048695,1.91400341147579e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,0.0320072741224164,0.00614600637955312,0.0199611016184923,0.0440534466263405,1.93957161026853e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37056,0.059350293088844,0.0114001332345882,0.0370060319490511,0.0816945542286369,1.95742082688964e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,0.0603784712882287,0.0115994650734842,0.0376435197441997,0.0831134228322578,1.96619248064339e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0349882210804962,0.00672403542927444,0.0218091116391183,0.0481673305218741,1.98556713731226e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0288742566927558,0.00556202331438308,0.0179726909965649,0.0397758223889466,2.11359811152692e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0305719539522096,0.00588863144528156,0.0190302363194577,0.0421136715849614,2.11473561115699e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK13,Kallikrein-13,39490,0.0211662402430165,0.00408027521998605,0.0131689008118439,0.0291635796741892,2.15852143081829e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39489,0.0219642548907034,0.00424011538560821,0.0136536287349113,0.0302748810464954,2.24513350789371e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0210954865909476,0.00407305604060362,0.0131122967513645,0.0290786764305307,2.25496100234139e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0308594707942121,0.00596362269892564,0.0191707703043178,0.0425481712841063,2.31732255609236e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0336136572456016,0.00649746975281867,0.0208786165300771,0.0463486979611262,2.33280369944296e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.026154949949277,0.00505646297782019,0.0162442825127494,0.0360656173858046,2.33741006758634e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,0.0175760161948973,0.003400501867457,0.0109110325346816,0.024240999855113,2.39200730166944e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,-0.0180773261148429,0.00350251199390399,-0.0249422496228947,-0.0112124026067911,2.48877922334546e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCHE,Cholinesterase,37208,0.0137596423815761,0.0026805814085848,0.00850570282074992,0.0190135819424023,2.89042923810946e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX16,Syntaxin-16,39477,0.0289155146302845,0.0056380511436314,0.017864934388767,0.0399660948718021,2.95339674530608e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,39713,0.0377791144876393,0.00736907971926514,0.0233357182378796,0.0522225107373989,2.98322910949436e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.0123377217056891,0.00240665559969201,0.00762067673029273,0.0170547666810854,2.99232635368782e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,-0.0141108826010621,0.0027572954926653,-0.0195151817666861,-0.00870658343543815,3.12930489536586e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0317736347215896,0.00620972159102495,0.0196025804031807,0.0439446890399985,3.14516418891131e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37043,0.0580687411201019,0.0114100289159005,0.035705084444937,0.0804323977952669,3.64388723819219e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,0.0258299303899224,0.00507666998523292,0.0158796572188659,0.0357802035609789,3.6689919628123e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,0.0395739714272888,0.00778741909936928,0.0243106299925251,0.0548373128620526,3.7810387475571e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0185407315646357,0.00364989483158739,0.0113869376947244,0.025694525434547,3.82873582476006e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,39881,0.0312766731021879,0.00617024227627228,0.0191829982406942,0.0433703479636815,4.04465193461808e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0337112732441257,0.0066890876344076,0.0206006614806868,0.0468218850075646,4.7218947371933e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39455,0.0371543809526151,0.00737349454775828,0.0227023316390089,0.0516064302662213,4.73426330472143e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.014258537425468,0.00282988579192949,0.00871196127328622,0.0198051135776498,4.74109351614148e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0357700940053692,0.0071076212367757,0.0218391563812888,0.0497010316294496,4.89146931315196e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0347996273969662,0.00692086016021804,0.0212347414829389,0.0483645133109936,5.0135952447938e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSR,Insulin receptor,37056,0.00811539445671096,0.00161456337739612,0.00495085023701456,0.0112799386764074,5.06398707718744e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,37453,-0.0147720286608054,0.00293926659523823,-0.0205329911874724,-0.00901106613413851,5.07835615058055e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0113031953551806,0.00225145777238085,0.00689033812131417,0.0157160525890471,5.2123519233761e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0328640935666978,0.00654783285762644,0.02003034116575,0.0456978459676457,5.25970891092479e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,39761,0.0174647704463935,0.0034875623678856,0.0106291482053377,0.0243003926874492,5.56655982532273e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,0.0297255438206807,0.00595585624002675,0.0180520655902282,0.0413990220511331,6.08206455273216e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37039,0.0240894226533782,0.00483065678831845,0.0146213353482741,0.0335575099584824,6.2175139741041e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0319619276131045,0.00642495828326298,0.0193690093779091,0.0445548458482999,6.61663884602158e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0314175482450942,0.00631811074574736,0.0190340511834293,0.043801045306759,6.67509735265689e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37021,0.0364424882356009,0.00733785202424063,0.0220602982680892,0.0508246782031125,6.9073291419137e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40009,0.0122085111044334,0.00245974634850017,0.00738740826137305,0.0170296139474937,7.00038031548277e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0152373830682768,0.00307579013253692,0.00920883440850448,0.0212659317280492,7.34637016140635e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP3,Caspase-3,40052,0.0424982786212055,0.00858739370052003,0.0256669869681862,0.0593295702742248,7.53782018922664e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40014,0.044810671411443,0.00906261701095558,0.0270479420699701,0.062573400752916,7.70811547792443e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.0385083254406848,0.00779588682417408,0.0232283872653036,0.053788263616066,7.92542018998131e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0191332627638791,0.00387644841647134,0.0115354238675953,0.0267311016601629,8.06578111573836e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.0539694985631397,0.0109465282714774,0.0325143031510441,0.0754246939752354,8.29334284322721e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,39892,0.0212692235609103,0.00432196672923674,0.0127981687716063,0.0297402783502143,8.68732252109168e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.022449584710061,0.0045624293539528,0.0135072231763135,0.0313919462438085,8.71881549869107e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0210370000633998,0.00428111291148712,0.0126460187568851,0.0294279813699146,9.03526706006001e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,39866,0.0369519169323562,0.00752208616005873,0.022208628058641,0.0516952058060713,9.08309526396443e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99,CD99 antigen,39858,-0.00907124591188429,0.00184766782679626,-0.012692674852405,-0.00544981697136363,9.21784413850007e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0312083961971288,0.00636133795532132,0.0187401738046991,0.0436766185895586,9.38904543008727e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,0.0310133730390825,0.00632227997751378,0.0186217042831555,0.0434050417950095,9.41516044458249e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37169,0.0219382030336209,0.00447331971130559,0.0131704963994619,0.0307059096677799,9.49008077693878e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.0362898123765344,0.00741093945090166,0.0217643710527671,0.0508152537003016,9.83628205684189e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,0.0505948730358548,0.0103323447449633,0.0303434773357268,0.0708462687359828,9.85618394029561e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.0150956300545466,0.00308485856784488,0.00904930726157063,0.0211419528475225,1.00060116396198e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,39573,0.0160251329423292,0.00327760726869227,0.00960102269569239,0.0224492431889661,1.02206383169321e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNLY,Granulysin,39858,0.0240418090541991,0.00491809418261175,0.01440234445628,0.0336812736521181,1.02623612246654e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0279548992564738,0.00572122961859542,0.0167412892040268,0.0391685093089209,1.04013703849041e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,39858,0.0423084207294699,0.00865976471762316,0.0253352818829285,0.0592815595760113,1.04095239653342e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0328659974300368,0.00674920064262011,0.0196375641705013,0.0460944306895722,1.13080911621807e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0181384408825579,0.00372535232364944,0.010836750328205,0.0254401314369108,1.13477877108579e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0227794217421349,0.00468472384772111,0.0135973630006015,0.0319614804836683,1.17221419969021e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,39836,0.0415889432656076,0.00856348619939726,0.0248045103147889,0.0583733762164262,1.20583430429543e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,0.026078219337007,0.00537799157367643,0.0155373558526012,0.0366190828214128,1.25460537570475e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0205129008834372,0.00423733813773215,0.0122077181334822,0.0288180836333922,1.30625252014207e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,-0.0151922614336679,0.00314020552111296,-0.0213470642550493,-0.00903745861228651,1.32603896725783e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,39587,0.0242072156303271,0.00501211960471595,0.0143834612050839,0.0340309700555704,1.38001088249171e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,0.0200731987630906,0.00415928324377798,0.0119210036052858,0.0282253939208954,1.40525874597067e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0168992572661829,0.00350326702911463,0.0100328538891182,0.0237656606432476,1.42347085053853e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39477,0.0377063851066797,0.00784504476530985,0.0223300973666723,0.053082672846687,1.55105981990784e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,0.0273399447781013,0.00569791745406258,0.0161720265681387,0.038507862988064,1.61524514512755e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0285053735253301,0.00595187410053132,0.0168397002882887,0.0401710467623715,1.69176651067222e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39489,0.0327865480944442,0.00684829867078307,0.0193638826997093,0.046209213489179,1.7037881254571e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.0166531862267871,0.00347957740502964,0.00983321451292901,0.0234731579406452,1.71984142075486e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.039317116635057,0.00823490639471683,0.023176700101412,0.055457533168702,1.81836728425149e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37169,0.0342706488792757,0.00718199087715289,0.020193946760056,0.0483473509984953,1.84574551847187e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPTC,Opticin,39788,-0.0202425223413329,0.00425842418263221,-0.028589033739292,-0.0118960109433737,2.01648626665189e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,39587,0.0271982497607301,0.00572504318263665,0.0159771651227622,0.0384193343986979,2.04453692923063e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00926468982563748,0.00195258420218688,-0.0130917548619238,-0.00543762478935119,2.1087009969204e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.0489281074781967,0.0103171961937787,0.0287064029383904,0.069149812018003,2.13408908406267e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37368,0.0193844155586753,0.00409028513070694,0.0113674567024897,0.0274013744148609,2.16819886276708e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37257,-0.0492377067151338,0.0104322405714327,-0.0696848982351418,-0.0287905151951257,2.38508154437928e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37388,0.0138228659055831,0.00292972189322709,0.00808061099485797,0.0195651208163082,2.403810194756e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0136759789807562,0.00290291290984071,0.00798626967746839,0.019365688284044,2.48477804350045e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,0.0402473483087447,0.0085637285003359,0.0234624404480863,0.057032256169403,2.63053945576157e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK1,Docking protein 1,37388,0.0624223005115254,0.0132979389793502,0.0363583401119989,0.0884862609110519,2.70366016156009e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0217805365374707,0.00464428163945307,0.0126777445241426,0.0308833285507987,2.76209474067035e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.042934360375614,0.00916491231274233,0.024971132242639,0.0608975885085889,2.82763043607461e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,39764,0.0306079775902161,0.00654297416786411,0.0177837482212025,0.0434322069592298,2.92082968702227e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,-0.0159210856911527,0.00340689959956778,-0.0225986089063055,-0.00924356247599984,2.98970429356853e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40058,-0.0177630764034507,0.00380449425115819,-0.0252198851357207,-0.0103062676711806,3.05138963448824e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0275415327515591,0.00591091903243635,0.0159561314479839,0.0391269340551344,3.19680692278261e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,39866,0.0238246995458297,0.00512188855191616,0.013785797984074,0.0338636011075854,3.32092123643371e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTC,Probetacellulin,39477,0.0332334728206361,0.00716319050484357,0.0191936194311427,0.0472733262101295,3.52124598112469e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0323271629705297,0.006968452731442,0.0186689956169034,0.045985330324156,3.53310192553399e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0187301044702601,0.00404656577660684,0.0107988355481107,0.0266613733924095,3.71486492580537e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,0.0371815316365912,0.0080380143050914,0.021427023598612,0.0529360396745703,3.76845824042105e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0154419636608355,0.00334404849348011,0.00888762861361445,0.0219962987080565,3.90972744954714e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXN,Thioredoxin,37289,0.0193674815550658,0.00419632280479508,0.0111426888576675,0.0275922742524642,3.96074982941112e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,0.0135623506178877,0.00294721684166837,0.0077858056082177,0.0193388956275577,4.22232943388763e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0259336931639549,0.00564171111509694,0.0148759393783649,0.0369914469495449,4.32413205889084e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0135541509426,0.00295067665152665,-0.0193374771795922,-0.00777082470560776,4.39780058374069e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,39585,0.0560065383514716,0.0121939881916926,0.032106321495754,0.0799067552071892,4.40386207785778e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0522947364752536,0.0113916312536333,0.0299671392181323,0.0746223337323749,4.4531778852002e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0300458190840213,0.00657605215416067,0.0171567568618664,0.0429348813061762,4.94589662254259e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0262196415053048,0.00575108715848892,0.0149475106746665,0.0374917723359431,5.18281364864833e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0222412132409059,0.00487949384068235,0.0126774053131684,0.0318050211686433,5.20829576659899e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.0324299345778075,0.00712970189990636,0.018455718853991,0.0464041503016239,5.44893307168007e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0158387963168434,0.00348371665226441,0.00901071167840511,0.0226668809552816,5.50246521581749e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,0.0229421032130154,0.00504940326816553,0.013045272807411,0.0328389336186199,5.57206568874997e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,39788,0.0574893456108363,0.0126762139160556,0.0326439663353674,0.0823347248863052,5.79648285275203e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0652984778731262,0.0144104687399969,0.0370539591427323,0.0935429966035201,5.90397408148952e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37021,0.0263243147859708,0.00580935695333256,0.014937975157439,0.0377106544145026,5.91198788866309e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,39546,0.0315581810496374,0.00696982731874219,0.0178973195049027,0.0452190425943721,6.0031676530237e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40030,-0.0258426179190573,0.00570845153547325,-0.0370311829285849,-0.0146540529095298,6.02310100827918e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.0437697415060338,0.00967692598342617,0.0248029665785185,0.062736516433549,6.14733490392251e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,39868,-0.0303773650419759,0.00672609741343378,-0.0435605159723061,-0.0171942141116457,6.3366046410869e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0206695819344483,0.00458387309156576,0.0116851906749794,0.0296539731939172,6.55481217468119e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37437,0.0314930788194373,0.00698454368712,0.0178033731926821,0.0451827844461925,6.56894333121038e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,39866,-0.0111898222224184,0.00248336527519355,-0.0160572181617978,-0.00632242628303909,6.6556830975432e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0310270526021703,0.00689409181586946,0.0175146326430662,0.0445394725612745,6.83515639486293e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0159037914376697,0.00354078460647319,0.0089638536089822,0.0228437292663571,7.12906620921056e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40018,0.00902045177437638,0.00200877363806963,0.00508325544375991,0.0129576481049928,7.15390754638148e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0250274960143001,0.00557923876132845,-0.0359628039865039,-0.0140921880420964,7.32470794857972e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0229272046374077,0.00511273791468029,0.0129062383246343,0.032948170950181,7.3761227120444e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRN1,Secernin-1,39866,0.0242771262367139,0.00543094315293467,0.0136324776569619,0.0349217748164658,7.87018536712571e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0141482710566397,0.00316634976522855,0.0079422255167918,0.0203543165964877,7.94753730945956e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,39815,0.0256874672746823,0.00575375022684756,0.014410116830061,0.0369648177193035,8.0816072747121e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.0518498431357472,0.0116473950323247,0.0290209488723909,0.0746787373991036,8.57963146011223e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.039433394005609,0.00885920106938164,0.0220693599096209,0.056797428101597,8.6104382324621e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0135165526263998,0.00303993871998605,0.00755827273522719,0.0194748325175725,8.80654270391585e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,0.0148845947497394,0.00334941003160717,0.00831975108778933,0.0214494384116894,8.9024917136445e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37021,0.0521267643812945,0.0117445822961251,0.0291073830808893,0.0751461456816997,9.13810926053274e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37021,-0.0156999189280464,0.00353852358767064,-0.0226354251598809,-0.00876441269621197,9.20236665220473e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,0.0217207758131552,0.00489761748409495,0.0121214455443291,0.0313201060819812,9.28326322151023e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,0.0207529649122534,0.0047074841635073,0.0115262959517791,0.0299796338727277,1.04764025435723e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37445,-0.010997956497869,0.00249466194530437,-0.0158874939106656,-0.00610841908507247,1.04841580612909e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0487556745467515,0.0110772524000309,0.0270442598426909,0.0704670892508121,1.08367400206176e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40052,0.0173782165098354,0.00394886898855676,0.00963843329226415,0.0251179997274066,1.08537796908447e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAEP,Glycodelin,39749,0.061492531435053,0.0139799147896105,0.0340918984474164,0.0888931644226897,1.09642729505657e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARTN,Artemin,39587,0.0190265245779815,0.00432732090356129,0.0105449756070014,0.0275080735489616,1.10560390390745e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37382,0.0261709775578816,0.00595308188565001,0.0145029370620076,0.0378390180537556,1.10999552822058e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39480,0.0469636672280899,0.0107151730477595,0.0259619280544812,0.0679654064016985,1.17867292529363e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0275968405891208,0.00630785634738261,0.0152334421482508,0.0399602390299907,1.22196283194828e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,0.00992575535854903,0.00227317042142501,0.00547034133255601,0.0143811693845421,1.27064554483899e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0297530995199349,0.00682376704718137,0.0163785161074594,0.0431276829324104,1.30892537859416e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,0.0259353307497045,0.00595095844165942,0.014271452204052,0.0375992092953569,1.32149205299436e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37056,0.0119890709280931,0.00275162420749254,0.0065958874814077,0.0173822543747785,1.32799636797013e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.0252466793898783,0.00581135598046218,-0.0366369371115842,-0.0138564216681724,1.40720640524213e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.0167108778431755,0.00384996724594022,0.00916494204113268,0.0242568136452184,1.43030564253103e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40009,-0.0095152167367326,0.00219463054907844,-0.0138166926129263,-0.00521374086053885,1.46189827961048e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.00739435725912244,0.00170667044602279,0.00404928318491777,0.0107394313333271,1.48401815360763e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39315,0.0106231590774881,0.00245306975474257,0.00581514235819271,0.0154311757967836,1.49669376379121e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP2,Caspase-2,39866,0.028550285481676,0.00659770192589117,0.0156187897069294,0.0414817812564227,1.51858530968516e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37169,-0.0141411332025985,0.00326998773593951,-0.0205503091650399,-0.00773195724015701,1.53975786031566e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,0.0530400032619415,0.0122904210425048,0.028950778018632,0.0771292285052509,1.6035508568714e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,0.0175691092053707,0.00407312295283369,0.00958578821781667,0.0255524301929247,1.61902032880339e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,39868,0.0281870571876107,0.00654302728719451,0.0153627237047095,0.0410113906705119,1.65754210593651e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.017663562325582,0.00410482895109,0.00961809758144558,0.0257090270697184,1.69595114770458e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD84,SLAM family member 5,39866,0.0129380866010188,0.00300757829032365,0.00704323315198448,0.0188329400500532,1.70398640486838e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFP,Properdin,37453,0.00965403664001513,0.00224496295052038,0.00525390925699519,0.0140541640230351,1.71749024450816e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,39858,0.0182794858292907,0.0042537628547436,0.00994211063399321,0.0266168610245881,1.73951198976929e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0318525133857498,0.00744158128851228,0.0172670140602657,0.0464380127112339,1.87718859492329e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0167907288767948,0.00392731247179642,0.00909319643207384,0.0244882613215158,1.91949511033397e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37411,0.0174069901011789,0.00407159731860255,0.00942665935671788,0.0253873208456399,1.92251793962549e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0238308603191426,0.00558806736306026,0.0128782482875445,0.0347834723507407,2.01439846867296e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,0.0305420726042058,0.00716412933157951,0.01650037911431,0.0445837660941017,2.02666208682867e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0454528748826293,0.01066980754172,-0.0663656976644006,-0.024540052100858,2.05646748576635e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP8,Caspase-8,39984,0.025329288014199,0.00595420394891278,0.0136590482743299,0.036999527754068,2.11153053829683e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0356560056768712,0.00838353245222069,0.0192242820705187,0.0520877292832238,2.12283323116548e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37333,0.0199229919267435,0.00469033827627021,0.0107299289052539,0.0291160549482331,2.17459080404864e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.020233059272503,0.00476924002796097,0.0108853488176995,0.0295807697273065,2.22409174834829e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40024,-0.0145478980035723,0.00343120469675267,-0.0212730592092075,-0.00782273679793704,2.24881073365798e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0220878090287895,0.0052107531250822,0.0118747329036284,0.0323008851539506,2.25892927398052e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.0103553898732766,0.00244470312211309,0.00556377175393496,0.0151470079926183,2.28949206858951e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.00996505793913553,0.00235508077517701,0.0053490996197886,0.0145810162584825,2.33635874149088e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBN1,Drebrin,37056,0.0215117166246277,0.00508760099201328,0.0115400186802817,0.0314834145689738,2.37088555391624e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00891604031144819,0.00210872642952999,-0.013049144113327,-0.00478293650956941,2.3714885368895e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,0.0161342656624413,0.00381785566379128,0.00865126856141044,0.0236172627634722,2.39209928526006e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0193065892918678,0.0045692892443493,0.0103507823729432,0.0282623962107924,2.40190426667433e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0157952619056334,0.00374304884852016,0.00845888616253385,0.0231316376487329,2.46010604524479e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,0.0197162104274305,0.00467276065762312,0.0105575995384892,0.0288748213163718,2.46564259435448e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37388,-0.0171136683183288,0.00405822874891438,-0.025067796666201,-0.00915953997045663,2.49152281963752e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37124,0.0305843974213006,0.00729523376971385,0.0162857392326614,0.0448830556099397,2.77833072086479e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST5,Cystatin-D,39559,0.0219076274948231,0.0052389492466465,0.0116392869713959,0.0321759680182502,2.9092873695227e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37437,0.0400119366768509,0.00957455506310985,0.0212458087531556,0.0587780646005462,2.94644263812402e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,39858,-0.0356694500484049,0.00854092457918938,-0.0524096622236161,-0.0189292378731937,2.97860942004465e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGN,Secretagogin,39587,0.0173672819839901,0.00416234917742178,0.00920907759624343,0.0255254863717368,3.02932146783121e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.0123419207775243,0.00296149767537397,0.00653738533379137,0.0181464562212573,3.09660455471004e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39477,0.0292822747278646,0.00704257444670455,0.0154788288123237,0.0430857206434055,3.22910039447146e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0128973082571139,0.00310307985491918,0.00681527174147235,0.0189793447727555,3.25436846841236e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37411,0.0110218799810357,0.00265973897432904,0.00580879159135077,0.0162349683707206,3.43417263739264e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37368,0.0200826496426458,0.00490553824274408,0.0104677946868674,0.0296975045984242,4.26695552429542e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0282594670524622,0.00691204440285436,0.0147118600228676,0.0418070740820567,4.3683897593158e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39489,0.0128066958482416,0.00314918532175477,0.00663429261760225,0.018979099078881,4.79235750344865e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37348,0.0228477931361336,0.00562044360323324,0.0118317236737965,0.0338638625984708,4.82795513069198e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,0.0346013456016297,0.00851720587036839,0.0179076220957077,0.0512950691075518,4.8775653833005e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,36991,0.033345617435603,0.00821532927498503,0.0172435720566323,0.0494476628145736,4.95793205840462e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.0106895168770854,0.00263487515327985,0.00552516157665687,0.0158538721775139,4.99558048023169e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.0125290252855772,0.00309344709905588,0.0064658689714277,0.0185921815997268,5.14626880680664e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0386309389680391,0.00955077396684233,0.0199114219930281,0.0573504559430501,5.26673084961004e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0162046234393142,0.00402043339247388,-0.024084672888563,-0.00832457399006541,5.59558421159656e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0225284661901286,0.00559944478849513,0.0115535544046781,0.033503377975579,5.76413588052055e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0158665102295684,0.00394738545987983,0.00812963472820391,0.0236033857309328,5.86461625040306e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,0.0359303036577373,0.00895036869080485,0.0183875810237598,0.0534730262917148,5.98703448022739e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSV,Cathepsin L2,39967,-0.0158586930645034,0.00395416037116903,-0.0236088473919947,-0.0081085387370121,6.08289603060974e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.0494754484615566,0.0123414316687177,0.0252862423908698,0.0736646545322433,6.13314305067439e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.0342943006491109,0.00856742220921597,0.0175021531190476,0.0510864481791742,6.2918460957618e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,39587,0.0321969690293186,0.00805006171625378,0.0164188480654612,0.047975089993176,6.37417414691438e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.0103401821949051,0.0025908137217383,0.00526218730029807,0.0154181770895122,6.60674900734162e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,0.00779981644676529,0.00195474495992359,0.00396851632531506,0.0116311165682155,6.63753312382503e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40030,0.0166632964978641,0.00417944751816716,0.00847157936225644,0.0248550136334717,6.72189906424558e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37430,-0.0421855650128454,0.0105814667636053,-0.0629252398695118,-0.0214458901561789,6.73379752961784e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0135341998868851,0.00339950101516584,-0.0201972218766101,-0.00687117789716005,6.89268816344244e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37437,0.0205604132135161,0.00516453665836286,0.0104379213631249,0.0306829050639073,6.89611749313263e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.0157276380219275,0.00396529866164897,0.00795565264509555,0.0234996233987595,7.33053703301388e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELL,L-selectin,37453,-0.00870397413389017,0.00219449704738588,-0.0130051883467665,-0.00440275992101384,7.33796001643585e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,37453,0.00993826134755504,0.00250724868269037,0.00502405392948191,0.0148524687656282,7.41398011279325e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOSB,Protein fosB,39489,0.0148921803504871,0.00376754789356099,0.00750778647910755,0.0222765742218666,7.75976963268516e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRGN,Neurogranin,37445,0.0351585689768237,0.00890560608436871,0.0177035810514611,0.0526135569021864,7.92324450040274e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.00769071709889595,0.00194905349512937,0.00387057224844238,0.0115108619493495,7.98478834821466e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,36991,-0.0343753496491549,0.00873241026073532,-0.0514908737601961,-0.0172598255381137,8.30965600846792e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,37453,0.00935164587622867,0.00237584794000295,0.00469498391382289,0.0140083078386345,8.3218681601506e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37056,-0.0101542633401825,0.00258217767848192,-0.015215331590007,-0.00509319509035789,8.45173167154889e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37249,0.0231660458438085,0.00590671534451417,0.0115888837685607,0.0347432079190563,8.82607917855812e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,36962,-0.00984042812574398,0.00251305903531182,-0.0147660238349552,-0.00491483241653281,9.05926815823268e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37124,0.0364125521716074,0.00929926241784598,0.0181859978326293,0.0546391065105855,9.06164720155971e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRTN,Neurturin,39587,0.0187638607383593,0.00479477138037382,0.00936610883282666,0.028161612643892,9.13886384891708e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,39868,0.0290420020847554,0.00742401181571201,0.0144909389259599,0.0435930652435509,9.1950597414427e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,37453,0.00732438042415098,0.00187563068273094,0.00364814428599835,0.0110006165623036,9.46719727031262e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP9,Caspase-9,37056,0.023919415634797,0.00614791396927077,0.0118695042550263,0.0359693270145677,0.000100464702885873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,0.0177253481040792,0.00455907487533565,0.00878956134842136,0.0266611348597371,0.000101515353649275
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0218638051229947,0.00565060606942894,0.010788617226914,0.0329389930190754,0.000109600943156907
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,0.0289543680224365,0.00749175537655533,0.0142705274843881,0.043638208560485,0.000111699023848249
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37124,-0.00791033967916003,0.00204710533923546,-0.0119226661440615,-0.00389801321425852,0.000112003491616214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,0.0104790596699823,0.00271554836630474,0.00515658487202498,0.0158015344679396,0.000114421377951802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,0.0273481851087911,0.00708714096174925,0.0134573888237625,0.0412389813938196,0.000114450517870642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.0419512092841843,0.0108756608536217,0.0206349140110858,0.0632675045572829,0.000115083828987391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39477,0.0132500848034367,0.00344543184580109,0.00649703838566652,0.0200031312212068,0.00012068778531688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.014554680917001,0.00378996511462615,0.00712634929233378,0.0219830125416683,0.000123434894897533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG1,Arginase-1,39754,0.0191516272556901,0.0049951975393726,0.00936104007851982,0.0289422144328604,0.00012655821022263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD1,Polycystin-1,37437,0.00971561477993973,0.00254040221816719,0.00473642643233203,0.0146948031275474,0.000131656156621914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37380,0.00945008638875558,0.00247473904234688,0.00459959786575568,0.0143005749117555,0.000134800009279462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.0399649939781275,0.0104668368734938,0.0194499937060797,0.0604799942501753,0.00013500256634245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40052,-0.0100574979758615,0.00263431466866716,-0.0152207547264491,-0.00489424122527384,0.000135104680013157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37056,0.0197294312801367,0.00516899215900739,0.00959820664848223,0.0298606559117912,0.000135766332397306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37021,-0.0116059511524019,0.00304195585766273,-0.0175681846334208,-0.00564371767138293,0.000136643790215351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LXN,Latexin,39682,-0.0246163378459731,0.00645697980037966,-0.0372720182547172,-0.0119606574372289,0.000138167593895509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,0.0210808663555419,0.00553611643230666,0.0102300781482208,0.0319316545628629,0.000140798551657534
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,0.013248363857835,0.00348893722072831,0.00641004690520749,0.0200866808104624,0.00014684939928448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,39856,-0.0225979659053199,0.00596391797333183,-0.0342872451330503,-0.0109086866775896,0.000151739558211495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0271661997833648,0.00717248805346643,0.0131081231985706,0.041224276368159,0.000152816330614916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,36962,-0.0113899122809864,0.00300738754005747,-0.0172843918594991,-0.00549543270247378,0.000152966766383323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,0.0198448816123639,0.00524023441510968,0.0095740221587489,0.0301157410659788,0.000153021058002093
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37411,0.028736427619415,0.00759211920799933,0.0138558739717363,0.0436169812670937,0.000154350076875154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON1,Spondin-1,39885,0.011637682239693,0.0030749787645813,0.00561072386111363,0.0176646406182723,0.000154492977869876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0138626256144648,0.00367033698876563,0.00666876511648413,0.0210564861124454,0.00015946696661575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB1,Calbindin,39788,0.015276421095209,0.00404686963214699,0.00734455661620094,0.0232082855742171,0.00016066980727921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0243895926087886,0.00649215689506654,0.0116649650944581,0.037114220123119,0.000172851775128254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMB,Granzyme B,39866,0.0232333071478487,0.00618726812517751,0.0111062616225008,0.0353603526731966,0.000173942196713982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0317506317642105,0.00850925513235601,0.0150724917047927,0.0484287718236283,0.000191296489758844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFD,Complement factor D,37453,0.00659729497845354,0.00177075230265127,0.00312662046525704,0.01006796949165,0.000195561084725315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,39788,-0.0274808923681228,0.00737883874675598,-0.0419434163117645,-0.0130183684244811,0.00019654579441427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOC,Myocilin,39858,-0.0164706208966628,0.00443578142833358,-0.0251647524961967,-0.00777648929712903,0.000205409011291861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP2,Neuropilin-2,39858,-0.0102073759393112,0.0027538573174568,-0.0156049362815265,-0.00480981559709586,0.000210790496546165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37039,0.0210246407111656,0.00567947546239032,0.00989286880488062,0.0321564126174507,0.000214894449498129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.00786017216517653,0.00212340648517935,0.00369829545422501,0.012022048876128,0.000215023007789272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.0263655576145147,0.00714041753700581,0.0123703392419833,0.0403607759870461,0.000223009891865871
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37411,0.0247886429368416,0.00672562672394299,0.0116064145579134,0.0379708713157699,0.000228964162860245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,0.0167632784760832,0.0045501684337646,0.00784494834590455,0.0256816086062618,0.000230430007010847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37368,0.0148793675194685,0.00404400200271882,0.00695312359413966,0.0228056114447974,0.000234722322506109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.0365509758070596,0.00994298237289862,0.0170627303561783,0.0560392212579409,0.000237806213715741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA5,Annexin A5,39415,0.0107084719378971,0.00291713365125708,0.00499088998143317,0.0164260538943609,0.000242517533065733
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,39868,0.0308776805146228,0.00842346308524345,0.0143676928675456,0.0473876681617,0.000247484393231629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0219211033150599,0.00598516362099965,0.0101901826179005,0.0336520240122192,0.000250642875873965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCP1,Plastin-2,37437,0.0166629745603985,0.00455015884313091,0.00774466322786193,0.0255812858929351,0.00025114143476573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40012,0.0103020652258377,0.00282277330070821,0.00476942955644956,0.0158347008952258,0.000263450805357515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_A,,37411,0.0114240339389868,0.00313409574134743,0.00528120628594586,0.0175668615920278,0.000268307067288255
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0108310498783455,0.00297831261686225,-0.0166685426073955,-0.00499355714929552,0.00027727247937042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0228048377566483,0.00627557890574874,0.0105047031013807,0.0351049724119158,0.000280218125884137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37368,0.0153619639554118,0.00423441697631501,0.00706250668183436,0.0236614212289892,0.000286809495620504
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37039,-0.0109557172443352,0.00302016301238835,-0.0168752367486164,-0.00503619774005407,0.000287231735844057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40017,0.0210866822685381,0.00581386080431696,0.00969151509207683,0.0324818494449993,0.000287652534551392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37368,0.0187691213345636,0.00517829745573934,0.00861965832131453,0.0289185843478127,0.000290501672715471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.0163302732234627,0.00451921491955406,0.00747261198113677,0.0251879344657887,0.000302985998460665
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.016318946009616,0.00452051028772534,0.00745874584567429,0.0251791461735576,0.000307179665122785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0128662153976486,0.00356724419497993,0.00587441677548794,0.0198580140198093,0.000311154895978389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.0189386468116791,0.00525734215226046,0.00863425619324862,0.0292430374301096,0.000316343344385336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11,Coagulation factor XI,37249,-0.0109324923371417,0.00303654793514961,-0.016884126290035,-0.00498085838424851,0.000318995465261066
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.0147391273558418,0.00410166442808734,0.00669986507679061,0.022778389634893,0.000327318236542865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37437,0.0186218894561657,0.0051920592635932,0.00844545329952307,0.0287983256128084,0.000336182411118238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.0102849793314818,0.00286983820988359,0.00466009644010996,0.0159098622228536,0.000339607462930332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37169,0.00991518040386788,0.00276836023953542,0.00448919433437846,0.0153411664733573,0.000342703942862114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0310704228018651,0.00869800574959509,0.0140223315326587,0.0481185140710714,0.00035534151580673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,-0.00931631710011739,0.00260814481359614,-0.0144282809347658,-0.00420435326546895,0.000355489100860768
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.0149172762310862,0.00419266618076358,-0.0231349019453828,-0.00669965051678962,0.000375078609399595
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40052,-0.00985558788668901,0.00277348126029744,-0.015291611156872,-0.00441956461650604,0.000381211146862684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,-0.0126167200151612,0.00355149030979549,-0.0195776410223603,-0.00565579900796199,0.000382866606107326
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.014209870863525,0.00400131812473551,0.0063672873390434,0.0220524543880066,0.000384673681264019
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD8,Frizzled-8,36991,0.0146565197401084,0.00413912969603349,0.00654382553588278,0.0227692139443341,0.000400044737092031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0165884164564204,0.00468492425290806,0.00740596492072065,0.0257708679921202,0.000400242352513304
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,39585,0.0176680353654929,0.00499632998974539,0.00787522858559194,0.0274608421453939,0.000407090916002496
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.023186038070354,0.00656256963835281,0.0103234015791825,0.0360486745615255,0.000412166367620616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,0.027154508347047,0.00769243798552672,0.0120773298954146,0.0422316867986793,0.000416899610784191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37021,-0.0141524432712785,0.00401265370368737,-0.0220172445305058,-0.00628764201205127,0.000421801560771403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB9,Serpin B9,39749,0.0113182001811926,0.00322864044680482,0.00499006490545516,0.01764633545693,0.000456899612965306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGN,Cingulin,37039,0.0132052390891167,0.00377560333751883,0.00580505654757981,0.0206054216306536,0.000471157047723705
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39520,0.0301233655833231,0.00862692911196121,0.0132145845238791,0.0470321466427671,0.000481129741213101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100G,Protein S100-G,37411,-0.0152209711677927,0.00436141075227398,-0.0237693362422497,-0.00667260609333572,0.000484702299877034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.00886687912145877,0.00254460944373802,-0.0138543136311853,-0.00387944461173225,0.000494532925568341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,0.0226978151150367,0.00651414548029837,0.00993008997365192,0.0354655402564215,0.000494605224702085
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR2,Complement receptor type 2,39931,0.0152643090191388,0.00438360309959097,0.0066724469439405,0.0238561710943371,0.000498749941419554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.0097471325545125,0.00280019172969392,-0.0152355083447126,-0.00425875676431242,0.000501392114965322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.00873529057727101,0.00251023073192098,-0.0136553428118361,-0.00381523834270589,0.000503270906944294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0221597985834999,0.00637974679765342,-0.0346641023069006,-0.00965549486009925,0.000515400191528707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7,Complement component C7,37149,0.0107617454227311,0.00311313333367304,0.00466000408873196,0.0168634867567303,0.000548166441029959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.0402695841327791,0.0116691532083846,0.0173980438443453,0.0631411244212129,0.000560072616611515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0202032855205191,0.00585488283008529,0.00872771517355198,0.0316788558674863,0.000560943202228415
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0147896250238987,0.00430385464544044,-0.023225180128962,-0.00635406991883543,0.000591055382347144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0199479421102769,0.00581768817666837,0.00854527328400694,0.0313506109365469,0.000607724083958993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0174650957166844,0.00509657399750846,0.00747581068156788,0.027454380751801,0.000612489041598331
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,-0.00784855327456084,0.00230066911153616,-0.0123578647331717,-0.00333924181594997,0.000647845356508436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37411,0.0168814405273193,0.00496148304753815,0.00715693375414457,0.0266059473004941,0.000669657176104616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,0.0280966904289138,0.00826538769610149,0.0118965305445549,0.0442968503132727,0.000677539556389775
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.0276615009476964,0.00815747611476281,-0.0436501541326315,-0.0116728477627613,0.000698530085525817
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40030,-0.0101518343335418,0.00299467400190621,-0.016021395377278,-0.00428227328980565,0.000700691004975847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0156791427606143,0.00462665795320973,-0.0247473923489054,-0.00661089317232326,0.000703871208304417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37368,0.0264073748975547,0.00781092857362254,0.0110979548932545,0.0417167949018549,0.000724735388851669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0153487896322106,0.00454127467545296,0.00644789126832277,0.0242496879960984,0.000727050832557565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,0.015487762864386,0.0045838614520749,0.00650339441831919,0.0244721313104528,0.000729918129570591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,36962,0.0117897823503475,0.0034940005498209,0.00494154127269849,0.0186380234279964,0.000742200937257726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00979161971995959,0.00290507478605229,-0.0154855663006221,-0.0040976731392971,0.000752424555630425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0123993924336746,0.00368558174280555,-0.0196231326495735,-0.00517565221777571,0.000769584518379204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0100138466615271,0.00297670887406764,-0.0158481960546997,-0.00417949726835454,0.000769811901025215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,0.0356157189505119,0.0106019597046633,0.0148358779293719,0.0563955599716519,0.000783083004494644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37124,0.00915726824275809,0.0027336057261394,0.00379940101952486,0.0145151354659913,0.000810701589242538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37430,0.0122008551075531,0.00366032982890955,0.00502660864289039,0.0193751015722158,0.000860622935275027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,-0.00899226388086122,0.00269780625878825,-0.0142799641480862,-0.00370456361363625,0.000860973483941495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0127562716282422,0.0038392590940971,0.0052313238038119,0.0202812194526725,0.000893903407134282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0283508437484639,0.00854337731860159,0.0116058242040048,0.045095863292923,0.000907212797605023
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37056,0.00837781266875831,0.0025325612861214,0.00341399254796038,0.0133416327895563,0.000942028781454847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0145639043658996,0.00440279324581367,0.0059344296041048,0.0231933791276944,0.000942165614060803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,-0.0159269852835348,0.00482391523002074,-0.0253818591343754,-0.00647211143269414,0.000963595225816492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0197646225261429,0.00600656495918033,0.00799175520614946,0.0315374898461363,0.00100270838819279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0214984407126519,0.00654428070430266,0.00867165053221867,0.0343252308930851,0.00102215531702103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37021,-0.0136435617435569,0.00415761611012956,-0.0217924893194108,-0.00549463416770291,0.00103494930936935
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPP1,Osteopontin,40012,-0.0142519171904524,0.00434366248561531,-0.0227654956622584,-0.00573833871864638,0.00103628512128608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37056,-0.0170832182670864,0.00521127205232551,-0.0272973114896444,-0.00686912504452843,0.0010476816827172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0140801308313733,0.00429922504059172,0.00565364975181355,0.0225066119109331,0.00105913286046699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.0131264667392648,0.0040130519344542,0.00526088494773455,0.020992048530795,0.00107459926493803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0131499994977296,0.00402400487037877,0.00526294995178717,0.0210370490436719,0.00108585426186703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37186,-0.0557239666776737,0.0170678386929198,-0.0891769305157964,-0.0222710028395509,0.00109797618515638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37021,0.0190284221472448,0.00583062120233753,0.00760040459066322,0.0304564397038264,0.00110313210997884
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2,Ataxin-2,36991,0.0353126631881247,0.0108253650633689,0.0140949476639216,0.0565303787123279,0.00110899850648816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00941889275717915,0.00289043840786057,-0.0150841520365859,-0.00375363347777243,0.00112231594401187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4,Interleukin-4,39587,0.0283923650514888,0.00871988363332682,0.0113013931301682,0.0454833369728094,0.00113213494190627
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC4,Syndecan-4,39868,0.0142466290923093,0.00438089209812287,0.00566008057998846,0.0228331776046301,0.00114836140215056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37187,0.00786383887200812,0.00242694757472358,0.00310702162554989,0.0126206561184663,0.00119731404026601
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37043,0.0228854096213354,0.00707019293332778,0.00902783147201297,0.0367429877706578,0.00121140152350483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39477,0.0243900081268593,0.00754633911471343,0.00959918346202094,0.0391808327916976,0.0012316825729807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,-0.0115417234808137,0.0035971031580798,-0.0185920456706501,-0.00449140129097726,0.0013364465914416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17D,Interleukin-17D,39587,0.0104955303102207,0.00327278869089494,0.00408086447606659,0.0169101961443747,0.00134438611114964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,0.0136851295431332,0.00427025756367601,0.00531542471832827,0.0220548343679382,0.00135499884400797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00795643380017305,0.00248393192240979,-0.0128249403680962,-0.00308792723224986,0.00136253055344501
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,0.0741873128622757,0.023164756863141,0.0287843894105193,0.119590236314032,0.00136511060208259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD177,CD177 antigen,39844,0.0385057004628036,0.0120508316932037,0.0148860703441244,0.0621253305814828,0.00139969838770965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0187384587401866,0.00586796102547595,0.00723725513025371,0.0302396623501194,0.00140962104614215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0149810005981996,0.00469141487093626,0.00578582745116451,0.0241761737452347,0.00140997202099819
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,0.00788769806128153,0.00247426024349662,0.00303814798402817,0.0127372481385349,0.00143635603297429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40009,0.0203520652585743,0.00639093719033032,0.00782582836552686,0.0328783021516217,0.00145269759800163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,-0.00580796313033651,0.0018249664354796,-0.00938489734387652,-0.0022310289167965,0.00146336788976333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0319079985230107,0.0100261822324861,0.0122566813473379,0.0515593156986835,0.00146356315162515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0179850112309185,0.00566204747810536,0.00688739817383203,0.029082624288005,0.0014938770540965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00480097448031616,0.00151301183852168,0.00183547127681366,0.00776647768381866,0.00151089835027374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,39868,-0.0107836943316168,0.00340749243518934,-0.0174623795045879,-0.0041050091586457,0.00155533059098957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0103824758586335,0.00328386380655802,-0.0168188489194872,-0.00394610279777975,0.00157226917686101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,0.0156002724846896,0.00493782369177096,0.00592213804881854,0.0252784069205607,0.00158427892529266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0214608338117586,0.0068147862800475,0.00810385270286548,0.0348178149206517,0.0016410760165666
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0195984873241592,0.00624059660192833,0.00736691798437966,0.0318300566639387,0.00169039994491009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37411,0.0182384723003611,0.00581870681977618,0.00683380693359977,0.0296431376671224,0.00172541454848601
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39453,-0.0132510583856163,0.00423063030191639,-0.0215430937773724,-0.00495902299386014,0.00173839692265607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,0.0114125871285123,0.0036510389655284,0.00425655075607665,0.018568623500948,0.00177669980191281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.0118053621784177,0.00377749013025151,0.00440148152312476,0.0192092428337107,0.00178075552314187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC1,Glypican-1,40030,-0.00874783270584557,0.00280039312762582,-0.0142366032359922,-0.00325906217569896,0.00178854825316963
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.00820782343444863,0.00262973162170484,0.00305354945590714,0.0133620974129901,0.00180465971645206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.00834966325844984,0.0026761746454182,0.00310436095343017,0.0135949655634695,0.00181171442582436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,39587,0.0084629506961263,0.00271699409069361,0.00313764227836682,0.0137882591138858,0.00184387266570632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA1,Annexin A1,37072,0.0131882003013715,0.00424579952476415,0.00486643323283378,0.0215099673699093,0.00189925308889012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.0301990279074453,0.00972726403639771,0.0111335903961058,0.0492644654187848,0.0019088459385783
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0148084307979904,0.0047755189943721,0.00544841356902109,0.0241684480269597,0.00193267784700915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.0358070573838008,0.0115817041551713,0.013106917239665,0.0585071975279367,0.00199361025417148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37021,-0.0137868056366868,0.00447304650636585,-0.0225539767891639,-0.00501963448420974,0.00205904176756842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0125240883006529,0.00407308727913033,0.00454083723355741,0.0205073393677483,0.00211036445188038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNN,Tenascin-N,37437,0.0127931791546715,0.00416670156987745,0.00462644407771165,0.0209599142316313,0.00214239456825554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.0362849575721911,0.0118357288251318,0.0130869290749328,0.0594829860694494,0.00217512801342802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,39587,-0.00979696558603377,0.00319899340244982,-0.0160669926548354,-0.00352693851723212,0.00219856123577125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40009,-0.00914041750292408,0.00298941839412784,-0.0149996775554146,-0.00328115745043352,0.00223489055954472
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37056,0.0116558202101583,0.00381381970506935,0.00418073358822233,0.0191309068320942,0.00224604759203096
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0867254130144074,0.0283877165863537,0.0310854885051541,0.142365337523661,0.00225405932490931
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0202716784303262,0.00665352631838456,0.00723076684629245,0.0333125900143599,0.00231710380878233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40031,-0.0119714190250721,0.00394377074680084,-0.0197012096888018,-0.0042416283613425,0.00240498291308868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,0.0129172371350932,0.00426071570290222,0.00456623435740483,0.0212682399127815,0.00243564828671327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0184584719586688,0.00609568605171321,-0.0304060166200267,-0.00651092729731091,0.00246555884252063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0214480178327922,0.00708684901695761,0.00755779375955525,0.0353382419060291,0.00247838036353939
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37021,0.0112292574335728,0.00371765178945564,0.00394265992623976,0.0185158549409059,0.00252821743568784
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCN,Decorin,39585,-0.00632214123567006,0.0020934745178021,-0.0104253512905622,-0.00221893118077795,0.00253240979436213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37124,0.0106054465298135,0.00351429632962538,0.00371742572374777,0.0174934673358793,0.0025509938481751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,-0.0117391157983201,0.00389040942344876,-0.0193643182682797,-0.00411391332836057,0.00255316051550168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRNN,Cornulin,39397,-0.0188533480790558,0.00625009673724322,-0.0311035376840525,-0.00660315847405913,0.00256134133015113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.00729803034537961,0.00241987286793069,0.00255507952423546,0.0120409811665238,0.00256716096766241
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRL,Prolactin,40009,0.0220635127180024,0.00732017421399895,0.00771597125856443,0.0364110541774403,0.00258168849290721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0131029539357605,0.00435044110700053,0.00457608936603948,0.0216298185054816,0.00260127034707035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.00816832602449799,0.00271708180872725,0.00284284567939257,0.0134938063696034,0.00264957799549239
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.0216609145618393,0.00722354960607517,0.00750275733393197,0.0358190717897466,0.00271603511658478
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37124,-0.00978250966711606,0.00326668188436007,-0.0161852061604618,-0.00337981317377032,0.00275283273542513
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0159955794180957,0.00535902767950539,0.00549188516626516,0.0264992736699263,0.00284279087333826
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.0164410435280414,0.00551102091946776,0.00563944252588463,0.0272426445301983,0.00285585541927834
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,36962,-0.0103188391577221,0.00345933788465863,-0.017099141411653,-0.00353853690379114,0.00286062415400843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37411,0.0179198603912691,0.00601876631543996,0.00612307841300681,0.0297166423695314,0.00291283940935408
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBN,Ameloblastin,39587,-0.00818377118405748,0.00275665659377435,-0.0135868181078552,-0.00278072426025976,0.00299483308299947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0132244786124888,0.00446293645853964,0.00447712315375116,0.0219718340712265,0.0030500971483987
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00501998524533399,0.0016974001810612,0.00169308089045403,0.00834688960021395,0.00310642765595741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.0113740307013331,0.00384919989261997,0.00382959891179796,0.0189184624908682,0.00313299529180365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL,Podocalyxin,39788,-0.00428808957188936,0.00145234460458804,-0.00713468499688192,-0.0014414941468968,0.00315642357392409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP6,Gastrotropin,39564,0.0153226866471555,0.00521069238305347,0.00510972957637067,0.0255356437179403,0.003280296471314
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0174849211490127,0.00595916942227892,0.00580494908134604,0.0291648932166794,0.00334988196823302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,0.0150035792894261,0.00511844657588223,0.00497142400069689,0.0250357345781552,0.00338152695530379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,39868,0.0211939842664435,0.00723092298178479,0.0070213752221453,0.0353665933107417,0.00338327999955981
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37056,0.00950044867109422,0.00324197288553783,0.00314618181544008,0.0158547155267484,0.00339048464534673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37424,0.00638886447518359,0.00219044119238789,0.00209559973810332,0.0106821292122639,0.0035433328178077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37021,-0.0140070693899417,0.00481147191278654,-0.0234375543390033,-0.00457658444088005,0.00360668560325077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0103147360607568,0.00354573524903553,0.00336509497264712,0.0172643771488664,0.0036311500974434
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37411,0.0103208422545661,0.00355121795743456,0.00336045505799439,0.0172812294511379,0.0036634352133659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0108839797036345,0.00375028405885831,0.00353342294827224,0.0182345364589968,0.00371180115841518
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,0.0197794336864851,0.00681641977126959,0.00641925093479671,0.0331396164381735,0.0037171938954282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0235482593300931,0.00814235977598705,0.0075892341691585,0.0395072844910277,0.0038333487084759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,0.0277841316605622,0.00960861325299515,0.00895124968469174,0.0466170136364327,0.00383913400061664
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0394033265902452,0.0136450440196237,0.0126590403117828,0.0661476128687077,0.00388553926411655
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,0.0181158662394011,0.00630149082983532,0.00576494421292391,0.0304667882658784,0.00404860567259517
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.0170526895251557,0.00594442290907254,-0.0287037584269378,-0.00540162062337348,0.00412718315240793
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD276,CD276 antigen,39862,0.00972978016279293,0.00339738195471299,0.00307091153155546,0.0163886487940304,0.00418997171859205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37169,-0.0102309050933341,0.00357378870642178,-0.0172355309579208,-0.0032262792287474,0.00420622028096946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00224477576521971,0.000784286704243377,0.00070757382490269,0.00378197770553673,0.00421380152356667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.0166808992870652,0.00584885214083456,0.00521714909102945,0.0281446494831009,0.00435023466067789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37382,0.0124685998666631,0.00438667428566762,0.0038707182667546,0.0210664814665717,0.00448449815520813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,0.0145461110489909,0.00512364965666175,0.00450375772193391,0.024588464376048,0.00453220074254492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37021,0.016994057200746,0.00599648847092733,0.00524093979772847,0.0287471746037636,0.00460390845361142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,0.0265188185474353,0.00938032168192153,0.00813338805086913,0.0449042490440015,0.00470469241125921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0169144726992917,0.00600119082740978,0.00515213867756851,0.0286768067210149,0.00483178521175885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0212896787354313,0.00755725322908253,0.00647746240642955,0.0361018950644331,0.00485286814363449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00830423185852922,0.00294893650388364,-0.0140841474061411,-0.00252431631091729,0.00486852431020814
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37039,0.0179984595109075,0.00639292339612788,0.00546832965449687,0.0305285893673181,0.00487930613956313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40052,0.00869299215427012,0.00308996846388703,0.00263665396505154,0.0147493303434887,0.0049095747567572
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH22,Cadherin-22,37169,-0.00791967037475525,0.00281561906453614,-0.0134382837412461,-0.00240105700826442,0.00491897135215552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37437,0.0212710456590685,0.00759891500597292,0.00637717224736162,0.0361649190707754,0.00512982758672651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,36991,-0.00764636466550526,0.00273754160874618,-0.0130119462186478,-0.00228078311236275,0.0052273019761759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,39913,-0.00725840581898781,0.00259880563924694,-0.0123520648719118,-0.00216474676606381,0.00522871352713416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.015242498054615,0.00545990258682242,0.00454108898444311,0.025943907124787,0.00525049118531151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0149838671845086,0.005382361695669,0.00443443826099741,0.0255332961080199,0.00537747115070115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37124,0.0304512385250966,0.0109817845712731,0.00892694076540127,0.051975536284792,0.00556391098953354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,36971,0.0263247286230256,0.00951070128574637,0.00768375410296269,0.0449657031430885,0.00564968558938959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0105286007979063,0.00380542025782932,0.00306997709256081,0.0179872245032517,0.00566991518756152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.013157448783634,0.00475751337393941,0.00383272257071277,0.0224821749965553,0.0056880663688922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00883398628473886,0.00319585930856703,-0.0150978705295302,-0.00257010203994747,0.0057128572213912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37043,0.00814691867877535,0.00295812113067075,0.00234900126266069,0.01394483609489,0.00589370408896006
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37124,0.00873682094204984,0.00317516703671766,0.00251349355008322,0.0149601483340164,0.00593836392879653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL34,Interleukin-34,39456,0.00949226154982913,0.00345034329968579,0.00272958868244498,0.0162549344172133,0.00594628807255077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.010304238785124,0.00374995086248872,0.00295433509464612,0.0176541424756019,0.00600593331503561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,0.0074358869589045,0.00270902191676636,0.00212620400204243,0.0127455699157666,0.00606038789802991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0102253509714541,0.00372834872685009,0.00291778746682795,0.0175329144760803,0.00610380049342271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH7B,Myosin-7B,36962,-0.0116942776245197,0.00426461892366629,-0.0200529307149057,-0.00333562453413382,0.00611190199327699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37271,0.0168061939409331,0.006133949073376,0.00478365375711614,0.0288287341247501,0.00615456520295544
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,0.0221083093681713,0.00810616120697939,0.0062202334024917,0.0379963853338509,0.00639168021285374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,0.00883815382009787,0.00325397312031407,0.0024603665042823,0.0152159411359134,0.00661248642805959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH4,Myosin-4,37021,-0.0125634754710691,0.00462861335447383,-0.0216355576458378,-0.0034913932963004,0.00665012066084118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00841837171507146,0.00310345795984466,0.00233559411377592,0.014501149316367,0.00668490502980449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39489,0.0191303999751886,0.00705798232835037,0.0052967546116219,0.0329640453387554,0.00672626792717427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MB,Myoglobin,40052,0.0135683783174245,0.00500691708398353,0.0037548208328168,0.0233819358020322,0.00673689270145221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37411,0.0211458353687831,0.00783104293313083,0.00579699121984664,0.0364946795177195,0.00693717994283812
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVPL,Envoplakin,37169,-0.00857979635890673,0.00319767864938274,-0.0148472465116969,-0.00231234620611656,0.00730261821819009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39393,-0.0179442928068758,0.00669161957874758,-0.031059867181221,-0.0048287184325305,0.00733469519655231
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.00719775117589358,0.00268584718365156,-0.0124620116558506,-0.00193349069593652,0.00737389482847342
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,36962,0.00940063315146015,0.00350897755727745,0.00252303713919634,0.016278229163724,0.00739294251221034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,-0.00927205907601249,0.00347867514637005,-0.0160902623628978,-0.00245385578912718,0.00769746512271418
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0117789137983397,0.00442526656833743,0.00310539132439838,0.0204524362722811,0.00778318254758386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,0.025030775986368,0.00943441732222359,0.00653931803480979,0.0435222339379263,0.00798438906864494
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRH,Corticoliberin,39455,-0.0223230237719326,0.00841946873713737,-0.0388251824967218,-0.00582086504714332,0.00802499087928256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,39858,0.00602772144475912,0.00227363523216556,0.00157139638971462,0.0104840464998036,0.00803000074862538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC16,Mucin-16,39788,0.0474469621494075,0.0179698069768728,0.0122261404747368,0.0826677838240781,0.00828960004608167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00513778537716822,0.00195341811405529,0.00130908587361984,0.00896648488071659,0.00854281079805299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37021,-0.0089007228623911,0.00338519036411264,-0.0155356959760519,-0.00226574974873032,0.00856572050024864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37445,-0.0365783289016183,0.013932385219852,-0.0638858039325282,-0.00927085387070837,0.00866397227868647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRAXIN,Draxin,39749,0.0106506986520393,0.00406056459962463,0.00269199203677505,0.0186094052673036,0.00872527181395215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39315,0.00879422262120064,0.00335384323459041,0.00222068988140345,0.0153677553609978,0.00874670231284565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.013591312439314,0.00518351254125843,0.0034316278584475,0.0237509970201805,0.00875064137601029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37437,-0.00853100614758074,0.00326828923611268,-0.0149368530503616,-0.00212515924479989,0.00905791413563825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,36962,0.0185043979135271,0.00709965490077716,0.00458907430800383,0.0324197215190503,0.00916084836697579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.017699893467284,0.00682994608592858,-0.031086587795704,-0.00431319913886395,0.00956576463070654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,0.0116376049643214,0.00449832634407983,0.00282088532992497,0.0204543245987179,0.00968779575921072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,36962,-0.0090695018008027,0.00350884089307047,-0.0159468299512208,-0.00219217365038458,0.00975546736277281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0132358064336122,0.00512140745720114,0.00319784781749794,0.0232737650497264,0.00976517969309975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.00650496499875022,0.00252388546657997,-0.011451780513247,-0.00155814948425348,0.00996654246740662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,39587,0.0107978247858534,0.00419006907626109,0.00258528939638166,0.0190103601753251,0.00997510599270092
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40009,-0.0320340268787116,0.0124577652163018,-0.0564512467026632,-0.00761680705476004,0.0101373874576291
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0152955152432671,0.00595582143482279,-0.0269689252555197,-0.00362210523101443,0.0102348880134353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0124551266988936,0.00485622139254117,0.00293693276951288,0.0219733206282743,0.010334896334396
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA4,Annexin A4,39783,0.0178948498133783,0.00700274963891138,0.00416946052111197,0.0316202391056446,0.0106156902500289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37043,0.021163875033248,0.00835917228930886,0.00477989734620264,0.0375478527202934,0.0113589102742558
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.0090248845156345,0.00357101286488037,0.00202569930046898,0.0160240697308,0.0115068531388327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN2,Contactin-2,40030,-0.010791873910473,0.00428014411763066,-0.0191809563810291,-0.00240279143991693,0.0116990522821098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37388,0.0234131435753235,0.00933629332055473,0.00511400866703622,0.0417122784836108,0.0121616771207192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0105516238156488,0.0042141805024135,0.00229183003091832,0.0188114176003792,0.0122974141403785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,0.0118110391988871,0.00472542647497891,0.00254920330792843,0.0210728750898458,0.0124482011501513
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39489,0.0166679773043784,0.00668240994293406,0.00357045381622761,0.0297655007925291,0.0126306053455181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.00650084124061517,0.00260772474788114,0.00138970073476814,0.0116119817464622,0.012679843353385
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.017012691795993,0.00682508468489004,0.00363552581360855,0.0303898577783775,0.012690681769961
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.00326116505571124,0.00130868598815503,0.000696140518927387,0.0058261895924951,0.0127168257686736
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,0.0264941998942671,0.0106387501960449,0.0056422495100192,0.0473461502785151,0.0127739787221668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BEX3,Protein BEX3,36962,-0.0112724727158532,0.00453692448747367,-0.0201648447113016,-0.00238010072040484,0.0129818560207989
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.00725549854348858,0.0029229458811062,0.00152652461652044,0.0129844724704567,0.0130657828220345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.0202440287404373,0.0081560453923627,0.00425817977140644,0.0362298777094682,0.0130738340536632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00790582281107601,0.00319232514184353,-0.0141627800890893,-0.00164886553306268,0.0132776327702353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37056,-0.0141446262920836,0.0057121873696188,-0.0253405135365364,-0.00294873904763072,0.0132906598983692
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,39866,0.00923246635960256,0.00373258463465647,0.00191660047567589,0.0165483322435292,0.0133907995882181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,39908,0.0196506977341696,0.00796373177879935,0.00404178344772287,0.0352596120206163,0.0136154738952493
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39489,0.00842467597247348,0.0034232184452762,0.00171516781973213,0.0151341841252148,0.0138642378173844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37021,0.0101499399635323,0.00414257839070063,0.00203048631775907,0.0182693936093055,0.014292585895574
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST1,Cystatin-SN,35640,0.0239100392319307,0.00980294585593202,0.00469626535430399,0.0431238131095575,0.0147399085317472
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00764118204606948,0.00313328068446579,-0.0137824121876224,-0.00149995190451653,0.0147527007746238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37021,-0.00954709449014111,0.00391868437622738,-0.0172277158675468,-0.00186647311273545,0.0148515031653038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00962058831304691,0.00395988324128095,-0.0173819594659576,-0.00185921716013624,0.0151324360529221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,39749,-0.00287907904450377,0.00118713289830273,-0.00520585952517711,-0.00055229856383042,0.0153094494950908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37411,0.00706033657637112,0.00291288715695834,0.00135107774873277,0.0127695954040095,0.0153708923504133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX3,Syntaxin-3,37388,0.00890959833665584,0.00368417832431606,0.00168860882099636,0.0161305878523153,0.0156045890399263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0080435782645099,0.00332724958593698,0.00152216907607343,0.0145649874529464,0.0156392975047654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37368,0.0146610564374575,0.00607964215877209,0.0027449578062642,0.0265771550686508,0.0159003102381604
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,-0.00933695241338859,0.00387327712911238,-0.0169285755864489,-0.00174532924032833,0.015937160892398
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00808737526491148,0.00335981557159528,-0.0146726137852382,-0.00150213674458474,0.0160939604699035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.0312809331301755,0.0130409886796947,0.00572059531797394,0.0568412709423772,0.0164684693874843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,39731,-0.0066509190110945,0.00277625469751175,-0.0120923782182175,-0.00120945980397148,0.0166026889821328
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.0174127616377314,0.00726866548117543,0.00316617729462757,0.0316593459808353,0.0166074341984402
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00850603169768702,0.00355297091770292,-0.0154698546963847,-0.0015422086989893,0.0166768538179616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,0.0106020277215695,0.004429947867741,0.00191932990079715,0.0192847255423419,0.0167132165050714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37424,-0.00337852778727928,0.00141274133230185,-0.0061475007985909,-0.000609554775967654,0.0167946194151095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,39585,0.0248658252716823,0.0104229810393282,0.00443678243459906,0.0452948681087655,0.0170596632681892
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG4,Desmoglein-4,39725,-0.0112652078711235,0.00474290579029149,-0.0205613032200948,-0.00196911252215222,0.0175526808477332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CX3CL1,Fractalkine,39749,-0.00760912239910164,0.00320401537198008,-0.0138889925281826,-0.00132925227002068,0.0175668972832773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37106,-0.00832291683708947,0.00351490481963028,-0.0152121302835648,-0.00143370339061413,0.0179040106768318
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,39657,0.0240278146544918,0.0101972142100328,0.00404127480282758,0.0440143545061561,0.0184695681669489
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0102644832430774,0.00436776370278395,0.00170366638562086,0.018825300100534,0.0187827004641682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00760630089902773,0.00324097936681934,-0.0139586204579936,-0.00125398134006184,0.0189443485043245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37437,0.01152970586347,0.00491716754825501,0.00189205746889015,0.0211673542580498,0.0190523269798974
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0130491030565651,0.0055968635160505,0.00207925056510613,0.0240189555480241,0.0197395142949615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37021,-0.0121975590624986,0.00524914606141441,-0.0224858853428708,-0.00190923278212631,0.0201555207496797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.012226772842542,0.00527770877234678,0.00188246364874229,0.0225710820363417,0.0205339251006924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,0.0103690294235872,0.00448195320483297,0.00158440114211463,0.0191536577050598,0.0207099504368996
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,0.0088370234155882,0.00382349564596358,0.00134297194949959,0.0163310748816768,0.0208321745251703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37149,0.00690780129501404,0.00299161299811457,0.00104423981870949,0.0127713627713186,0.0209557483082087
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37064,-0.00758201337213008,0.00329057171591729,-0.014031533935328,-0.00113249280893218,0.0212289459095389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP13,Collagenase 3,39489,-0.0071285164404495,0.0030956528042608,-0.0131959959368007,-0.00106103694409833,0.0213059486290734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,-0.0065228186372363,0.00284374317033742,-0.0120965552510976,-0.000949082023374956,0.0218204741735973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,-0.0113823065768317,0.00498885740284818,-0.0211604670864142,-0.00160414606724929,0.0225316583653738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.024194785627325,0.0106306063300426,0.00335879722044139,0.0450307740342085,0.0228650634518076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.0113885995297503,0.00502119503440977,-0.0212301417971935,-0.00154705726230718,0.0233389162575359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0123823975057342,0.00545945463203399,0.00168186642694756,0.0230829285845208,0.0233413835375538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37169,0.0159888390763947,0.00705541979456985,0.0021602162790378,0.0298174618737516,0.0234564565509713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0135480752903938,0.00599129378908818,-0.0252910111170067,-0.001805139463781,0.023757361160716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.0155792751112027,0.00690088957642832,0.00205353154140321,0.0291050186810022,0.0239884696861763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,39587,0.0113576761053452,0.00503760944748834,0.00148396158826801,0.0212313906224223,0.0241736196165103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37021,0.00798697027931319,0.00354344561436791,0.00104181687515208,0.0149321236834743,0.0242117687482146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0141836565661289,0.00629513322784029,0.00184519543956189,0.0265221176926958,0.0242678476697722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,-0.00636985082161378,0.00283652077362762,-0.0119294315379239,-0.000810270105303639,0.0247425113893444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,39931,-0.00649519601837893,0.0029055468787114,-0.0121900679006533,-0.000800324136104585,0.0254016971199512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.00442372121761333,0.00198050328763039,0.000541934773857755,0.0083055076613689,0.0255209348936013
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39489,0.0101292727865034,0.0045371915121139,0.00123637742276012,0.0190221681502466,0.0255961499030464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,36962,-0.0105578840534178,0.00474234228489916,-0.0198528749318201,-0.00126289317501546,0.0260109272862805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39489,0.0122193510360374,0.00549763802558569,0.00144398050588944,0.0229947215661854,0.0262533451421546
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,-0.00801119664127875,0.00361494664884735,-0.0150964920730196,-0.000925901209537948,0.0266995457704001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37169,0.00487138934386584,0.00220511270747679,0.000549368437211346,0.00919341025052034,0.0271822942341252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIT,Vitrin,37437,0.00787365014101447,0.00356756902152238,0.000881214858830606,0.0148660854231983,0.0273302330861557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL11,Interleukin-11,39587,0.0132391743768374,0.00601196719693273,0.00145571867084922,0.0250226300828255,0.0276701052280007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,-0.00605710185157563,0.00275488623135611,-0.0114566788650336,-0.000657524838117652,0.027918183620467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39477,0.00648878596198873,0.0029562788726526,0.00069447937158963,0.0122830925523878,0.0281842381900056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.018055331710524,0.0082268090927028,0.00193078588882653,0.0341798775322215,0.0282029119809409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00782716123661396,0.00356826889475348,-0.0148209682703308,-0.000833354202897147,0.0282854825026968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.00542289319173126,0.00247289958740456,0.000576010000418315,0.0102697763830442,0.0283293994918052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,39691,-0.0100795203850393,0.0045985183035662,-0.0190926162600291,-0.00106642451004956,0.0284007979339384
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37039,0.0140938111797751,0.00645740379517553,0.00143729974123104,0.0267503226183191,0.0290842213409579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,-0.0100852802118476,0.00462194294694532,-0.0191442883878604,-0.00102627203583474,0.0291234447592988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS1,Nephrin,37056,-0.00725481689534945,0.0033260435369704,-0.0137738622278114,-0.000735771562887456,0.0291850904100334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.0135446273956396,0.00621396204807298,-0.0257239930098626,-0.00136526178141653,0.029293547605447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0182456308998425,0.00838140616125211,0.00181807482378838,0.0346731869758966,0.0295045040565203
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37021,0.0232397290540358,0.0106906553682947,0.00228604453217818,0.0441934135758935,0.0297352344443097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.0120978073799297,0.00556943657820812,0.00118171168664174,0.0230139030732176,0.0298595512591115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37420,0.00747543465215291,0.00346361030537028,0.000686758453627165,0.0142641108506786,0.0309237032296381
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37039,0.0147276978012625,0.00682496763602476,0.00135076123465396,0.028104634367871,0.0309524738849855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,36931,-0.0084530494575818,0.00392629005461199,-0.0161485779646213,-0.000757520950542293,0.0313419839328194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.00544665354151089,0.00253369349638606,0.000480614288594222,0.0104126927944276,0.0315973997060359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39477,0.0117370308546824,0.0054631685611639,0.00102922047480116,0.0224448412345636,0.0316979113498575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0084546686728861,0.00395801757995621,-0.0162123831296003,-0.00069695421617193,0.0326908272308807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37056,0.00720538060108868,0.00337526248690477,0.000589866126755327,0.013820895075422,0.0327988609915962
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5,Interleukin-5,39587,0.0297546746154008,0.0139399325774998,0.00243240676350126,0.0570769424673004,0.0328179439648804
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37056,-0.00961422980219452,0.00452216794461765,-0.0184776789736451,-0.000750780630743932,0.0335199171893684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40030,-0.00932713043062211,0.00439492897523988,-0.0179411912220923,-0.000713069639151947,0.0338320527594792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37039,-0.00594368282000749,0.00280111436604376,-0.0114338669774533,-0.000453498662561726,0.0338647931668739
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00713930434557474,0.0033807954974038,0.000512945170663292,0.0137656635204862,0.0347284053246919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00886790158386571,0.00421834921372446,-0.0171358660427657,-0.00059993712496577,0.0355529706608383
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,39587,0.00637507445127762,0.00303355534747622,0.000429305970224227,0.012320842932331,0.0356112915530573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.00619747677135823,0.00295383579624676,0.00040795861071458,0.0119869949320019,0.0359139117452796
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,36962,-0.00850692032156109,0.00405997907715637,-0.0164644793127876,-0.000549361330334607,0.0361624686054873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,-0.0120686240914939,0.00579315533771054,-0.0234232085534066,-0.000714039629581291,0.0372435887184702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG3,Secretogranin-3,39885,-0.00651775066810063,0.00313017181907315,-0.012652887433484,-0.000382613902717257,0.0373369118079324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37043,0.0083725557873781,0.0040247581501907,0.000484029813004336,0.0162610817617519,0.0375206767036406
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK6,Kallikrein-6,39889,0.00592010166262923,0.00285430947313142,0.000325655095291652,0.0115145482299668,0.0380866539283049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.00685612641206349,0.00331011778642771,0.000368295550665177,0.0133439572734618,0.038353016484315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,39709,-0.00550033981435985,0.00267127959687405,-0.010736047824233,-0.000264631804486715,0.0395042601163972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,39858,-0.00566616688833283,0.00276264553362389,-0.0110809521342356,-0.000251381642430009,0.0402838718630836
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37021,0.0134036282127007,0.00654736702204134,0.000570788849499664,0.0262364675759017,0.0406603869194185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00862898509208292,0.00422517672557745,0.000347638709951116,0.0169103314742147,0.0411436389056147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37056,-0.00432170798738422,0.00211942280404555,-0.00847577668331351,-0.000167639291454939,0.0414602635607237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00906892261420993,0.00445516836662115,-0.0178010526127874,-0.000336792615632475,0.0418108823385844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,39585,0.011761333989409,0.00578585709292475,0.000421054087276475,0.0231016138915415,0.0420922288280191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37021,-0.00697285765844978,0.00343071240966607,-0.0136970539813953,-0.000248661335504269,0.042125024942443
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCIN,Adseverin,36991,0.0145405024688161,0.00719075314914648,0.000446626296488962,0.0286343786411432,0.0431851016625341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.014206223278766,0.00702781584618673,0.000431704220240053,0.027980742337292,0.0432521271504102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,-0.0085076950682508,0.00421108043911012,-0.0167614127289066,-0.000253977407594967,0.0433712554037675
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSB,Lupus La protein,39489,0.0118242602053453,0.00585657660858095,0.000345370052526592,0.0233031503581639,0.0435072413431997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39489,0.00729391127300144,0.00362245908900529,0.00019389145855107,0.0143939310874518,0.0440765550676874
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.0120647173638096,0.005993435598362,-0.0238118511365992,-0.000317583591020118,0.0441361559693934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,36991,-0.00932796934820018,0.00464281124102143,-0.0184278793806022,-0.000228059315798187,0.0445447352504827
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39405,0.0130315414724338,0.0064990575908268,0.00029338859441329,0.0257696943504544,0.0449650385320002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37039,0.0116616977069842,0.00584032832764308,0.000214654184803806,0.0231087412291647,0.0458724668519212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCT,Secretin,37039,0.00855441361319677,0.00429299183938431,0.000140149608003525,0.01696867761839,0.0463207984245676
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.0043554800116599,0.00218622019040088,7.04884384741811e-05,0.00864047158484561,0.0463612582449941
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTN,Neuroplastin,39477,-0.0161833129062314,0.00812739281995844,-0.0321130028333499,-0.000253622979112869,0.0464756426754761
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.00852053336482506,0.00427983808441904,0.000132050719363744,0.0169090160102864,0.0465139820687425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0109090571693091,0.00548938096012811,0.000149870487457977,0.0216682438511601,0.0469062710321856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,0.0132695412086524,0.00667814991980961,0.000180367365825594,0.0263587150514793,0.0469419127596681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNC,Tenascin,39931,-0.00904005243990356,0.00455168874982167,-0.017961362389554,-0.000118742490253081,0.0470405614764329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,0.00930950861049711,0.00469183046250164,0.000113520903993889,0.0185054963170003,0.0472547650839563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39489,0.00816222076837765,0.00411989094837868,8.72345095554519e-05,0.0162372070271999,0.0475892632433839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.00906532055972879,0.00461901039811791,1.20601794176903e-05,0.0181185809400399,0.0497124273126641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.0150493014336031,0.00767007206892217,1.59601785156213e-05,0.0300826426886905,0.0497707921707839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.006937511911444,0.00354058687492632,-0.0138770621862996,2.03836341158576e-06,0.0500841960888244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP10,Stromelysin-2,39857,-0.011110269578303,0.00567249693623266,-0.022228363573319,7.82441671298532e-06,0.0501745801025623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37368,0.00647437285041076,0.00331104493214428,-1.52752165920251e-05,0.0129640209174135,0.0505580467249397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTN,Titin,37021,0.0129560830474221,0.006626486644569,-3.18307759331546e-05,0.0259439968707773,0.050581023592256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.0106397167526721,0.00544563550398305,-0.0213131623404789,3.37288351346578e-05,0.0507453812648441
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD82,CD82 antigen,37169,-0.00798563220962452,0.00409437811406926,-0.0160106133132003,3.93488939512306e-05,0.0511506710675445
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.013033394484115,0.00668724900991528,-7.3613575318987e-05,0.0261404025435489,0.051313624714859
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,0.00676729807964956,0.00347771131382598,-4.90160954493583e-05,0.0135836122547485,0.0516838635784485
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,-0.00619179277331598,0.00318854831825675,-0.0124413474770992,5.7761930467257e-05,0.0521724819870603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,-0.00575996907020976,0.00296821696048706,-0.0115776743127644,5.77361723448763e-05,0.0523305961657163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00867715607185073,0.00447749193317158,-0.017453040260867,9.87281171655544e-05,0.0526507645553641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,39585,0.0111901548359589,0.00580703827694296,-0.000191640186849314,0.0225719498587671,0.0539977956854804
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37368,0.00679050364410774,0.00352888004014355,-0.000126101234573612,0.0137071085227891,0.0543422413907902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.0155766164237617,0.00811326958035244,-0.000325391953729123,0.0314786248012524,0.0548923446286933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37411,0.00707497923163095,0.00370541102929629,-0.000187626385789772,0.0143375848490517,0.0562362197357317
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37021,-0.00960431507019761,0.00503471227630422,-0.0194723511317539,0.00026372099135865,0.0564621620656371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37124,0.0157219122653966,0.00824166115493444,-0.000431743598274865,0.0318755681290681,0.0564626346069403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37056,-0.00513069324878214,0.00269535737395576,-0.0104135937017354,0.000152207204171144,0.0569931757011491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,0.00477945174308255,0.00251546329152979,-0.000150856308315831,0.00970975979448093,0.0574474316241064
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00605237597903785,0.00318753875558143,-0.000195199981901761,0.0122999519399775,0.0576176501427603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_DRA,,39799,0.00642340890167235,0.00342834085005701,-0.000296139164439388,0.0131429569677841,0.0610010652240273
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37411,-0.00810469012242953,0.00434559684268888,-0.0166220599340997,0.000412679689240681,0.0621980987746704
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,36962,-0.00812452109372062,0.00436018523881574,-0.0166704841617995,0.000421441974358241,0.0624363659023334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,0.017092648097696,0.00918318419651951,-0.000906392927482257,0.0350916891228742,0.0627203350328732
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,0.00840838026648831,0.00452031984387041,-0.000451446627497692,0.0172682071604743,0.0628894985143661
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.0116431699317098,0.00625943663656296,-0.0239116657393732,0.000625325875953644,0.0628938551879294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37411,0.0052794729607871,0.00283994426703729,-0.000286817802605983,0.0108457637241802,0.063047973090432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.0088222731767749,0.0047465035975225,-0.000480873874369195,0.018125420227919,0.0630941681788221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,39788,-0.0033823292282978,0.00182122005679936,-0.00695192053962455,0.000187262083028955,0.0633043256036041
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.00478357751158289,0.00257732727444137,-0.000267983946322197,0.00983513896948797,0.0634686893913637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00713640740599184,0.00384580946892136,-0.000401379153094033,0.0146741939650777,0.0635283585496547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0057040810081448,0.0030743710427995,-0.000321686235742218,0.0117298482520318,0.0635627948097433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37391,-0.00427550999727341,0.00230624645476331,-0.0087957530486095,0.000244733054062676,0.0637777160891284
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37056,0.0083895563930057,0.00452785524350455,-0.000485039884263218,0.0172641526702746,0.0639223780940475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB5,Serpin B5,39585,0.00866203008987196,0.00468721823998292,-0.000524917660494563,0.0178489778402385,0.0646195407793495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP3,Stromelysin-1,39858,-0.00850647007455421,0.00460449965588457,-0.017531289400088,0.000518349250979541,0.0647039465047353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.0121917410525292,0.00660128246460602,-0.000746772578098607,0.025130254683157,0.0647874972540769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37445,0.00951127464932286,0.00515088211398104,-0.000584454294079979,0.0196070035927257,0.0648365648840998
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0122545724705722,0.00663987728900068,-0.000759587015869159,0.0252687319570135,0.0649723662884045
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39489,0.00542697253257865,0.00294080751032002,-0.00033701018764859,0.0111909552528059,0.0649979626936148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,0.00829519480352601,0.00449698258586981,-0.00051889106477881,0.0171092806718308,0.0651162379554916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37021,0.0135201807855602,0.00733011952188233,-0.000846853477329152,0.0278872150484496,0.0651372269357474
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00503190917005153,0.00272902402394961,-0.000316977916889708,0.0103807962569928,0.0652240703052999
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00673287665966747,0.00366962828552308,-0.0139253480992927,0.000459594779957761,0.0665642413159868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37056,-0.00606882373433508,0.00333963357877851,-0.012614505548741,0.000476858080070798,0.0692072594230276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.00420326737753129,0.00231923103476482,-0.000342425450607756,0.00874896020567034,0.0699536551632075
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00470113277034861,0.00260310747607391,-0.000400957882756246,0.00980322342345347,0.0709416621119005
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,0.0112564757649992,0.00624104484400603,-0.000975972129252645,0.023488923659251,0.0713136952305821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD10,Frizzled-10,37039,0.0104613377210853,0.00581990374233463,-0.000945673613890589,0.0218683490560612,0.0722775053556622
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.0068861691910992,0.0038335378486363,-0.000627564992227944,0.0143999033744263,0.0724703583296236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,0.00631590413965318,0.00352087830586218,-0.000585017339836685,0.013216825619143,0.0728610837329735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,0.0183399119634304,0.0102290161769551,-0.00170895974340153,0.0383887836702624,0.0730070937490073
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.00643189342435369,0.00359432946235381,-0.000612992321859764,0.0134767791705672,0.0735642589200977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL33,Interleukin-33,39587,0.00675808325106308,0.0037819107258693,-0.000654461771640744,0.0141706282737669,0.0739649139234065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.0065046827103909,0.0036448720969728,-0.000639266599675782,0.0136486320204576,0.0743471116415054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERC2,ERC protein 2,37039,0.0129921275384638,0.00728641514859616,-0.00128924615278464,0.0272735012297123,0.0745992743100404
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37169,-0.00687683951952982,0.00385811204492206,-0.0144387391275771,0.00068506008851741,0.0747008758770725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0173638146843175,0.00974943939998921,-0.00174508653966132,0.0364727159082964,0.0749344193015258
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,39780,0.0115061226655204,0.00647198109691301,-0.00117896028442909,0.0241912056154699,0.0754498348992376
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEB,Nebulin,37021,0.00644804776020432,0.00363729159480767,-0.000681043765618711,0.0135771392860274,0.0762914864951426
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,-0.00490546208646992,0.00278696621861898,-0.0103679158749631,0.000556991702023291,0.0784022522535389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37039,0.0109323529172842,0.00624086819792966,-0.00129974875065791,0.0231644545852264,0.0798424876908357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37021,0.00872279294837907,0.00499128757631961,-0.00106013070120736,0.0185057165979655,0.0805559838741613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.0195762595743572,0.0112309020575621,-0.00243630845846457,0.0415888276071789,0.081343896289422
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.00855929142664824,0.00491865994037673,-0.0181998649097866,0.00108128205649016,0.0818530110003578
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPS,Colipase,39836,0.0116300543802636,0.00668571291256946,-0.00147394292837251,0.0247340516888998,0.0819593618367482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00807456608918205,0.00465047949495469,-0.0171895058992932,0.00104037372092914,0.0825364776161619
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37056,-0.00722498677197661,0.00417184211818721,-0.0154017973236235,0.000951823779670315,0.0833244106278866
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP73,Tumor protein p73,37039,-0.00582346784564,0.00336391918322772,-0.0124167494447663,0.00076981375348633,0.0834474032424652
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00428191569494832,0.00247492860437392,-0.00913277575952119,0.000568944369624556,0.0836321238943895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37411,0.0042475677286345,0.00245745291760932,-0.000569039989879759,0.00906417544714877,0.083931579192998
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00723941550135967,0.00420729199764576,-0.0154857078167454,0.00100687681402601,0.0853312044709914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTG,Protogenin,40030,0.00412951014383505,0.00240495676094295,-0.000584205107613138,0.00884322539528324,0.0859831741023436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00868666659506753,0.00505954661110808,-0.0012300447627043,0.0186033779528394,0.0860232031792738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.0047192696778432,0.00275531355908937,-0.000681144897971962,0.0101196842536584,0.0867743850244428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37056,-0.00789193343512854,0.00462178426306105,-0.0169506305907282,0.00116676372047112,0.0877431653480536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,0.00881412007200804,0.0051674698256271,-0.00131412078622108,0.0189423609302372,0.0880850318431042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.0100744921276704,0.0059244514918429,-0.00153743279634171,0.0216864170516824,0.0890576795218042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,36962,0.0117872885083599,0.00694780676017782,-0.00183041274158863,0.0254049897583084,0.0898058789712559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,-0.00617374879921135,0.00364596943351834,-0.0133198488889073,0.000972351290484588,0.0904171626007768
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37056,0.014432961473293,0.00853957742061036,-0.00230461027110332,0.0311705332176893,0.0910274788111896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39123,0.00458159205983296,0.00271100353507006,-0.000731974868904361,0.00989515898857027,0.0910486520082213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,36991,-0.00577122193520117,0.00341664180015471,-0.0124678398635044,0.000925395993102055,0.0912143485859398
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,-0.00540832894240501,0.00320331250350778,-0.0116868214492803,0.000870163564470246,0.0913667788557112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAG,S-arrestin,36991,-0.00870970014249097,0.00516956719686242,-0.0188420518483413,0.00142265156335937,0.0920504309083376
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00600051852955858,0.00356896852487375,-0.0129956968383111,0.000994659779193978,0.0927277457288027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37039,0.00806471953569828,0.00480204712548022,-0.00134729283024296,0.0174767319016395,0.0930912632601557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37083,0.0134627782060252,0.00801732596526632,-0.00225118068589675,0.0291767370979472,0.0931346457847096
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,-0.00492726634719705,0.00293662989054209,-0.0106830609326595,0.00082852823826544,0.0933966999691015
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00411959469723027,0.00245705224768543,-0.0089354171026937,0.000696227708233172,0.0936357967477287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00788852898965532,0.00473380260514528,-0.00138972411642943,0.0171667820957401,0.0956518963071551
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00541341396031009,0.00325674162121561,-0.0117966275378927,0.000969799617272505,0.0964930295702953
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37169,0.00675795226220961,0.00406904408520555,-0.00121737414479327,0.0147332786692125,0.0967730366272509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00787834265201475,0.00474464197840396,-0.00142115562565702,0.0171778409296865,0.0968434637630607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.00649548328706013,0.00392099376467229,-0.00118966449169756,0.0141806310658178,0.0976260147516657
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37388,0.0081521587370281,0.00492318076860736,-0.00149727556944234,0.0178015930434985,0.0977708726501467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00624701638842985,0.00377895899660471,-0.00115974324491539,0.0136537760217751,0.0983290238213661
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0124667074140379,0.00755599386037799,-0.00234304055230291,0.0272764553803788,0.0989813828468832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0143775820996993,0.00872636352797468,-0.00272609041513105,0.0314812546145297,0.0994579876951226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.00478092307339167,0.00290618111981034,-0.0104770380682199,0.000915191921436603,0.0999712858428797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,0.00474979178152835,0.00289014961553184,-0.000914901464914067,0.0104144850279708,0.100314821661463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDAN1,Codanin-1,37388,-0.00357673767949485,0.00218461533533588,-0.00785858373675318,0.00070510837776348,0.101603776072492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.00576808242629775,0.00352773045316043,-0.00114626926189668,0.0126824341144922,0.102057900791909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,0.015861451220494,0.00970283158767898,-0.00315609869135683,0.0348790011323448,0.102130844413324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3,Interleukin-3,36962,-0.00943165770240922,0.0057805285800822,-0.0207614937193703,0.00189817831455188,0.102782441026463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39477,0.0062666260616092,0.00384988635996733,-0.00127915120392677,0.0138124033271452,0.103599537000196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.0120403040599546,0.00741080874133978,-0.00248488107307136,0.0265654891929806,0.104250815468909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,39903,0.00858054957774346,0.00528556430656219,-0.00177915646311843,0.0189402556186053,0.104525007307829
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37039,0.0067030864303872,0.00413005468533462,-0.00139182075286866,0.0147979936136431,0.104612925223103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40030,0.00943324529095534,0.00581244561769744,-0.00195914811973165,0.0208256387016423,0.104621916667173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,-0.00620960230008418,0.0038314030022684,-0.0137191521845302,0.00129994758436188,0.105102603141295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39489,0.00734864786265706,0.00456481957949307,-0.00159839851314936,0.0162956942384635,0.107452090946086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39238,-0.00478824976154764,0.00297804637152897,-0.0106252206497444,0.00104872112664915,0.107888717993458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSND,Barttin,36962,-0.0052324630147054,0.00326902512174243,-0.0116397522533206,0.00117482622390975,0.109485488928533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0196479818593667,0.0122888117111917,-0.00443808909456909,0.0437340528133025,0.10987388991449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPS,Calcyphosin,37388,0.0134181989562576,0.0084332906605728,-0.00311105073846503,0.0299474486509803,0.111610700213204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37445,-0.00948179508656764,0.00596180238136678,-0.0211669277540465,0.00220333758091124,0.111762476304032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,36962,-0.00983731443916225,0.00619787856959391,-0.0219851564355663,0.00231052755724183,0.112489967086902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0150104312259176,0.00945725945598904,-0.00352579730782093,0.0335466597596561,0.112493896385575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0128772455010054,0.00811418443275985,-0.00302655598720387,0.0287810469892147,0.112531902717749
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,36962,-0.00919848065608221,0.00579777960874251,-0.0205621286892175,0.0021651673770531,0.112638206687018
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37368,0.00804398711798126,0.00509246540432483,-0.00193724507449539,0.0180252193104579,0.11422511921162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THPO,Thrombopoietin,39585,0.00579920185992563,0.00367467342538005,-0.00140315805381928,0.0130015617736705,0.114550268696701
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,36931,-0.0120406856428647,0.00766491889629427,-0.0270639266796015,0.00298255539387208,0.116234188770186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,39587,0.00997005518852411,0.0063557743439209,-0.00248726252556084,0.0224273729026091,0.116747074256524
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00451705205650685,0.0028836386992963,-0.0011348797941139,0.0101689839071276,0.117269212911051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00937616136683778,0.00600683927212116,-0.00239724360651969,0.0211495663401952,0.118563589186345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37039,0.014008543936339,0.00898497511416813,-0.00360200728743056,0.0316190951601085,0.118994901719944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIM,Vimentin,39585,0.0174790330337945,0.0112967342242555,-0.00466256604574618,0.0396206321133352,0.121819661730787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00957950773874866,0.00623398741338982,-0.00263910759149538,0.0217981230689927,0.124397280832059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,36991,0.0085996436069331,0.00565127283717339,-0.00247685115392675,0.0196761383677929,0.128103834407345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00775979873233031,0.00510682696883741,-0.0177691795912516,0.00224958212659101,0.128662098658303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,39587,-0.00587879482393459,0.00389871960102672,-0.013520285241947,0.00176269559407778,0.131605754855592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,-0.00328158733762736,0.00218721377728883,-0.00756852634111347,0.00100535166585874,0.133547552503687
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37368,-0.00806838821984849,0.00540758395937616,-0.0186672527802258,0.00253047634052878,0.135709266401312
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37388,-0.005393656387414,0.00361546343586766,-0.0124799647217146,0.00169265194688663,0.135767066311903
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.00626285488789995,0.00420291393663673,-0.00197485642790805,0.0145005662037079,0.136212317363425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.00394652089902084,0.00265212601901781,-0.00125164609825407,0.00914468789629574,0.136754886944476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20,Interleukin-20,39587,0.00700494384303805,0.00471772981616742,-0.00224180659665008,0.0162516942827262,0.137613562129483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.00365847551700524,0.00246600509491469,-0.00117489446902755,0.00849184550303803,0.137947904335235
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENG,Endoglin,40052,-0.00242615089398776,0.00163632238138526,-0.00563334276150287,0.000781040973527357,0.138177543933633
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,0.0112016474341826,0.00759283016006903,-0.00368029967955274,0.0260835945479179,0.140157738525836
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XG,Glycoprotein Xg,39985,0.00427729048835168,0.00290197455102022,-0.00141057963164796,0.00996516060835132,0.140521524998477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,36962,-0.00588044947697461,0.00399779274666663,-0.0137161232604412,0.00195522430649199,0.141335674409899
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.00460064073334937,0.00312887739308499,-0.00153195895709721,0.010733240423796,0.141478838911406
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,36962,-0.0114380232361886,0.0077958406949094,-0.0267178709982111,0.00384182452583381,0.14234685356225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00716963067566338,0.00488838455218247,-0.00241160304661427,0.016750864397941,0.14249058454338
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00985397422005334,0.00674417373393184,-0.0230725547385597,0.00336460629845306,0.144009406219503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00326257609111026,0.00223401866642694,-0.00111610049508655,0.00764125267730707,0.144198064859536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00693153594296721,0.00477457271105481,-0.00242662657070022,0.0162896984566346,0.146588290263385
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,0.0145701138864873,0.0100503713539197,-0.0051286139671953,0.03426884174017,0.147163478231494
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00796972059180176,0.00550393435565216,-0.00281799074527647,0.01875743192888,0.147639777343517
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.00872648340327961,0.00603600245675793,-0.00310408141196595,0.0205570482185252,0.14827426739237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37021,-0.00473293653663779,0.00327945771259329,-0.0111606736533206,0.00169480058004507,0.14898595038954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00659169078554329,0.00458723406872808,-0.00239928798916375,0.0155826695602503,0.150751926999557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.00568362560402679,0.00395731550063875,-0.00207271277722516,0.0134399639852787,0.150955703901054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00752369534719351,0.00524451441171626,-0.0178029435941574,0.00275555289977035,0.151429552098174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00728759481388756,0.0050909677660648,-0.0172658916353746,0.00269070200759946,0.152317549887865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00385739249394485,0.00271229615852769,-0.00145870797676942,0.00917349296465912,0.154995010291131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31,Interleukin-31,37056,-0.00792010566374362,0.00557781623588276,-0.0188526254860738,0.00301241415858659,0.155651838248346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,0.0100438250674401,0.00709678520213185,-0.0038658739287383,0.0239535240636186,0.157014485012865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37039,0.00430298905450639,0.00304091771082679,-0.00165720965871412,0.0102631877677269,0.157083398349127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00733711068898508,0.00520783230545298,-0.00287024062970275,0.0175444620076729,0.15889623248489
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.00599111475113136,0.00425318734705522,-0.00234513244909687,0.0143273619513596,0.158971618626195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,-0.00540254956830174,0.00384306908467071,-0.0129349649742563,0.00212986583765285,0.159809945353321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37043,0.00400473576971428,0.00284963602943428,-0.0015805508479769,0.00959002238740546,0.159940815185167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NENF,Neudesin,37368,0.0149483610556007,0.0106401122397764,-0.00590625893436107,0.0358029810455624,0.160072128772327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,36991,-0.00463221037649296,0.00330100732251242,-0.0111021847286173,0.00183776397563137,0.160559459693656
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0118364949352769,0.00844182328289188,-0.00470947869919123,0.0283824685697449,0.160901385137293
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.00947049755860962,0.0067583619275475,-0.00377589181938348,0.0227168869366027,0.161144016892616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX5,Syntaxin-5,37056,0.00553942603956653,0.00395339498861664,-0.00220922813812209,0.0132880802172552,0.161183161312112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALLD,Palladin,37056,-0.00552124308703121,0.00395454190817894,-0.0132721452270619,0.00222965905299951,0.162684486515418
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00466420878765605,0.00335130448729691,-0.011232765582758,0.0019043480074459,0.164018937081605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.00529139063542617,0.00380399481269294,-0.0127472204683043,0.002164439197452,0.164245639394468
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.00965936032287875,0.00694550049976181,-0.0232725413024119,0.00395382065665439,0.16432894415659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.00791289556155689,0.00571296128449796,-0.0191102996791729,0.00328450855605911,0.166048232265076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSPN,Claspin,39453,0.0045977921396564,0.00332293723561499,-0.00191516484214898,0.0111107491214618,0.166484531862895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39489,0.00433748029294868,0.003150145064313,-0.00183680403310479,0.0105117646190021,0.168558417401817
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00499678855360786,0.00363881649107062,-0.00213529176889056,0.0121288688761063,0.169716436559674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,36991,0.00968845650726925,0.00706005252888677,-0.00414924644934881,0.0235261594638873,0.169995867531081
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.00950867984543397,0.00694218340632367,-0.0231153593218284,0.00409799963096043,0.170805230828649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.00601134158247373,0.00439151587340597,-0.00259602952940198,0.0146187126943494,0.171067856054858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00274527985027308,0.00201093703966739,-0.00119615674747499,0.00668671644802116,0.17221751038427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERVV_1,,37021,-0.00635207016582384,0.00466108546332848,-0.0154877976739477,0.00278365734229999,0.172972729958656
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,-0.0158234860639681,0.0116504471120109,-0.0386583624035094,0.00701139027557321,0.174423967817033
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,39913,-0.00497401846235468,0.00366294298402643,-0.0121533867110465,0.00220534978633712,0.174505130208132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,0.0101024109854987,0.00745968519769503,-0.00451857200198361,0.0247233939729809,0.175674164600846
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37056,-0.00536938718052605,0.00397887726945216,-0.0131679866286523,0.00242921226760017,0.177208259248345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,39720,-0.00598022547420368,0.00443902650282919,-0.0146807174197489,0.00272026647134154,0.177937325618897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00706158625025437,0.00524885913559489,-0.0173493501560204,0.00322617765551162,0.178533087928132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37021,-0.00643206965924242,0.00478386822748887,-0.0158084513851206,0.00294431206663576,0.178799199811904
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37437,0.00604207390766903,0.0045238424219511,-0.00282465723935513,0.0149088050546932,0.181700272694674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNPO1,Transportin-1,37169,-0.00459517029955019,0.003440811074355,-0.011339160005286,0.00214881940618561,0.181738720584957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.0034402533507201,0.00258812686312661,-0.00163247530100807,0.00851298200244826,0.183786102109956
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,36991,-0.00561854369553469,0.00422706938822537,-0.0139035996964564,0.00266651230538704,0.183811091509454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37088,0.00397105588826037,0.00299304431327092,-0.00189531096575064,0.00983742274227138,0.184610500505524
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,0.00774530549222105,0.00585107086068024,-0.00372279339471223,0.0192134043791543,0.18560814139828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,-0.00895813347325638,0.00677020495658864,-0.0222277351881701,0.00431146824165736,0.185797822533332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPN1,Epsin-1,37169,0.00553605174505531,0.00418480787257396,-0.00266617168518964,0.0137382751753003,0.185893795148895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00770599025640894,0.00583630438057685,-0.00373316632952169,0.0191451468423396,0.186739615808449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37056,-0.005372804004137,0.00407510554675543,-0.0133600108757776,0.00261440286750364,0.18737748696207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39477,0.0129530812267127,0.00983198484005451,-0.0063176090597941,0.0322237715132196,0.18770944765278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2,Interleukin-2,39587,-0.00396455112579511,0.00301082593880931,-0.00986576996586135,0.00193666771427113,0.18793649399964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.004597936581849,0.00350758529746019,-0.00227693060117298,0.011472803764871,0.189925814519214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH23,Cadherin-23,37388,-0.00340285086785779,0.00260314862462128,-0.00850502217211551,0.00169932043639992,0.19116505858824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,39906,0.018889837457944,0.0145497274948142,-0.00962762843189184,0.0474073033477798,0.194204666959956
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO6,Coronin-6,36991,0.00478310473407833,0.00368719218253001,-0.00244379194368048,0.0120100014118371,0.194577798416942
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK1,Kallikrein-1,39720,-0.0157007759684656,0.0121171701093687,-0.0394504293828282,0.00804887744589696,0.195081828721165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,-0.00587478907420681,0.00454182639381295,-0.0147767688060802,0.00302719065766658,0.195864999104581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-0.00307705915489211,0.00238282053963478,-0.00774738741257629,0.00159326910279206,0.196600432962625
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,0.0104273036433141,0.00809350645223094,-0.00543596900305858,0.0262905762896867,0.197645418333217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,-0.0213474342202163,0.0165768236915464,-0.0538380086556473,0.0111431402152147,0.197838665233017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,0.00740534401967102,0.00576809757787879,-0.00390012723297141,0.0187108152723134,0.1992188003937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL24,Interleukin-24,39587,0.00583679927093001,0.00456226036764536,-0.0031052310496549,0.0147788295915149,0.20078719312006
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.01491244472716,0.0117082318461333,-0.00803568969126131,0.0378605791455813,0.20279857776227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,0.0177701534511809,0.0139593422629153,-0.00959015738413317,0.0451304642864949,0.20304289750395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00425901229419013,0.00334841183787285,-0.0108218994964209,0.00230387490804066,0.203413374424394
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37056,0.00899586434958808,0.00708393690126254,-0.0048886519768865,0.0228803806760626,0.204144009315058
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00597030724481342,0.00470693684993502,-0.015195903470686,0.00325528898105922,0.204675513443243
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00491686139380218,0.00388415855556617,-0.00269608937510751,0.0125298121627119,0.205575919871389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.00246194693820328,0.00194653407029458,-0.0013532598395741,0.00627715371598066,0.20596677865966
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00579344325030397,0.00458368450565903,-0.0147774648813957,0.00319057838078772,0.206278564801088
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37039,0.00978802232785134,0.00774911147975207,-0.00540023617246272,0.0249762808281654,0.206570043099737
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.00574876492908584,0.0045704459634413,-0.00320930915925912,0.0147068390174308,0.208477905801262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37056,-0.00328168660235107,0.00261167503950564,-0.00840056967978212,0.00183719647507999,0.208940768676876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39489,0.00637800042959382,0.00508021104386098,-0.0035792132163737,0.0163352140755613,0.209330684557223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00340579678659556,0.00271813058058398,-0.00192173915134905,0.00873333272454017,0.2102269347333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRP15,RRP15-like protein,36991,0.0110026025107618,0.00879511625615731,-0.00623582535130652,0.0282410303728301,0.210960413297201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,36991,-0.0116542441534235,0.00935349936530533,-0.029987102909422,0.00667861460257494,0.212795105043197
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00534977731173635,0.00430116546249902,-0.0137800616182344,0.00308050699476173,0.213596138999174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,39587,0.00742171674178714,0.0059702660957468,-0.0042800048058766,0.0191234382894509,0.213844644748544
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.00742279682051954,0.0059783403003029,-0.00429475016807414,0.0191403438091132,0.214397174475409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,0.00714160511282261,0.00579510307009586,-0.00421679690456528,0.0185000071302105,0.217839184673173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESPL1,Separin,36962,-0.00638315615342204,0.00521642731784119,-0.0166073536963908,0.0038410413895467,0.221100878112733
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCLN,Nicalin,39587,0.00620884287312296,0.00509321255924755,-0.00377385374300225,0.0161915394892482,0.222846323243811
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLLT1,Protein ENL,36962,-0.00840937074857423,0.00692001599222041,-0.0219726020933262,0.00515386059617777,0.224302498886245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.0112725728888659,0.00928754372630491,-0.00693101281469177,0.0294761585924235,0.224872466626051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37056,0.00343863724469971,0.00283981427131806,-0.00212739872708369,0.00900467321648311,0.225968086756869
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40030,0.00239087058636397,0.0019784470689184,-0.00148688566871609,0.00626862684144402,0.226888736056866
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37039,0.00316885430823926,0.00262595428803059,-0.00197801609630069,0.00831572471277921,0.227552448362256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37056,-0.0050978259910455,0.00423714812231664,-0.0134026363107861,0.00320698432869512,0.22894888334861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37039,-0.00690611837874838,0.00575120472153287,-0.0181784796329528,0.00436624287545604,0.229845533106281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00684518339139683,0.00570355188604291,-0.00433377830524727,0.0180241450880409,0.230098226647439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,36991,0.00721460376220266,0.006027577023268,-0.00459944720340262,0.019028654727808,0.23135441402831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,39587,-0.00342182826309357,0.00286665818699297,-0.0090404783095998,0.00219682178341266,0.232627216620714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,-0.00269791264141091,0.00226461984930681,-0.00713656754605226,0.00174074226323044,0.233541141442704
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,36931,0.00406720979595869,0.00342499212605782,-0.00264577477111464,0.010780194363032,0.235048393217033
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.0049833484554299,0.00420732518091702,-0.0132297058100273,0.00326300889916745,0.236258046007705
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37235,0.00393609380803376,0.00332357521741507,-0.00257811361809977,0.0104503012341673,0.236317317206289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,-0.00278736369796505,0.00235441339460094,-0.0074020139513829,0.00182728655545279,0.236474665913906
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39489,0.00505661780729321,0.00429554696054407,-0.00336265423537318,0.0134758898499596,0.239142911912069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK7,Kallikrein-7,36818,-0.00446524571385431,0.00379634331677764,-0.0119060786147385,0.00297558718702986,0.239537971281057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37368,0.00315012346150458,0.00268597635577507,-0.00211439019581456,0.00841463711882373,0.240895147554199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00588345214318885,0.00502092383211054,-0.00395755856774782,0.0157244628541255,0.2413048831107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC5,Glypican-5,39749,-0.00632260934386538,0.00540120818412454,-0.0169089773847495,0.00426375869701872,0.241780500688225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.00233484983709469,0.00200057094018027,-0.00158626920565864,0.00625596887984801,0.243190791512919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00424200294837813,0.00364499351944347,-0.00290218434973108,0.0113861902464873,0.244527232509851
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00864460524605596,0.00743191730707452,-0.023211163167922,0.00592195267581011,0.244779882317779
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN3,Matrilin-3,39720,-0.00351067807116284,0.00302609021429464,-0.00944181489118034,0.00242045874885465,0.24601065032929
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.00562518380043992,0.00489903691535818,-0.00397692855366212,0.015227296154542,0.250897644195179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,0.00566182353488594,0.00496183234826611,-0.00406336786771563,0.0153870149374875,0.253859389982698
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37039,0.00565627165670734,0.00498866224317709,-0.00412150633991975,0.0154340496533344,0.256888444010516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGB,Secretogranin-1,39952,0.0043112541331669,0.00381023689611092,-0.00315681018321051,0.0117793184495443,0.257864757081313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37056,-0.00418424851557662,0.00370729182770847,-0.0114505404978852,0.00308204346673198,0.259064480085383
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37056,0.0035047864638555,0.00311527312215486,-0.00260114885556802,0.00961072178327902,0.260595322857828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37039,-0.00395198756932669,0.00352608245330146,-0.0108631091777976,0.00295913403914418,0.262398938086207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.00317097475416222,0.00282998962053122,-0.00237580490207898,0.00871775441040342,0.262524878522759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00609131834610208,0.00548744350524583,-0.0168467076163839,0.00466407092417974,0.266999246838557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00315516301045938,0.00287150010417865,-0.00878330321464954,0.00247297719373078,0.271881071840175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00437942467453603,0.00398861578392667,-0.0121971116110323,0.00343826226196025,0.272232836968428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37002,0.00879713488140521,0.00805744903237103,-0.00699546522204201,0.0245897349848524,0.274940377716257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00860872194434077,0.00789417526243267,-0.00686386157002727,0.0240813054587088,0.275506102681334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37437,-0.00527035275848859,0.00484512004698817,-0.0147667880505854,0.00422608253360821,0.27671810529324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00490745423495254,0.00452444670827327,-0.00396046131326308,0.0137753697831682,0.278095284947258
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.0050811672724024,0.00468764062304138,-0.0142689428935635,0.00410660834875871,0.278406944424173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TG,Thyroglobulin,37368,-0.011399327791447,0.0105306568019444,-0.032039415123258,0.00924075954036391,0.279054301214946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00691108901103129,0.00638839882262726,-0.0194323507033807,0.00561017268131815,0.279353026807764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37039,-0.00353112428612868,0.00326691050980952,-0.00993426888535533,0.00287202031309798,0.279772173741444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD70,CD70 antigen,39866,-0.00439045091280236,0.00408065824340108,-0.0123885410698685,0.00360763924426376,0.281980448648295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS2,Podocin,37056,-0.0106042608602657,0.00990708652929884,-0.0300221504576914,0.00881362873716001,0.284471799771052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSTN,Osteocrin,37039,0.00434965400433911,0.0040643735446488,-0.00361651814317253,0.0123158261518507,0.284553163499837
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37380,0.00328832789213549,0.00307267705298645,-0.00273411913171795,0.00931077491598894,0.284555881867392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.00360560268546676,0.00337709497274168,-0.0102247088320405,0.00301350346110694,0.28568861204983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,-0.00276899148474362,0.00259870553896727,-0.00786245434111947,0.00232447137163222,0.286656431788522
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00533645811852534,0.00501390798255392,-0.015163717764331,0.00449080152728035,0.287198267836108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,39891,0.0028682042045196,0.00270151816745481,-0.00242677140369184,0.00816317981273103,0.288387495522504
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.00611825842756201,0.00577850055005464,-0.00520760265054509,0.0174441195056691,0.28971180836305
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37056,0.00700843181550739,0.00663767224508932,-0.00600140578486768,0.0200182694158825,0.291052942958812
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37169,0.00603884616074252,0.00575199164500328,-0.00523505746346392,0.017312749784949,0.293796734159811
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,0.00525720332487052,0.00501698401841416,-0.00457608535122123,0.0150904920009623,0.294712553299364
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,36962,0.00807618460658374,0.00773252199171739,-0.00707955849718233,0.0232319277103498,0.296299380062983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00419620045016432,0.00402290723074545,-0.00368869772209676,0.0120810986224254,0.296931919301289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,0.0038696047888398,0.0037288736249578,-0.00343898751607748,0.0111781970937571,0.299409722530173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.00489621513546283,0.00472734796020853,-0.0043693868665459,0.0141618171374716,0.300348191114638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37056,-0.00262608496549518,0.00254156499019787,-0.007607552346283,0.00235538241529264,0.301503473090233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37021,-0.00542152422816719,0.00525354036088305,-0.015718463335498,0.00487541487916358,0.302102621621644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC2,Mucin-2,37437,0.00902796075921231,0.00874845343102086,-0.00811900796558858,0.0261749294840132,0.302114231212529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37169,0.00595834170385779,0.00578627867288788,-0.00538276449500246,0.017299447902718,0.303152481747805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPT,Dermatopontin,40052,0.00266493785038879,0.00258880034485535,-0.0024091108255277,0.00773898652630527,0.303302267355993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.0257598788488258,0.0250755501538929,-0.0233881994528043,0.0749079571504558,0.304302460118852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLC,Galectin-10,39841,0.00657357125068665,0.00643594791101552,-0.00604088665490377,0.0191880291562771,0.307088222493867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.00247696813790165,0.00242592160127427,-0.00227783820059593,0.00723177447639922,0.307252675624563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,-0.00384611301908922,0.00377992538602883,-0.0112547667757057,0.00356254073752728,0.308929436925373
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPLX2,Complexin-2,36962,-0.00292292987921766,0.00290836958592919,-0.00862333426763888,0.00277747450920356,0.314912356078136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00618211947966503,0.00616828103074881,-0.0182719502999327,0.00590771134060264,0.31624443642902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,0.0035832643538534,0.00357860057147674,-0.00343079276624101,0.0105973214739478,0.316698609927507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.0029070515314375,0.00292082408875835,-0.00863186674540387,0.00281776368252887,0.31961615619609
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00408893633887668,0.00410953512667591,-0.0039657525094081,0.0121436251871615,0.319760606188579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37021,0.00569184403582031,0.00572301565908463,-0.00552526665598557,0.0169089547276262,0.31997186111221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,39866,0.00567500519939505,0.00571016393490237,-0.0055169161130136,0.0168669265118037,0.320314439107582
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37039,0.00324287217596158,0.00327311119091771,-0.00317242575823713,0.00965817011016028,0.32182029869115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,36991,-0.0032494471994005,0.00329328824429071,-0.00970429215821028,0.00320539775940929,0.323813912718947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00536190780797751,0.00545367814053906,-0.0160511169634341,0.00532730134747905,0.325540490508216
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37039,0.00574186861232301,0.00588418156202113,-0.0057911272492384,0.0172748644738844,0.329174399302438
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00513677922084802,0.00527031856618694,-0.0154666036105744,0.00519304516887837,0.329745943731613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.00830042419234913,0.00854403367677363,-0.00844588181412718,0.0250467301988254,0.331320156557503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37411,0.0147969436518578,0.015258297189385,-0.0151093188393369,0.0447032061430524,0.332181569004356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37056,0.00259176396089285,0.00267681054741097,-0.00265478471203264,0.00783831263381834,0.332948065232852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37437,0.00272829052056075,0.00281814826164209,-0.00279528007225775,0.00825186111337926,0.333004376234189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM,Paralemmin-1,37299,0.00265495562522307,0.00275821153502823,-0.00275113898343227,0.00806105023387841,0.335783599297903
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37021,0.00824060836790558,0.0085964610363101,-0.00860845526326222,0.0250896719990734,0.337775508759752
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,-0.00278309977374419,0.00291204820933508,-0.00849071426404095,0.00292451471655257,0.33922891563599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL9,Interleukin-9,37169,-0.00530323178954912,0.00556457574197134,-0.016209800243813,0.00560333666471472,0.340589978132888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.00275293945561487,0.00289459809649738,-0.00292047281351999,0.00842635172474974,0.341590323952177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00176594484307087,0.00185899349075528,-0.00540957208495121,0.00187768239880946,0.342156194621276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00289829901606857,0.00305266400856537,-0.00888152047285669,0.00308492244071955,0.34241475847595
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL25,Interleukin-25,36903,-0.00315119865285562,0.00332645974974693,-0.0096710597623596,0.00336866245664836,0.343496845018252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.00283181257462152,0.00299018962504577,-0.00869258423971124,0.00302895909046819,0.343638420788926
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.004502129943708,0.00480145864015249,-0.00490872899099087,0.0139129888784069,0.348433931421366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37437,0.00274256139451052,0.00293554824506852,-0.00301111316582378,0.00849623595484482,0.350187094075645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWF,von Willebrand factor,40052,0.00658728019396586,0.00705781875816071,-0.00724604457202913,0.0204206049599608,0.350663073002702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.00194191449878977,0.00211416880701289,-0.0022018563629555,0.00608568536053503,0.358361460112722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37039,0.00600357701747125,0.00653828556689276,-0.00681146269363856,0.0188186167285811,0.358521108742266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.00345110330675427,0.00377370248914112,-0.00394535357196232,0.0108475601854709,0.360460662075332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00293927001514048,0.00322791797033722,-0.00338744920672046,0.00926598923700142,0.362531899335496
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.0042768349649346,0.00472194160602331,-0.00497817058287109,0.0135318405127403,0.365091945554516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00517971509812999,0.0057190329773906,-0.0163890197338156,0.00602958953755559,0.365112490270816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTPN,Myotrophin,39585,0.00281153329186341,0.00312649081088132,-0.00331638869746398,0.00893945528119081,0.3685270780233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37021,0.00529958641829022,0.00590666013940397,-0.00627746745494156,0.016876640291522,0.369616790090772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,-0.00218003254901023,0.00243435975035919,-0.00695137765971423,0.00259131256169377,0.370519282160351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.0043774937527674,0.00494541785484356,-0.0140705127482608,0.00531552524272598,0.376085496151722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,39788,0.00248306158109329,0.00280923565236214,-0.0030230402975365,0.00798916345972308,0.376767730073919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17F,Interleukin-17F,39587,0.00658140958908984,0.00748844275034525,-0.00809593820158686,0.0212587573797665,0.37948215911139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00662923959018543,0.00757326258562942,-0.00821435507764823,0.0214728342580191,0.381400584881202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39477,0.00747455884734914,0.00856662636545089,-0.00931602882893461,0.0242651465236329,0.382937794034457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00331872970578698,0.00381525202170876,-0.00415916425676218,0.0107966236683361,0.384393127094634
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00351568401029493,0.00404436858515374,-0.0114426464371963,0.0044112784166064,0.384710447000467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00312973702840174,0.00360119207364713,-0.0101880734927501,0.00392859943594664,0.384817317372944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.00286682735858192,0.00331821780015919,-0.00363687952973009,0.00937053424689394,0.387619361672516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,0.00703230849281351,0.00818616251114557,-0.00901257002903181,0.0230771870146588,0.390327077470074
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00264119076363222,0.00308620960895344,-0.00869016159718096,0.00340778006991653,0.39212171885667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.00356256271514116,0.00416601089221065,-0.011727944063874,0.00460281863359172,0.392483913851647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,0.00326348949252532,0.00382226403959767,-0.00422814802508611,0.0107551270101367,0.393225315858384
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,-0.00760207820072983,0.00891805094111872,-0.0250814580453225,0.00987730164386286,0.393987038558679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37368,-0.00369979290331694,0.00437403234242911,-0.012272896294478,0.00487331048784413,0.397649160490255
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,36991,0.00613813922009819,0.0072936284706353,-0.00815737258234699,0.0204336510225434,0.400040918850029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMCH,Pro-MCH,37021,-0.00675538134318781,0.00803014475040456,-0.0224944650539808,0.00898370236760513,0.400221639851505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00707209994868346,0.00840766648953892,-0.0235511262681797,0.00940692637081283,0.400279600421298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,-0.00371386505326479,0.00444322499217793,-0.0124225860379335,0.00499485593140396,0.403252347933266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,-0.00335156181646756,0.00401076848260339,-0.0112126680423702,0.00450954440943508,0.403371784230789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00385801282112484,0.00465280150579892,-0.00526147813024104,0.0129775037724907,0.407016863244446
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37039,-0.00390990219514892,0.00472578079013564,-0.0131724325438148,0.00535262815351694,0.408050399464592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.00214269054095911,0.00259503811036439,-0.0029435841553551,0.00722896523727331,0.408995890408011
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.00263702327837809,0.00320640457723104,-0.00364752969299474,0.00892157624975093,0.410850209780857
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37021,-0.003204343842142,0.00390081491739523,-0.0108499410802367,0.00444125339595264,0.411402037221699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39477,0.00743357714249594,0.00910377589889287,-0.0104098236193341,0.025276977904326,0.414205068301759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00271132094592147,0.00333137632991768,-0.00924081855256011,0.00381817666071718,0.415729482541823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00260536777231403,0.00321273843330461,-0.00890233510159107,0.00369159955696301,0.417406888611091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,36962,-0.00309584660826649,0.00382760761103173,-0.0105979575258887,0.0044062643093557,0.41863322350723
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,36868,0.00341763284876996,0.00423331311180161,-0.0048796608503612,0.0117149265479011,0.419497652934898
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.00434287970330498,0.00538394811155939,-0.00620965859535143,0.0148954180019614,0.419891495845483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.0044010531313299,0.00546727216853486,-0.00631480031899842,0.0151169065816582,0.420844943711801
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.00414535387072384,0.00515866673948985,-0.00596563293867627,0.014256340680124,0.421659395287111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39489,0.00431962326712829,0.0053857103851263,-0.00623636908771926,0.0148756156219758,0.422534699988214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,36991,0.00748576496660835,0.00934247321154705,-0.0108254825280239,0.0257970124612406,0.422994718754898
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLU,Clusterin,37453,-0.00247137443297619,0.00309102165235784,-0.00852977687159755,0.00358702800564517,0.423995274729859
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37021,-0.00549255924384541,0.00688242885391487,-0.0189821197975186,0.00799700130982774,0.424852763460007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37056,0.00486172170707293,0.00613500489227504,-0.00716288788178614,0.016886331295932,0.428109058047813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00594000508981014,0.00750444742673929,-0.00876871186659887,0.0206487220462192,0.428647867996295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,-0.00215266522401435,0.00271987841661536,-0.00748362692058045,0.00317829647255174,0.428689380301158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,39788,0.00642434928634865,0.00813011245146326,-0.00951067111851935,0.0223593696912166,0.429427449504175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,39701,-0.00480052359877787,0.00608589529815878,-0.0167288783831691,0.00712783118561334,0.430243654497374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37445,0.00195083554763198,0.00249117983432014,-0.00293187692763549,0.00683354802289945,0.433583781855576
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37039,0.0045837080642397,0.0058541230252099,-0.00689037306517171,0.0160577891936511,0.433648229673646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEO1,Neogenin,37411,0.00163404421342003,0.00209821586144067,-0.00247845887500368,0.00574654730184375,0.43612413701141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39477,0.00657304207278484,0.00851835697519309,-0.0101229375985936,0.0232690217441633,0.440343726489783
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.00208361323446998,0.00271033875078984,-0.00322865071707811,0.00739587718601807,0.442044244843945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,-0.00423456216514928,0.00556276681439418,-0.0151375851213619,0.00666846079106331,0.446529127513954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,36962,-0.00490276145452341,0.00644591536388589,-0.0175367555677398,0.00773123265869294,0.446909871238219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH6,Cadherin-6,39868,0.00277769143837636,0.00367392798267299,-0.0044232074076627,0.00997859028441542,0.449627375711037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00345883689878482,0.00459973558224036,-0.00555664484240628,0.0124743186399759,0.452086012381689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,36991,-0.00323305892796119,0.00432712756735512,-0.0117142289599772,0.00524811110405484,0.454980044326846
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.00313739162832774,0.00421049568763568,-0.00511517991943819,0.0113899631760937,0.456202819792649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,39788,0.00203844372486903,0.00273687948348367,-0.00332584006275897,0.00740272751249702,0.456400114426387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37124,-0.00677389561789802,0.00909793377660931,-0.0246058458200523,0.0110580545842562,0.456555065503371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00450525552744475,0.00607104623219625,-0.0164045061425494,0.00739399508765989,0.458046619517143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP4,Caspase-4,37169,0.0118105034179536,0.0160189032617744,-0.0195865469751242,0.0432075538110314,0.460961809403027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37437,-0.00562113361498548,0.00763264500770588,-0.020581117830089,0.00933885060011804,0.461463855128931
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,-0.00225467804658382,0.00306641834399725,-0.00826485800081843,0.00375550190765078,0.462179561290976
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,-0.00664180839641073,0.00904000271638141,-0.0243602137205183,0.0110765969276968,0.462527297630569
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPN3,Calpain-3,37368,0.00264504460152799,0.00364844074356814,-0.00450589925586557,0.00979598845892155,0.468477189085222
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.00474489390920946,0.00658960089238575,-0.00817072383986662,0.0176605116582855,0.471502142185879
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.00261753942327171,0.003642903932899,-0.00975763113175376,0.00452255228521034,0.472442675962684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37388,-0.00257074326792288,0.00358960914877317,-0.0096063771995183,0.00446489066367253,0.473903410647142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00470548676857181,0.00660577878720317,-0.01765281319149,0.00824183965434639,0.476273653568589
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00280853001821978,0.00396166849566837,-0.0105734002697298,0.00495634023329023,0.478382901489912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00321751645435612,0.00454273917176881,-0.00568625232231075,0.012121285231023,0.478784153413208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,-0.00272093018834487,0.00384964885241526,-0.0102662419390788,0.00482438156238904,0.479703549388383
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,0.00279277128683056,0.00395523186711239,-0.00495948317270972,0.0105450257463708,0.480141269993942
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37021,0.0028437687232016,0.00405879872126869,-0.00511147677048503,0.0107990142168882,0.48353825142582
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00479738757607577,0.0068502689751849,-0.00862913961528662,0.0182239147674382,0.483736916301828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.00171657009701003,0.00246256401885594,-0.00311005537994762,0.00654319557396768,0.485771450112801
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.00443025450051783,0.00635759507329331,-0.00803063184313706,0.0168911408441727,0.485912486350601
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00407658757110536,0.0058596062492894,-0.0155614158197126,0.00740824067750186,0.486622677035969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.00210869936960921,0.00303705850227118,-0.0038439352948423,0.00806133403406071,0.487490039997493
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,0.00348502279241504,0.00504200296152768,-0.00639730301217921,0.0133673485970093,0.489453122697667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37021,-0.00319613990157187,0.00462606931302191,-0.0122632357550948,0.00587095595195107,0.489642118103782
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,0.00263114262766325,0.00382091371596049,-0.0048578482556193,0.0101201335109458,0.491075120106789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00268468608700738,0.0039044622998101,-0.0049680600206204,0.0103374321946352,0.491720405110283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.00653563565512235,0.00955588142207443,-0.0121938919321435,0.0252651632423882,0.494023844090901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,36962,-0.00270308466890114,0.00395521768814128,-0.0104553113376581,0.00504914199985577,0.49435200624895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,0.00762582398711631,0.0112244204124091,-0.0143740400212055,0.0296256879954381,0.496899064034308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMP,Olfactory marker protein,36991,-0.00321265625368367,0.00472929795132505,-0.0124820802382808,0.00605676773091343,0.496953855512887
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00358606138496999,0.00530613158038098,-0.0139860792825167,0.00681395651257672,0.499158302127001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37388,-0.00474429279986455,0.00702719590845786,-0.018517596780442,0.00902901118071286,0.499602722557335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,39971,0.00744065080239254,0.0110254785244021,-0.0141692871054356,0.0290505887102207,0.499774609589447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37039,0.00229872537307792,0.00340971099625969,-0.00438430817959108,0.00898175892574692,0.500214969409982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,-0.00121301867726706,0.00180746957342832,-0.00475565904118657,0.00232962168665244,0.502159121481431
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37031,0.00455303680549827,0.00678984648442894,-0.00875506230398244,0.017861135914979,0.502509124169278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.00353198006517558,0.00529412621589018,-0.00684450731796919,0.0139084674483203,0.504685728504193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGR,Progesterone receptor,37056,0.00679668553359348,0.0101978579336311,-0.0131911160163235,0.0267844870835104,0.505114918495766
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0110072119411251,0.0165216171741703,-0.0433895816024989,0.0213751577202486,0.505274888538659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37169,0.00330921640451134,0.00498649378093443,-0.00646431140612015,0.0130827442151428,0.50693485449824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00317486103811237,0.00479343239507134,-0.0125699885324522,0.00622026645622746,0.507765924501416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.00212074118469248,0.0032019349368227,-0.00415505129148,0.00839653366086497,0.507768737033115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37382,0.0162378840923168,0.0246219944145723,-0.0320212249602449,0.0644969931448784,0.509594352193129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,39585,0.00449145380929137,0.00686974649364073,-0.00897324931824446,0.0179561569368272,0.513248955739523
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00305793241349929,0.00475680193692226,-0.0123812642098669,0.00626539938286834,0.520329619782908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,36991,-0.00469749749325092,0.00731076527135288,-0.0190265974251026,0.00963160243860074,0.520530437565224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00569027653164907,0.00886069707615703,-0.0230572428009169,0.0116766897376187,0.520759194440403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,36962,0.0036937612606579,0.00580575188735185,-0.00768551243855172,0.0150730349598675,0.524641257424313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.00569781776959719,0.00898815881839728,-0.0119189735144615,0.0233146090536559,0.526140894754581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,-0.00193980563077079,0.0030711408693398,-0.00795924173467681,0.00407963047313522,0.527641667253702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,-0.00163600664988002,0.00259688785142469,-0.00672590683867241,0.00345389353891237,0.528713444065599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37021,0.00283690368498058,0.0045531874791939,-0.00608734377423946,0.0117611511442006,0.533256656001491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37368,-0.00264486542752179,0.00425064139020981,-0.010976122552333,0.00568639169728943,0.533802871444316
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.0043683731368118,0.00702252485086955,-0.00939577557089252,0.0181325218445161,0.533918709594548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,0.00193278410200757,0.00312113036008224,-0.00418463140375362,0.00805019960776875,0.535757353440771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.00337098908355802,0.00545549849048496,-0.0140637661249085,0.0073217879577925,0.536647556609183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.00330967283338983,0.00537513300651782,-0.0072255878593851,0.0138449335261648,0.538077916543323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,0.00465325584252027,0.00761183062786804,-0.0102659321881011,0.0195724438731416,0.540998929380908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.00586204504083701,0.00960805662501539,-0.0129697459441932,0.0246938360258672,0.54179429109986
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,-0.00235909470383451,0.00387655770652233,-0.00995714780861828,0.00523895840094926,0.542830609088276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.00208129612775617,0.00342933872611838,-0.00464020777543585,0.00880280003094819,0.543919996984678
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00191316936308644,0.0031533566744327,-0.00809374844497453,0.00426740971880165,0.544054645224325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.0027115602303432,0.00448747702396292,-0.00608389473662412,0.0115070151973105,0.545687527225652
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,39868,0.00670737282342383,0.0111268524059459,-0.0151012578922301,0.0285160035390777,0.546643936412067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.00493470598328609,0.00820421610829609,-0.0210149695555464,0.0111455575889742,0.547526364750842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00350238277503322,0.00584042848477632,-0.0149496226051948,0.00794485705512837,0.548730429813234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.00403188311987643,0.00673896200287838,-0.0091764824057652,0.0172402486455181,0.549651891732353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,-0.00492343372945817,0.00829610806473977,-0.0211838055363481,0.0113369380774318,0.552881515334228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,36962,-0.00262058600129783,0.00442817700912417,-0.0112998129391812,0.00605864093658555,0.553996118401822
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00220729300157671,0.00373283371188435,-0.00510906107371662,0.00952364707687003,0.554317029335278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,38832,0.00274466338767715,0.00464296704099316,-0.00635555201266943,0.0118448787880237,0.554432680150487
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00378631443956761,0.00642035624674529,-0.0163702126831884,0.00879758380405316,0.555377883411494
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,39913,-0.00225249846939876,0.00382845481469492,-0.00975626990620081,0.00525127296740329,0.556300921883615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.0032556085360296,0.00558415024481692,-0.00768932594381156,0.0142005430158708,0.559897434033825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00282171470584887,0.00486005539931503,-0.0123474232885063,0.00670399387680859,0.561524698829383
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,0.00222339941806691,0.00385007040905013,-0.00532273858367133,0.00976953741980516,0.563614511219553
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37368,-0.00192452732693611,0.00336142891440064,-0.00851292799916137,0.00466387334528914,0.566970797717237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HK2,Hexokinase-2,39585,0.00150504246135508,0.0026343906594312,-0.00365836323113008,0.00666844815384024,0.567800587617368
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37056,-0.00271665184370308,0.00477550470686866,-0.0120766410691657,0.00664333738175949,0.569452557569858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37169,0.002911116109135,0.00513741446174055,-0.00715821623587649,0.0129804484541465,0.570961525891952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,-0.00176213787567316,0.00311606396167452,-0.00786962324055522,0.0043453474892089,0.571742542666993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00252927739909088,0.0044894137853578,-0.00626997362021041,0.0113285284183922,0.573179204483089
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,-0.00172709102757483,0.0030685820567846,-0.00774151185887265,0.00428732980372299,0.573560017619607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM2,Isthmin-2,37437,-0.00242854804882534,0.00431506665398677,-0.0108860786906394,0.00602898259298873,0.573575869595482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,39868,-0.00184302717278762,0.00328432531368012,-0.00828030478760065,0.00459425044202542,0.574697323835895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39489,0.00187757293898057,0.00337424589350866,-0.0047359490122964,0.00849109489025754,0.577916537294165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37445,-0.00122221420748591,0.00220129976037404,-0.00553676173781903,0.00309233332284721,0.57875067484183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.00210150605945398,0.00380391008926495,-0.00535415771550531,0.00955716983441328,0.580642706558396
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,0.00349643511060477,0.00636594810136486,-0.00898082316807037,0.0159736933892799,0.582849780564728
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,0.00212273826253865,0.00387328065480023,-0.00546889182086979,0.00971436834594709,0.583669227407699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,-0.00472249082919443,0.00866160454486711,-0.021699235737134,0.0122542540787451,0.585608937497446
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37021,-0.00249372408229536,0.00460651543119465,-0.0115224943274369,0.00653504616284616,0.58827747822444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,0.00211941512899203,0.00391924105007428,-0.00556229732915355,0.00980112758713761,0.588673916229297
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,39587,0.00277356789474957,0.00515941700695263,-0.00733888943887757,0.0128860252283767,0.590878862944839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,-0.00188609873562585,0.00354598343474109,-0.00883622626771838,0.00506402879646669,0.594804476616581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRN1,Neuritin,37411,0.00177909813433748,0.00341896882600602,-0.00492208076463431,0.00848027703330928,0.602820468513916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.00226460563850458,0.00435220100244735,-0.00626570832629223,0.0107949196033014,0.602838259568099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,-0.00314495791636476,0.00604941143593926,-0.0150018043308057,0.00871188849807619,0.603157123474924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.00426827404063947,0.00823839930398088,-0.020415536676442,0.0118789885951631,0.604400650845031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,39699,0.00337815336591478,0.00652987108050253,-0.00942039395187017,0.0161767006836997,0.604927143965964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0017271115583729,0.00334661351704379,-0.00483225093503294,0.00828647405177873,0.605807489912662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00306164929059447,0.00593291105074356,-0.0085668563688629,0.0146901549500518,0.605831402391955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37021,0.0016677361428383,0.00325005993497387,-0.00470238132971049,0.00803785361538709,0.607861922428686
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00132336108523418,0.00258014825479039,-0.00638045166462334,0.00373372949415499,0.608029041790033
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,0.00216095503593798,0.00422432028510326,-0.0061187127228644,0.0104406227947404,0.608973926485458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00230282013097133,0.00451458386538801,-0.0111514045071318,0.00654576424518917,0.610000453150283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM1,Myomesin-1,36991,0.00235120185038731,0.00461070355326838,-0.00668577711401872,0.0113881808147933,0.610099077712943
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,-0.00165134255769246,0.00330683779068153,-0.00813274462742826,0.00483005951204335,0.617525356622396
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTTG1,Securin,37169,0.00199166447312305,0.00405522745841637,-0.00595658134537303,0.00993991029161912,0.623339008121726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37056,-0.00121327289388787,0.00253249688520832,-0.00617696678889617,0.00375042100112043,0.63188845178026
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.00273295064955727,0.00571621738482718,-0.0139367367238186,0.00847083542470401,0.63258350844429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37056,0.00220798466531568,0.00468965947407391,-0.00698374790386918,0.0113997172345005,0.63777718634054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH4,Cadherin-4,36991,0.00213761459701461,0.00455324396605497,-0.00678674357645314,0.0110619727704824,0.638741024044315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37411,-0.00238750745189273,0.00509492795290012,-0.012373566239577,0.0075985513357915,0.639359717449805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,39866,-0.00151590947961463,0.00325177269516962,-0.0078893839621471,0.00485756500291783,0.641093429435492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37382,-0.00511261036830601,0.0110441501361172,-0.0267591446350957,0.0165339238984836,0.643425760654867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00237392536811139,0.00512904112503648,-0.00767899523696012,0.0124268459731829,0.643486747867185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,0.00250151509311725,0.00541605459511747,-0.008113951913313,0.0131169820995475,0.644181958082673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00151799041973185,0.0033298234779283,-0.00500846359700761,0.00804444443647131,0.648485763425409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.00200156673068324,0.00440524593475729,-0.0106358487628075,0.00663271530144105,0.649576006507946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00261513251008735,0.00579182394692389,-0.0139671074460582,0.00873684242588347,0.651621271931515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.00170002197346363,0.00377884569236471,-0.00910655953049846,0.00570651558357121,0.652805356988773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.0025606783095877,0.00571337508818219,-0.0137588934824248,0.00863753686324939,0.654023381716875
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.0023973618997527,0.00535311116119365,-0.0128894597756923,0.00809473597618685,0.654272708397858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00192714738235136,0.00430323153927289,-0.00650718643462352,0.0103614811993262,0.654277839086564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.00113287475378932,0.00254445974585753,-0.00612001585567008,0.00385426634809143,0.656159501138031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,36991,0.00275787322873064,0.00623948479126714,-0.00947151696215295,0.0149872634196142,0.658494055266841
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39489,-0.00212662789644276,0.00485850750330862,-0.0116493026029277,0.00739604681004213,0.661600989788882
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM1,Dynamin-1,37382,0.00486948514786221,0.01112691275506,-0.0169392638520555,0.0266782341477799,0.661660577014366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.0019615850049984,0.00449505428572994,-0.00684872139503228,0.0107718914050291,0.662562845208417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37351,0.00205967216891048,0.00488354223211698,-0.00751207060603881,0.0116314149438598,0.673208509745931
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMI,N-myc-interactor,37311,0.00294366953169226,0.00698689378920638,-0.0107506422951522,0.0166379813585368,0.673533234177115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST6,Cystatin-M,39524,0.00189502266778203,0.00452909782368241,-0.00698200906663549,0.0107720544021996,0.67565265304179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00205516370590931,0.0049224383699112,-0.0117031429109353,0.00759281549911664,0.676312747609458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.00200984587570383,0.00481648510764127,-0.0114501566866807,0.00743046493527307,0.676476725673769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00226311969561532,0.00546114538586034,-0.0129669646519016,0.00844072526067095,0.678585136056084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37039,-0.00264021363963721,0.00641378761218054,-0.0152112373595111,0.00993081008023664,0.680605190239748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00296074257113677,0.00730701727756961,-0.0113610112928997,0.0172824964351732,0.685343224727424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAN,Versican core protein,40009,-0.0011406480907349,0.00285527991164489,-0.00673699671755888,0.00445570053608907,0.689539455477683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00207066422200693,0.005285226861962,-0.00828838042743859,0.0124297088714525,0.695223559691509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00192655243227794,0.00492217795690874,-0.0115740212278191,0.00772091636326318,0.695506075616185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.00343840108547916,0.0089470090326904,-0.0209745387895524,0.014097736618594,0.700755786762309
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37411,0.00130960399564195,0.00342073757321086,-0.00539504164785134,0.00801424963913524,0.70184249332306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13,Interleukin-13,39587,0.00179339636691401,0.00471021800432074,-0.00743863092155464,0.0110254236553827,0.703396921507707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00186557893610406,0.00492115586320874,-0.00777988655578507,0.0115110444279932,0.704624465111307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH2,Growth hormone variant,39477,0.00600948972681686,0.0159116211218365,-0.0251772876719826,0.0371962671256163,0.705673988983003
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,-0.00167974567798102,0.00447230784051781,-0.0104454690453959,0.00708597768943389,0.707229024313403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.00151414120156068,0.00403275388826503,-0.00639005641943877,0.00941833882256013,0.707323741191393
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00179314202794477,0.00477994942427115,-0.00757555884362669,0.0111618428995162,0.7075636844685
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.00081759591999424,0.00219176735565542,-0.00347826809709038,0.00511345993707886,0.709130678746378
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,-0.0012528858061442,0.00336771970630813,-0.00785361643050814,0.00534784481821974,0.709876919516832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37056,0.00228364139682921,0.00618979661071463,-0.00984835996017146,0.0144156427538299,0.712181035734564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37043,0.000638656926841306,0.00173230421386092,-0.0027566593323261,0.00403397318600871,0.712376047083895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.00114190511519726,0.00310093387848693,-0.00493592528663713,0.00721973551703165,0.712696052433246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,0.00193409071592895,0.00527428526310343,-0.00840350839975378,0.0122716898316117,0.713847186650143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37021,0.00170475532670765,0.00472489024636789,-0.00755602955617342,0.0109655402095887,0.718252391900248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,-0.0024900188654042,0.0069394989997568,-0.0160914369049275,0.0111113991741191,0.719736817151325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.000972999158808378,0.00272002675822061,-0.00435825328730402,0.00630425160492078,0.720560005514416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,36991,-0.00324939281023594,0.00916649651770379,-0.0212157259849354,0.0147169403644635,0.722980539781366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO1,Alpha-enolase,39830,-0.00268531934648378,0.00762974922679559,-0.0176396278310031,0.0122689891380356,0.724877543339771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,0.00220338685066688,0.00626586409605789,-0.0100777067776066,0.0144844804789403,0.725106851923303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,-0.00142241629458377,0.00404686755371358,-0.00935427669986239,0.00650944411069485,0.72522961010049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00121963374415561,0.00350092707132254,-0.00564218331563656,0.00808145080394778,0.727564356777127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.00136261601808857,0.00393986130461842,-0.00635951213896353,0.00908474417514068,0.729458108404466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,36962,0.00266705748492332,0.00771640464176746,-0.0124570956129409,0.0177912105827875,0.729622786263223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,-0.00121354601559675,0.00353157601770416,-0.00813543501029691,0.00570834297910342,0.73113205496248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,37453,0.00115872192776956,0.00343456627949218,-0.00557302798003512,0.00789047183557423,0.735842700841509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,-0.00090876406688817,0.00269721238597931,-0.00619530034340761,0.00437777220963127,0.736177180420912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,-0.00082386528344875,0.00245285544785842,-0.00563146196125124,0.00398373139435374,0.736966685890064
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,-0.0019008617893023,0.00568117825371856,-0.0130359711665907,0.00923424758798608,0.73794021711584
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.00112638230370887,0.00346051827418609,-0.00565623351369586,0.00790899812111361,0.744811301663842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,36991,-0.00149143248324131,0.00458551315213398,-0.0104790382614239,0.00749617329494128,0.744997987093797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,0.00151879747151273,0.00469678769387088,-0.00768690640847419,0.0107245013514997,0.746420623129846
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,-0.000450695415202879,0.00140410773553329,-0.00320274657684812,0.00230135574644236,0.748227846427223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40052,-0.000724204916671319,0.00226215138080578,-0.00515802162305065,0.00370961178970801,0.74886641104856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.0012292525191212,0.00385139658749983,-0.00877798983062087,0.00631948479237848,0.749602093084491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00198986827706372,0.00637578770254945,-0.0144864121740606,0.0105066756199332,0.754971211366086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,36703,-0.00211333276623534,0.00679743058091509,-0.0154362967048289,0.0112096311723582,0.755880392880225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,-0.00250913386813981,0.00814005130044464,-0.0184636344170113,0.0134453666807317,0.757900386378329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00189291621379583,0.00615394992554832,-0.0139546580678705,0.0101688256402789,0.758396405400593
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.00191776984300212,0.00626385754247595,-0.0103593909402507,0.014194930626255,0.759484354313578
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37056,-0.00158537776564594,0.00527800099654743,-0.0119302597188789,0.00875950418758701,0.76389612034392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,39858,-0.00543333607799294,0.0182631628605598,-0.0412291352846902,0.0303624631287044,0.766086784722458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,36962,0.00152756066278059,0.0051496582457632,-0.00856576949891528,0.0116208908244765,0.766751106145008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTOA,Otoancorin,36991,0.00152432938724764,0.00515419885894014,-0.00857790037627504,0.0116265591507703,0.7674293796736
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37043,0.00202666361435103,0.00689514581185629,-0.0114878221768873,0.0155411494055894,0.768818968022947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39489,-0.00179735960189195,0.00618946427039061,-0.0139287095718575,0.0103339903680736,0.771521613374014
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.00151240976067617,0.00528638777582734,-0.00884891027994542,0.0118737298012978,0.774809763571811
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,0.00137145319282403,0.00485400218091724,-0.00814239108177376,0.0108852974674218,0.777533377233682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,-0.0018678009013834,0.00662069696806409,-0.014844366958789,0.0111087651560222,0.777859417092414
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000981239713437823,0.0034797527975645,-0.00780155519666424,0.0058390757697886,0.777959082633873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00124155943863806,0.00443589504124743,-0.00745279484220691,0.00993591371948303,0.7795668442371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,36962,-0.00135390820014251,0.00485727956842133,-0.0108741761542483,0.0081663597539633,0.780450327416146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,36962,0.00192631095483015,0.00701177102584716,-0.0118167602558303,0.0156693821654906,0.783531617629065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,39695,-0.000699400576765071,0.00254672839081293,-0.00569098822275841,0.00429218706922827,0.78360634323118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00219587200457762,0.00804662856305375,-0.0135755199790077,0.017967263988163,0.784939434476441
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.00165141183222473,0.00608972519151409,-0.0135872732075923,0.0102844495431429,0.786256820867032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00202228263947659,0.00746710467240487,-0.0166578077973901,0.012613242518437,0.786529474011714
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00220027558035672,0.00841033786563093,-0.0142839866362799,0.0186845377969933,0.793621928699416
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00216960827804094,0.00832156928387288,-0.0184798840744318,0.0141406675183499,0.794311665828032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,36962,-0.00151885224878098,0.00591428391983529,-0.0131108487316582,0.0100731442340962,0.797328830423072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.00131609144385999,0.00512573733079692,-0.011362536612222,0.00873035372450198,0.797366999734519
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.00125014268542622,0.00506238498546541,-0.00867213188608598,0.0111724172569384,0.804952194712959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.000932564384360298,0.00384795845579016,-0.00847456295770901,0.00660943418898841,0.808510403884043
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40009,-0.0006565821772254,0.00271751029983561,-0.0059829023649032,0.0046697380104524,0.809084153314095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00128026887746039,0.0053436686408806,-0.00919332165866558,0.0117538594135864,0.810654187905091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC1,Hamartin,37056,-0.00175809957494127,0.00741980381095709,-0.0163009150444172,0.0127847158945346,0.812701656281173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00168156627646571,0.00713125426455065,-0.015658824634985,0.0122956920820536,0.813589747888094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,-0.00130164748037095,0.00555472211908645,-0.0121889028337804,0.00958560787303848,0.814731028903374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37169,0.00197794755033256,0.00851795397011502,-0.0147172422310929,0.018673137331758,0.816379077889374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.00414991665376324,0.0180497565708089,-0.0395274395325486,0.0312276062250221,0.818160474375148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37437,-0.000507131714323334,0.00221948715142666,-0.00485732653111959,0.00384306310247292,0.819268387003195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.000702982057614506,0.00315270243753224,-0.00547631471994869,0.0068822788351777,0.823556386324185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00160069864746372,0.00721004944205062,-0.0125309982589555,0.0157323955538829,0.824309983303965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,39587,-0.000988205629444479,0.00458551122541379,-0.0099758076312555,0.00799939637236654,0.829375553202226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.000578701614516564,0.00280083180073792,-0.00491092871492976,0.00606833194396289,0.836311149783542
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00101027055143027,0.00492249879664836,-0.010658368192861,0.00863782709000051,0.837391459607767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37056,0.00118005238894947,0.00577161016529687,-0.0101323035350324,0.0124924083129313,0.837998692901503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.00123004225783449,0.00616899951571837,-0.0133212813086425,0.0108611967929735,0.841960086130767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37039,0.000890930425258899,0.00448437251249465,-0.00789843969923062,0.00968030054974842,0.842520444278027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37368,0.00113908824930517,0.00576780472982257,-0.0101658090211471,0.0124439855197574,0.843446468149192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.000552295189580889,0.00286243718177936,-0.00505808168670667,0.00616267206586844,0.84700440045267
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.00142526246423942,0.00745491854420952,-0.0131863778824112,0.0160369028108901,0.848384216452145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.000590559715083633,0.00319000206535783,-0.00684296376318499,0.00566184433301772,0.853130758578047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37056,-0.000530629245572331,0.00287340035697523,-0.00616249394524378,0.00510123545409912,0.853491152113587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37056,0.000831731545203925,0.00454970030840958,-0.00808568105927886,0.00974914414968671,0.85494976688066
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,-0.000781222632438417,0.00430024344983488,-0.00920969979411479,0.00764725452923795,0.855844982027352
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00125982639880109,0.00703064322549393,-0.012520234323167,0.0150398871207692,0.857790635759436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.000725452235238309,0.00406706133421189,-0.00724598797981699,0.00869689245029361,0.858433121301903
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000706794880278024,0.00397116538925778,-0.00849027904322327,0.00707668928266723,0.858740060633802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,39585,0.000907900402514161,0.00517700623226607,-0.00923903181272734,0.0110548326177557,0.860789831253359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPGN,Epigen,37368,0.00081849117746831,0.00483660424769601,-0.00866125314801587,0.0102982355029525,0.865619464282354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRAS,GTPase Hras,37161,-0.00156962974047439,0.00949630775554162,-0.020182392941336,0.0170431334603872,0.868719481927547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00121898668871991,0.00738994416711619,-0.0132653038788278,0.0157032772562676,0.868984236124673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,-0.000648009023322843,0.00401054293185784,-0.00850867316976421,0.00721265512311852,0.871641932115047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDSN,Corneodesmosin,39992,-0.000652537137134226,0.00408718255804876,-0.00866341495090979,0.00735834067664134,0.873155234030923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00117083650326986,0.00747265961740192,-0.0134755763468379,0.0158172493533776,0.875497320173639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37039,-0.000342079425759575,0.00219789354915752,-0.00464995078210832,0.00396579193058917,0.876319437833225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37368,-0.00119395583030241,0.00781021210115289,-0.0165019715485621,0.0141140598879573,0.878502198552356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,-0.000579598255537437,0.00392487741324325,-0.0082723579854942,0.00711316147441932,0.882602743554547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37437,0.00123108829943142,0.00838802359283291,-0.0152094379425211,0.0176716145413839,0.883317806896779
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.000554411256457147,0.003974975843641,-0.00723654139707921,0.0083453639099935,0.889076594056966
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.000570139675135,0.00419592142442882,-0.0087941456670155,0.00765386631674549,0.891918570116706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00045937658358723,0.0034201184033474,-0.00624405548697368,0.00716280865414814,0.893154761948367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.00189625772159896,0.0141384444463252,-0.0296076088363963,0.0258150933931984,0.893309146590962
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.000458253873572449,0.00343865831630526,-0.00628151642638586,0.00719802417353076,0.893985591908403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000421680990293958,0.00325165889222609,-0.00595157043846917,0.00679493241905709,0.896820104247882
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.000775915668738006,0.00654481431100695,-0.0120519203808356,0.0136037517183116,0.905630308028934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRELP,Prolargin,39862,0.000248783933467297,0.0021419650944564,-0.00394946765166725,0.00444703551860185,0.907537085666983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37056,-0.000715699904990251,0.00660167447332681,-0.0136549818727108,0.0122235820627303,0.913670630391464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,-0.000366338230848301,0.00346380704395747,-0.00715540003700494,0.00642272357530834,0.915772749056734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000487959085549814,0.00475794940074725,-0.0088376217399148,0.00981353991101443,0.918316456456027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.000612729956510448,0.00608836486377494,-0.0125459250895093,0.0113204651764884,0.919838180985497
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,0.000399681862805444,0.00413570407098934,-0.00770629811633367,0.00850566184194456,0.923012342760773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,-0.00043612891993237,0.00460321755426196,-0.00945843532628581,0.00858617748642107,0.924519330066767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2,Prothrombin,37453,0.000132819043865341,0.00142506522502703,-0.00266030879718765,0.00292594688491833,0.925744395148425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.000817708999300141,0.00883303221668251,-0.0164950341453976,0.0181304521439979,0.926243416571514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,36991,0.000685304113329623,0.00752906219214292,-0.0140716577832705,0.0154422660099297,0.927477151307792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTR,Methionine synthase,37021,0.000557186846964395,0.00624036528644781,-0.0116739291144733,0.0127883028084021,0.928854757082077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.000433528453001015,0.00485952003501358,-0.0090911308156256,0.00995818772162763,0.928914630612078
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.000344031991910211,0.00404056534693538,-0.00757547608808314,0.00826354007190356,0.932147798888949
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.000516064363924614,0.00617616509737186,-0.0115892192269242,0.0126213479547735,0.933409606283888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,39587,-0.000525946655048973,0.00630456899390131,-0.0128829018830955,0.0118310085729976,0.933516187486511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.000262834733173932,0.00317205446032755,-0.00648006147541593,0.00595439200906807,0.933964546108977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.000831924101861533,0.0102326001081334,-0.0192239721100799,0.0208878203138029,0.93520350662981
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.000317171499560636,0.00394592585234399,-0.00741684317103358,0.00805118617015485,0.93593644576987
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39477,0.000975218792955609,0.0133349597810491,-0.0251613023779006,0.0271117399638119,0.941701625356527
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.000344606944502591,0.00480492208739652,-0.0090730403467946,0.00976225423579978,0.942826138288181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37100,0.000375912961750703,0.00551767205280389,-0.0104387242617449,0.0111905501852463,0.945684048765933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,0.000317620566740526,0.00473033861241505,-0.00895384311359298,0.00958908424707403,0.946466961100003
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.000271140318486093,0.00415809837995612,-0.0078787325062279,0.00842101314320008,0.948009564594299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.000385854450329699,0.00609621112463351,-0.011562719353952,0.0123344282546114,0.949533244116654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,36991,0.000377017652364693,0.00624854116239444,-0.0118701230259284,0.0126241583306578,0.951888225483945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.000285456144853714,0.00499615850588072,-0.00950701452667249,0.0100779268163799,0.954438423109282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.000336435758349777,0.00614421359917064,-0.0117062228960247,0.0123790944127242,0.956333261851149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,36962,0.000279417340611005,0.00527556407661026,-0.0100606882495451,0.0106195229307671,0.95776104158598
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.000280743942588091,0.00550423741883348,-0.0110690492835017,0.0105075613983255,0.959322244035395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,-0.000169849188420408,0.00346454194434664,-0.00696035139933982,0.00662065302249901,0.960900090771881
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.00034763558342918,0.00753889420619814,-0.0151238682275775,0.0144285970607192,0.963221458871711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37039,-0.000212212920388279,0.00468481602976951,-0.00939445233873652,0.00897002649795996,0.963870446802709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.000121132531588705,0.00287420310035657,-0.00551230554511017,0.00575457060828758,0.966383959657203
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG3,Desmoglein-3,39964,0.000128538954017186,0.00322020213961019,-0.00618305723961878,0.00644013514765315,0.968160251879976
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39456,-0.000207451314594655,0.00599346544746595,-0.0119546435916279,0.0115397409624386,0.972388845347981
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-9.59251716469766e-05,0.00532127695434939,-0.0105256280021718,0.0103337776588778,0.985617810985883
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,8.16092875918059e-05,0.00581528399072892,-0.0113163473342369,0.0114795659094205,0.988803398125495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-4.0127241930518e-05,0.00288653379219399,-0.00569773347463074,0.0056174789907697,0.988908749629774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37056,-4.06054857693842e-05,0.0029885562444552,-0.00589817572490158,0.00581696475336281,0.989159688864897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,36962,-9.60124107715023e-05,0.00894163379218004,-0.0176216146434444,0.0174295898219014,0.991432898271499
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,8.48800868301319e-05,0.0113338446214154,-0.022129455371144,0.0222992155448043,0.994024747067417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-3.96279112515534e-05,0.00561274032770861,-0.0110405989535604,0.0109613431310573,0.994366809786333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD109,CD109 antigen,39858,-2.03483243110377e-05,0.00325865049431492,-0.00640730329316828,0.00636660664454621,0.995017798132254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,-3.43910909120244e-05,0.00569364763584608,-0.0111939404571703,0.0111251582753463,0.995180693468869
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,-2.7797557362551e-05,0.00567210548717621,-0.0111451243122279,0.0110895291975028,0.996089858255484
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,36962,-4.72935147995317e-05,0.0112067194241719,-0.0220124635861764,0.0219178765565773,0.996632918891496
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-3.20585126897167e-06,0.00450996567938896,-0.00884273858287133,0.00883632688033339,0.999432844837635
